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Abstract 
The increasing use of electronic platforms in healthcare has resulted in the generation of 
unprecedented amounts of data in recent years. The amount of data available to clinical 
researchers, physicians, and healthcare administrators continues to grow, which creates an 
untapped resource with the ability to improve the healthcare system drastically. Despite the 
enthusiasm for adopting electronic health records (EHRs), some recent studies have shown 
that EHR-based systems hardly improve the ability of healthcare providers to make better 
decisions. One reason for this inefficacy is that these systems do not allow for human-data 
interaction in a manner that fits and supports the needs of healthcare providers. Another 
reason is the information overload, which makes healthcare providers often misunderstand, 
misinterpret, ignore, or overlook vital data. The emergence of a type of computational system 
known as visual analytics (VA), has the potential to reduce the complexity of EHR data by 
combining advanced analytics techniques with interactive visualizations to analyze, 
synthesize, and facilitate high-level activities while allowing users to get more involved in a 
discourse with the data. The purpose of this research is to demonstrate the use of 
sophisticated visual analytics systems to solve various EHR-related research problems. This 
dissertation includes a framework by which we identify gaps in existing EHR-based systems 
and conceptualize the data-driven activities and tasks of our proposed systems. Two novel 
VA systems (VISA_M3R3 and VALENCIA) and two studies are designed to bridge the 
gaps. VISA_M3R3 incorporates multiple regression, frequent itemset mining, and interactive 
visualization to assist users in the identification of nephrotoxic medications. Another 
proposed system, VALENCIA, brings a wide range of dimension reduction and cluster 
analysis techniques to analyze high-dimensional EHRs, integrate them seamlessly, and make 
them accessible through interactive visualizations. The studies are conducted to develop 
prediction models to classify patients who are at risk of developing acute kidney injury (AKI) 
and identify AKI-associated medication and medication combinations using EHRs. Through 
healthcare administrative datasets stored at the ICES-KDT (Kidney Dialysis and 
Transplantation program), London, Ontario, we have demonstrated how our proposed 
systems and prediction models can be used to solve real-world problems. 
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Summary for Lay Audience 
Advances in healthcare technology have resulted in the generation of large amounts of 
electronic data in the form of electronic health records (EHRs). Adoption of EHR makes it 
easy to organize, access, and store medical records through computerized data management 
tools. Despite the potential benefits, healthcare professionals continue to report difficulty in 
adopting EHR-based systems. One of the main reasons for this problem is the complicated 
and improperly designed user interfaces in these systems, which often makes healthcare 
providers overlook vital information. The purpose of this research is to prove the use of 
visual analytics (VA) to solve various EHR-related problems. VA combines automated 
analysis with interactive visualizations for effective reasoning, understanding and decision 
making based on complex data. Through a literature survey and proposed framework, we 
first analyze the existing EHR-based systems and understand why they fail to fulfill the 
computational demand of EHRs. Two novel VA systems (VISA_M3R3 and VALENCIA) 
and two studies are designed to demonstrate how the VA approach can be used to overcome 
the challenges of EHRs. VISA_M3R3 is designed to assist healthcare providers in the 
identification of medications that may associate with a higher risk of developing acute kidney 
injury (AKI). VALENCIA provides users with the ability to explore high-dimensional EHRs 
using a number of dimension reduction and cluster analysis algorithms. The studies are 
conducted to identify AKI-associated medication and medication combinations and predict 
the risk of developing AKI using EHRs. Through healthcare administrative datasets stored at 
the ICES-KDT (Kidney Dialysis and Transplantation program), we have shown how our 
proposed approach can be used to solve real-world problems. 
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Chapter 1  
1 Introduction 
1.1 Motivation 
The increasing use of electronic platforms in healthcare has produced unprecedented 
amounts of data in recent years. In the healthcare industry, as a part of modernizing their 
operations, the medical organizations are adopting electronic health records (EHRs) and 
deploying new information technology systems that generate, collect, digitize, and 
analyze their data (Caban and Gotz, 2015). This data includes, but is not limited to, 
medical and demographic records of patients, hospital and emergency room records, and 
results of laboratory tests. The amount of information available to clinical researchers, 
physicians, healthcare administrators, and policymakers continues to grow, which creates 
an untapped resource with the ability to drastically improve the healthcare system 
(Kamal, 2014; Murdoch and Detsky, 2013). While initially created for archiving patient 
records and supporting healthcare administrative tasks such as billing, many researchers 
have observed the secondary use of EHRs for clinical research purposes (Shickel et al., 
2018). Healthcare providers use modern systems to diagnose patients (Graber et al., 
2017), detect hidden patterns and trends, study the effects of medications (Feng et al., 
2019), determine the effectiveness of treatments (Cowie et al., 2017), monitor patient 
improvement (Doupi, 2012), reduce medical errors (Agrawal, 2009), and ultimately 
improve quality of care (Ali et al., 2007; Christensen and Grimsmo, 2008; Tang and 
McDonald, 2006). Despite the growing interest in adopting EHRs, some studies have 
shown that EHR-based systems hardly improve the ability of healthcare providers to 
make better decisions (Heisey-Grove et al., 2014; Lau et al., 2012). One of the main 
reasons for this inefficacy is that these systems do not allow for human-data interaction in 
a manner that supports and fits the needs of healthcare providers  (Himmelstein et al., 
2010; Rind, 2013). Another reason is the information overload that arises when the 
number of data items exceeds the limit of human cognition (Halford et al., 2005). The 
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users often misunderstand, misinterpret, ignore, or overlook vital data because of 
information overload. In the healthcare domain, information overload often leads to an 
incorrect diagnosis, wrong interpretation of patient conditions, and erroneous treatment 
decisions (Caban and Gotz, 2015). For example, in a survey about the efficacy of 
electronic health records (EHRs) in the U.S., of over 500 primary-care physicians, only 
66% of physicians were somewhat satisfied with existing EHR systems. Many physicians 
still continue to report problems. About 40% of physicians thought that there are more 
challenges with existing EHR-based systems than benefits. These physicians suggested 
that these systems’ user interfaces were not designed well. They found this more 
important than the incorporation of analytics capabilities that support diagnosis, 
management, and prevention. Of those surveyed, 72% wanted improved user interfaces in 
these systems; whereas 43% believed that predictive analytics would improve the 
efficacy of EHR-based systems (EHRIntelligence, 2018). Thus, it seems that there is a 
growing demand for computational systems that integrates automated analysis techniques 
with user interfaces that facilitate interaction with visualizations of data (i.e., interactive 
visualizations). 
Interactive visualizations can be defined as computational systems that store and process 
data and use visual representations to amplify human cognition (Proctor and Vu, 2012; 
Sedig and Parsons, 2016). They have the potential to boost the utilization of data in 
healthcare by providing a means to access the EHR data at various levels of granularity 
and abstraction. Interactive visualizations enable users to explore the underlying data, 
modify the representation, and change different visual elements to achieve their goals. 
For the last two decades, several EHR-based visualization systems have been developed 
to support healthcare providers to perform various data-driven activities (Rind et al., 
2013). However, there are some gaps in support for certain types of higher-level activities 
and tasks supported by these systems for a number of reasons. Firstly, some of the 
visualizations are not capable of dealing with fast-paced data generated by different 
healthcare organizations (Cybulski et al., 2015; Zhang et al., 2012). Secondly, some 
improperly designed visualizations encode too much information at once, which often 
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overwhelm the cognitive abilities of users and limit users’ ability to make time-sensitive 
decisions (Pike et al., 2009; Tominski, 2015). Finally, most of these systems can only 
represent a limited number of attributes and relationships within the data (Aimone et al., 
2013; Faisal et al., 2013; Kosara and Miksch, 2002; Lavado et al., 2018). When working 
with high dimensional healthcare data, it is important to analyze hidden, non-explicit, and 
unknown relationships among the attributes. Thus, even the complex visualization 
systems are often inadequate to fulfill the computational demand of EHRs because they 
do not incorporate analytical processes, which is essential for recognizing hidden patterns 
and trends. 
Data analytics is the process of investigating raw data to gain both deeper and novel 
insights on associations within the data (Koh and Tan, 2005). Data analytics includes 
algorithms, techniques, and methods from different fields, such as statistics, machine 
learning, and data mining, to assist users in informed decision-making (Han and Kamber, 
2011). There are several systems developed in recent years that employ different 
analytics techniques to predict patient outcomes, enable disease diagnosis and prognosis, 
make treatment-related decisions, and discover relationships between risk factors (Yoo et 
al., 2012). Although these systems are designed to analyze large amounts of data, they 
often fail to build trust with healthcare providers. One of the main reasons lies in their 
lack of transparency and interpretability. The intermediary steps, adjustment of the 
configuration parameters, and theoretical assumptions are kept hidden from end-users, 
which limits their application in healthcare settings (Yoo et al., 2012). In addition, most 
of the analytics systems are not capable of efficiently managing ill-defined problems 
because they do not consider human judgment in the decision-making process (Ola and 
Sedig, 2014). In order to address these issues, analytical processes need to be made 
accessible through visualizations.  
Despite the advantages, both interactive visualization systems, with compelling 
interaction and representation techniques and data analytics systems, with their powerful 
computational capabilities, fall short in fulfilling the computational and cognitive 
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demands of EHRs. Thus, it seems that a combined approach may be needed—that is, 
combining analytical processes with interactive visualizations. Visual analytics (VA) has 
the potential to address the needs of EHRs by combining the strengths and alleviate the 
limitations of both types of systems mentioned above (Ola and Sedig, 2014). VA 
manages the complexity of EHRs and supports visuo-analytical reasoning in such a way 
that the initially overwhelming scale of data becomes a treasured asset (Kamal, 2014). It 
enables users to analyze, synthesize, and facilitate high-level cognitive activities while at 
the same time get more involved in the discourse with the data (D. Keim et al., 2010a; 
Thomas and Cook, 2006). Although the VA approach conceivably supports different 
EHR-driven activities (e.g., exploration of patient history and identification of patients at 
risk), to date, healthcare falls behind other sectors in the development of VA systems. 
The design of such systems is not straightforward, which requires designers to take into 
consideration users’ activities and tasks, human factors, and the structure of the data. A 
number of complicated decisions need to be made by the designers. For instance, when 
choosing an analysis technique, it is important to consider which algorithm to use, which 
samples and features to incorporate, and what granularity to seek for a specific task. 
Similarly, when developing visualizations, one needs to determine how to encode and 
organize data elements and how to support users’ tasks. Consequently, integrating 
analysis techniques with visualizations results in a more complicated challenge. Thus, 
there is a lack of direction and confusion over how to design effective VA systems for 
EHRs (Carroll et al., 2014; Folorunso and Shawn Ogunseye, 2008; Turner et al., 2008).    
The goal of this dissertation is to demonstrate how VA systems can be designed for 
EHRs. To begin with, we conducted a systematic literature survey to examine the design 
of existing EHR-based systems. Since there were not too many VA systems that are 
designed for EHRs, we included the EHR-based interactive visualization systems as well 
in the survey. We then presented a framework to analyze and evaluate EHR-data-driven 
tasks and activities of these systems. The framework helped us to identify gaps in the 
existing systems and conceptualize the data-driven activities and tasks of EHR-based VA 
systems. In light of this, we designed and developed two novel VA systems 
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(VISA_M3R3 and VALENCIA) and conducted two independent studies. The systems 
and studies in this dissertation were mainly focused on acute kidney injury (AKI) because 
they were designed to assist the clinicians, epidemiologists, and analysts at the ICES-
KDT program. ICES is an independent, non-profit, world-leading research organization 
that uses population-based health and social data to produce knowledge on a broad range 
of healthcare issues. KDT refers to the Kidney Dialysis and Transplantation 
program located in London, Ontario, Canada. We demonstrated the usefulness of these 
systems by investigating the process of analyzing the health administrative datasets 
housed at ICES to gain novel insights into the data and fulfill the tasks at hand. The 
tasks included, but are not limited to, predicting AKI, identifying AKI-associated 
medication, examining the synergistic effects of AKI-associated medication 
combinations, and identifying risk-factors for AKI.  
One of the main contributions of this dissertation is the conceptualization and design of 
human- and activity-centered computational systems for healthcare. There are several 
challenges that designers might face when developing a computational system for 
healthcare providers. These challenges include, but are not limited to, providing busy 
physicians timely information in the precise format, visualizing comparative-
effectiveness and casual relationships, facilitating data-driven decision-making, and 
characterizing and understanding similarity among information items. This dissertation 
describes how these challenges can be addressed using a combination of statistical 
methods, data mining algorithms, machine learning techniques, and information 
visualization. This dissertation also demonstrates how VA systems can be designed in a 
systematic way. It describes different components of VA in a structured manner and 
explains the design decisions that need to be made while developing a VA system. This 
dissertation then illustrates how different design choices can lead to the development of 
an optimized VA system for healthcare. Finally, this dissertation demonstrates how 
healthcare providers' abilities to interact with data mining and machine learning processes 
can be improved by using well-designed VA systems. Through the development of two 
novel VA systems, this dissertation offers the healthcare domain with evidence of the 
6 
 
 
 
efficacy of VA for analyzing EHRs.  This research has implications for other domains 
that require their data to be made accessible and analyzable through VA. 
1.2 Structure of this dissertation 
The rest of this dissertation is divided into six chapters, as follows:  
In Chapter 2, we present a framework to identify and analyze EHR-data-driven tasks and 
activities in the context of interactive visualization systems—that is, all the activities, 
sub-activities, tasks, and sub-tasks that are and can be supported by EHR-based systems. 
We conducted a systematic literature survey to analyze the researches that describe the 
design, implementation, and/or evaluation of these systems. The survey includes an 
overview of their goals, a short description of their visualizations, and an analysis of how 
sub-activities, tasks, and sub-tasks combine and blend to accomplish their higher-level 
activities. Our proposed framework reveals gaps in support of some higher-level 
activities supported by these systems. This chapter provides background for the 
dissertation. 
In Chapter 3, we describe how VA systems can be designed to utilize the prescription 
data stored in EHRs. To achieve this, we propose and describe VISA_M3R3, a novel VA 
system designed to assist healthcare providers in identifying medications and medication 
combinations that associate with a higher risk of AKI. By integrating multiple logistic 
regression models, data visualization, frequent itemset mining, and human-data 
interaction mechanisms, VISA_M3R3 allows users to explore complex relationships 
between medications, medication combinations, and AKI in such a way that would be 
difficult without the aid of a VA system. 
In Chapter 4, we present a population-based retrospective cohort study to test the 
hypotheses generated from the VISA_M3R3 and understand the synergistic effect of 
AKI-inducing medication combinations. By integrating multivariable logistic regression, 
frequent itemset mining, and stratified analysis, this study is designed to explore complex 
relationships between medications and AKI. We demonstrate that our results are 
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consistent with previous studies through an electronic literature search and a consultation 
with a nephrologist in this chapter.  
In Chapter 5, we present another novel VA system, called VALENCIA, to address the 
challenges of high-dimensional EHRs in a systematic way. VALENCIA brings together a 
wide range of cluster analysis and dimension reduction techniques, integrate them 
seamlessly, and make them accessible to users through interactive visualizations. It offers 
a balanced distribution of processing load between users and the system to facilitate the 
performance of high-level cognitive activities. Through a case study, we demonstrate 
how VALENCIA can be used to analyze the healthcare administrative dataset stored at 
ICES. During the cluster analysis of ICES datasets using VALENCIA, we identify 
several risk factors that may associate with AKI by investigating the characteristics of 
clusters where AKI is common. This motivated us to conduct a separate study on 
predicting AKI, which is described in chapter 6. 
In Chapter 6, we employ a number of machine learning techniques to identify older 
patients who are at risk of developing AKI within 90 days after they are discharged from 
the hospital or emergency department. The records of one million patients are included in 
this study who visited the hospital or emergency department in Southwestern Ontario 
between 2014 and 2016. We developed sixteen prediction models based on combinations 
of four machine learning techniques and four ensemble-based methods along with a cost-
sensitive logistic regression model. These models are evaluated through 10-fold cross-
validation and compared based on the AUROC metric. We also validate features that are 
most relevant in predicting AKI with a healthcare expert through a participatory design 
process to improve the performance and reliability of the models.  
In Chapter 7, we outline the conclusions drawn from the research presented in the 
preceding chapters, explain the contributions of this work to the broader scientific 
community, and discuss some areas of future research.   
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It is important to note that the chapters of this dissertation are self-sufficient and can be 
read individually or sequentially. Chapters 2,3, 4, and 5 have been published; Chapters 6 
has been accepted for publication. This dissertation is written in an integrated article 
format, so Chapters 2 through 6 are self-contained. 
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Chapter 2  
2 Data-Driven Activities Involving Electronic Health 
Records: An Activity and Task Analysis Framework for 
Interactive Visualization Tools 
This chapter has been published as N. Rostamzadeh, S.S. Abdullah, and K. Sedig, “Data-
Driven Activities Involving Electronic Health Records: An Activity and Task Analysis 
Framework for Interactive Visualization Tools” in the Multimodal Technologies Interact. 
Journal, 4(1), 7; February 2020. We changed the format to match the general format of 
the dissertation. Figure, Table and Section numbers specified herein are relative to the 
chapter number. For example, “Table 1” corresponds to Table 2-1; “Figure 1” 
corresponds to Figure 2-1; and “Section 1.1” corresponds to Section 2.1.1. Moreover, 
when the term “paper”, “research”, or "work" is used, it refers to this specific chapter. 
2.1 Introduction 
An electronic health record (EHR) contains patient data, such as demographics, 
prescriptions, medical history, diagnosis, surgical notes, and discharge summaries. 
Healthcare providers use EHRs to make critical decisions, study the effects of treatments, 
determine the effectiveness of treatments, and monitor patient improvement after a 
particular treatment. In addition to these benefits, EHRs can potentially aid clinical 
researchers in detecting hidden trends and missing events, revealing unexpected 
sequences, reducing the incidence of medical errors, and establishing quality control 
(Christensen and Grimsmo, 2008; Tang and McDonald, 2006). Recently, several 
healthcare organizations have used systems that incorporate EHR data to improve the 
quality of care; these systems are intended to replace traditional paper-based medical 
records (Boonstra et al., 2014). However, a few studies reveal that these EHR-based 
systems hardly improve the quality of care. One of the reasons for this is that they do not 
allow for human–data interaction in a manner that fits and supports the needs of 
healthcare providers (Himmelstein et al., 2010; Rind et al., 2013). A set of technologies 
and techniques that can improve the efficacy and utility of these EHR-based systems can 
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be found in information visualization (Rind et al., 2013), or broadly speaking interactive 
visualization tools (IVTs). 
IVTs can be defined as computational technologies that use visual representations (i.e., 
visualizations) to amplify human cognition when working with data (Sears and Jacko, 
2007; Sedig and Parsons, 2016). IVTs can help people who use them gain better insight 
by providing the means to explore the data at various levels of granularity and 
abstraction. An important feature of IVTs that makes them suitable for the exploration of 
EHRs is the ability to show relevant data quickly by mapping it to visualizations (Rind et 
al., 2013). Another feature is interaction. Making the visualization interactive allows 
healthcare providers to perform various data-driven tasks and activities. Interaction helps 
users accomplish their overall goals by dynamically changing the mapping, view, and 
scope of EHR data. In recent years, a number of EHR-based IVTs have been developed 
and deployed to support healthcare providers in performing data-driven activities. 
To provide a clear and systematic approach in examining EHR-based IVTs for clinical 
decision support, this paper provides a framework for analyzing tasks and activities 
supported by these tools. To do so, we will first provide a brief survey of some of the 
existing IVTs that support the exploration and querying of EHR data and examine overall 
patterns in these tools. This survey does not include EHR-based IVTs that are designed 
for clinical documentation, administration, and billing processes. 
There are a few studies that review EHR-based IVTs and their applications. Rind et al. 
(Rind et al., 2013) reviewed and compared state-of-the-art information visualization tools 
that involve EHR data using four criteria: (1) data types that they cover, (2) support for 
multiple variables, (3) support for one versus multiple patient records, and (4) support for 
user intents. Lesselroth and Pieczkiewicz (Lesselroth and Pieczkiewicz, 2011) surveyed 
different visualization techniques for EHRs. They cover a large number of visualization 
tools (e.g., Lifelines, MIVA, WBIVS, and VISITORS). Their survey is organized into 
five sections: (1) multimedia, (2) smart dashboards to improve situational awareness, (3) 
longitudinal and problem-oriented views to tell clinical narratives, (4) iconography and 
11 
 
 
 
context links to support just-in-time information, and (5) probability analysis and 
decision heuristics to support decision analysis and bias identification. Combi et al. 
(Combi et al., 2010) reviewed a few visualization tools (e.g., IPBC, KHOSPAD, KNAVE 
II, Paint Strips, and VISITORS) and described them based on the following features: 
subject cardinality (single/multiple patients), concept cardinality (single/multiple 
variables), abstraction level (raw data, abstract concepts, knowledge), and temporal 
granularity (single, single but variable, multiple). Finally, in a book chapter, Aigner et al. 
(Aigner et al., 2008) described strategies to visualize (1) clinical guidelines seen as plans 
(e.g., GEM Cutter, DELT/A), (2) patients’ data seen as multidimensional information 
space (e.g., Midgaard, VIE-VISU, Gravi++), and (3) patients’ data related to clinical 
guidelines (e.g., Tallis Tester, CareVis). 
A careful examination of the above surveys shows that a systematic analysis of IVTs with 
a focus on how they support EHR-data-driven tasks and activities is lacking. The purpose 
of the current paper is to fill this gap. Here, we present a framework for analyzing how 
IVTs can support different EHR-based tasks and activities. The framework can help 
designers and researchers to conceptualize the functionalities of EHR-based IVTs in an 
organized manner. In addition, this paper is suggestive of how this framework can be 
used to evaluate existing EHR-based IVTs and design new ones systematically. This 
paper also leads to the development of best practices for designing similar frameworks in 
similar areas. 
The rest of this paper is organized as follows. Section 2 discusses how the proposed 
framework is formed and examines the relationships among the three concepts of 
activities, tasks, and low-level interactions in the context of the framework. Section 3 
presents our strategy for searching relevant literature and explains our selection criteria. 
Section 4 provides a brief survey of a set of IVTs and outlines their main goal(s). In this 
section, using the proposed analytical framework, we identify the tasks and activities that 
IVTs support. Finally, Section 5 discusses how the framework can be used to evaluate the 
surveyed EHR-based IVTs. 
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2.2 A Proposed Activity and Task Analysis Framework 
In the context of IVTs, user-tool interaction can be conceptualized as actions that are 
performed by users and consequent reactions that occur via the tool’s interface. This bi-
directional relationship between the user and the tool supports the flow of information 
between the two. Interaction allows for human–information discourse (Ola and Sedig, 
2018). Furthermore, it allows users to adjust different features of the IVT to suit their 
analytical needs. Interaction can be characterized at different levels of granularity (Sedig 
and Parsons, 2016, 2013). As displayed in Figure 1, an activity can be conceptualized at 
the highest level, where it is composed of multiple lower-level tasks (e.g., ranking, 
categorizing, and identifying) that work together to accomplish the activity's overall goal. 
An activity and a task can consist of multiple sub-activities and sub-tasks, respectively. 
At the lower level, tasks can be considered to have visual and interactive aspects; tasks 
that are supported by visual processing are called visual tasks. For instance, consider a 
scenario in which a user is working with a stacked bar chart that aggregates laboratory 
test results. The user needs to understand the distribution of a specific test of a collection 
of patients after surgery over time. Some of the visual tasks that the user may need to 
perform can include detecting the time when the test is at its peak and observing the 
average test result at different times. Interactive tasks require users to act upon 
visualizations. For instance, in the example above, the user may want to cluster the test 
results based on different time granularities (e.g., over an hour, over a day, or over a 
month). Each interactive task is made up of a number of lower-level actions (i.e., 
interactions) that are carried out to complete the task.  
In most complex situations, activities, sub-activities, tasks, and sub-tasks are combined to 
support users in accomplishing their overall goal. It is important to note two perspectives 
from which we can view human–data discourse. From a top-down perspective, users’ 
goals flow from higher-level activities that need to be accomplished. From here, we go 
down to a number of tasks and sub-tasks (visual and interactive), and then to a set of low-
level interactions. From a bottom-up perspective, the performance of a series of low-level 
interactions that users perform with visual representations gives emergence to tasks. 
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Similarly, the performance of a sequence of tasks gives emergence to activities all the 
way up until an overall goal is accomplished.  
In this paper, we present an activity and task analysis framework for examining EHR-
based IVTs (i.e., ones that involve EHRs as their main source of data with which users 
perform data-driven tasks and activities). To identify what activities, sub-activities, tasks, 
and sub-tasks are supported in EHR-based IVTs, we have examined a number of such 
tools that have been developed by different researchers and have been reported in the 
literature (see Wang et al. (Wang et al., 2008); Wongsuphasawat et al. (Wongsuphasawat 
et al., 2011); Wongsuphasawat and Gotz (Wongsuphasawat and Gotz, 2012); Malik et al. 
(Malik et al., 2014); Fails (Fails et al., 2006); Klimov et al. (Klimov et al., 2010); 
Wongsuphasawat (Wongsuphasawat, 2009); Monroe et al. (Monroe et al., 2013); 
Brodbeck et al. (Brodbeck et al., 2005); Chittaro et al. (Chittaro et al., 2003); Rind et al. 
(Rind et al., 2011a); Plaisant et al. (Plaisant et al., 1998); Faiola and Newlon (Faiola and 
Newlon, 2011); Pieczkiewicz et al. (Pieczkiewicz et al., 2007); Bade et al. (Bade et al., 
2004); Hinum et al. (Hinum et al., 2005); Rind et al. (Rind et al., 2011b); and Ordonez et 
al. (Ordonez et al., 2012); Gresh et al. (Gresh et al., 2002); Horn et al. (Horn et al., 
2001)). To conceptualize and develop the elements of the framework, our focus is the 
identification of activities and tasks that are independent of any specific technology or 
platform. To be consistent, we re-interpret how activities and tasks are named by the 
authors of the afore-listed sources in light of the unified language of our proposed 
framework. The activity and task terms we use might differ from the language of the 
existing literature since the authors have described their tools using their own vocabulary. 
Unfortunately, the language that different authors use is not consistent. Such 
inconsistency makes it difficult to analyze how well and comprehensively such tools 
support EHR-based tasks and how they can be improved. In the next section, we define 
and categorize the higher-level activities that result from interaction and combination of 
different sub-activities, tasks, and sub-tasks. 
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2.2.1 Higher-Level Activities: Interpreting, Predicting, and 
Monitoring 
After reviewing numerous papers, we have concluded that, broadly speaking, all EHR-
data-driven healthcare activities can be organized under three main categories: 
interpreting (Auffray et al., 2016; Groves et al., 2003; Komaroff, 1979; Kumar et al., 
2007; Låg et al., 2014), predicting (Amarasingham et al., 2014; Cohen et al., 2014; 
Kankanhalli et al., 2016; Raghupathi and Raghupathi, 2014; Allan F. Simpao et al., 2014; 
Wang et al., 2018), and monitoring (Anderson et al., 2015; Hauskrecht et al., 2013; Kho 
et al., 2007; Li and Wang, 2016; Saeed et al., 2002; Tia Gao et al., 2005). Interpreting 
refers to the activity of detecting patterns from patients’ medical records and making 
sense of the relationships among different features. Predicting refers to the activity of 
anticipating patient outcomes and creating new hypotheses by analyzing patient history 
and status (Siegel, 2013). Lastly, monitoring refers to the activity of repetitive testing 
with the aim of adjusting and guiding the management of recurrent or chronic diseases 
(Glasziou et al., 2005). 
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Figure 2-1: Relationships among activities, tasks, and interactions. Top-down view: 
activity is made up of sub-activities, tasks, sub-tasks, and interactions. Bottom-up 
view: activity emerges over time, through performance of tasks and interactions. 
Visualizations are depicted as Vis and reactions as 𝐑𝐱. Source: adapted from (Sedig 
and Parsons, 2016). 
2.2.2 Hierarchical Structure of Activities, Sub-Activities, Tasks, 
and Sub-Tasks 
In this section, we identify sub-activities, tasks, and sub-tasks that blend and combine 
together to give rise to the three activities of interpreting, predicting, and monitoring. 
Interpreting, as a higher-level activity, can be comprised of four sub-activities: (i) 
understanding (e.g., gaining insight into patient medical records), (ii) discovering (e.g., 
finding patients with interesting medical event patterns), (iii) exploring (e.g., observing 
patient data in different temporal granularities), and (iv) overviewing (e.g., providing 
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compact visual summaries of all event sequences found in the data). Likewise, predicting 
can be comprised of two sub-activities: (i) learning (e.g., generating new hypotheses 
from the data), and (ii) discovering (e.g., recognizing the deterioration of the disease). 
Finally, monitoring is composed of (i) investigating (e.g., examining the development of 
a patient after treatment), (ii) analyzing (e.g., studying the aggregated event sequences for 
quality assurance), and (iii) evaluating (e.g., assessing the quality of care based on 
clinical parameters). 
 
Figure 2-2: Overview of the proposed activity and task analysis framework. The 
visual tasks are represented as blue and interactive tasks are represented as yellow. 
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At the next level of the hierarchy, as shown in Figure 2, each sub-activity can be 
composed of a number of visual (e.g., specifying, recognizing, and detecting) as well as 
interactive tasks (e.g., locating, ordering, querying, and clustering). Moreover, as shown 
in Table 1, each task consists of different sub-tasks; for instance, ordering can be carried 
out by a combination of sub-tasks such as ranking, aggregating, identifying, and 
classifying.  
Table 2-1: Shows the breakdown of the interactive and visual tasks. 
 Task Sub-tasks 
 
Ordering Aggregating, Classifying, Identifying, Ranking 
Locating Aggregating, Aligning, Classifying, Identifying, Ranking 
Querying Classifying, Identifying, Ranking,  
Organizing Aggregating, Classifying, Identifying, Highlighting 
Summarizing Aggregating, Classifying, Identifying 
Clustering Classifying, Identifying, Ranking 
Observing Aggregating, Aligning, Identifying, Ranking 
 
Recognizing Aggregating, Aligning, Classifying, Identifying, Ranking 
Specifying Aggregating, Aligning, Classifying, Identifying, Highlighting, Ranking 
Detecting Classifying, Identifying, Ranking 
2.3 Methods 
2.3.1 Search Strategy 
We conducted an electronic literature search in order to collect the research papers that 
describe the design, implementation, or evaluation of EHR-based IVTs. In order to assure 
a comprehensive document search, we included all the keywords that are relevant to the 
goal of the research and also covered all the synonyms and related terms, both for EHRs 
and visualization tools. We further broadened our search by adding an * to the end of a 
term to make sure the search engines picked out different variations of the term. We also 
added quotation marks around phrases to ensure that the exact sequence of words is 
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found. To ensure that relevant papers were not missed in our search, we used a relatively 
large set of keywords. We used two categories of keywords. The first category concerned 
visualization tools and included the following terms: “visualization*”, “visualization 
tool*”, “information visualization*”, “interactive visualization*”, “interactive 
visualization tool*”, “visualization system*”, and “information visualization system*”. 
For the second category, EHR, we used the following terms: “Health Record*”, 
“Electronic Health Record*”, “EHR*”, “Electronic Patient Record*”, “Electronic 
Medical Record*”, “Patients Record*”, and “Patient Record*”. As we were looking for 
papers about EHR-based visualization tools, we used the keywords shown in Table 2.  
We used the following search engines based on their relevance to the field: PubMed, the 
ACM Digital Library, the IEEE Library, and Google Scholar. We also looked for relevant 
papers in two medical informatics journals (International Journal of Medical Informatics 
and Journal of the American Medical Informatics Association). Furthermore, additional 
papers were collected in conference proceedings (e.g., IEEE Conference on Visual 
Analytics Science and Technology (VAST), HCIL Workshop 2015, and IEEE VisWeek 
Workshop on Visual Analytics in Health Care) that were published in 2007 and later. We 
then manually reviewed the reference lists of the papers that met the selection criteria to 
find other relevant studies that had not been identified in the database search. All the 
studies included in this survey were published from 1998 until 2015. We reviewed all of 
the abstracts, removed the duplicates, and shortlisted abstracts for a more detailed 
assessment. 
Table 2-2: Overview of the search terms used. 
Terms Used 
“Visualization*” +“Health Record*” 
“Visualization*” + “Electronic Health Record*” 
“Visualization*” + “EHR*” 
“Visualization*” + “Electronic Patient Record*” 
“Visualization*” + “Electronic Medical Record*” 
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“Visualization*” + “Patients Record*” 
“Visualization*” + “Patient Record*” 
“Visualization tool*” +“Health Record*” 
“Visualization tool*” + “Electronic Health Record*” 
“Visualization tool*” + “EHR*” 
“Visualization tool*” + “Electronic Patient Record*” 
“Visualization tool*” + “Electronic Medical Record*” 
“Visualization tool*” + “Patients Record*” 
“Visualization tool*” + “Patient Record*” 
“Information visualization*” +“Health Record*” 
“Information visualization*” + “Electronic Health Record*” 
“Information visualization*” + “EHR*” 
“Information visualization*” + “Electronic Patient Record*” 
“Information visualization*” + “Electronic Medical Record*” 
“Information visualization*” + “Patients Record*” 
“Information visualization*” + “Patient Record*” 
“Interactive visualization*” +“Health Record*” 
“Interactive visualization*” + “Electronic Health Record*” 
“Interactive visualization*” + “EHR*” 
“Interactive visualization*” + “Electronic Patient Record*” 
“Interactive visualization*” + “Electronic Medical Record*” 
“Interactive visualization*” + “Patients Record*” 
“Interactive visualization*” + “Patient Record*” 
“Interactive visualization tool*” +“Health Record*” 
“Interactive visualization tool*” + “Electronic Health Record*” 
“Interactive visualization tool*” + “EHR*” 
“Interactive visualization tool*” + “Electronic Patient Record*” 
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“Interactive visualization tool*” + “Electronic Medical Record*” 
“Interactive visualization tool*” + “Patients Record*” 
“Interactive visualization tool*” + “Patient Record*” 
“Visualization system*” + “Health Record*” 
“Visualization system*” + “Electronic Health Record*” 
“Visualization system*” + “EHR*” 
“Visualization system*” + “Electronic Patient Record*” 
“Visualization system*” + “Electronic Medical Record*” 
“Visualization system*” + “Patients Record*” 
“Visualization system*” + “Patient Record*” 
“Information visualization system*” + “Health Record*” 
“Information visualization system*” + “Electronic Health Record*” 
“Information visualization system*” + “EHR*” 
“Information visualization system*” + “Electronic Patient Record*” 
“Information visualization system*” + “Electronic Medical Record*” 
“Information visualization system*” + “Patients Record*” 
“Information visualization system*” + “Patient Record*” 
2.3.2 Selection Criteria 
Out of all the studies that survived the initial filtering, we only included those that 
described an interactive visualization tool and provided a detailed description of the 
tool’s visualization and its interaction design in order to analyze how the tool can support 
different EHR-data-driven tasks and activities. All the papers related to the visualization 
of any administrative tasks with patient data, medical guidelines, genetics data, and 
syndromic surveillance were excluded from our survey as we only focused on clinical 
EHR data. We also excluded the studies that were solely focused on the visualization of 
free text (e.g., the patient’s progress notes) and medical images (e.g., magnetic resonance 
imaging, and X-ray images). 
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2.3.3 Results 
A total of 912 articles were identified from our initial search of electronic databases. A 
search of the gray literature and manually searching references from articles resulted in 
an additional 34 papers. We removed a total number of 205 duplicates that were included 
in the 946 articles, both within and between search engines. We then reviewed all the 
abstracts and excluded 685 further articles. Next, we read the full text of 56 remaining 
articles and excluded the ones that did not meet the selection criteria. Finally, 24 studies 
remained for the analysis. The results of the selection procedure are displayed in the flow 
diagram in Figure 3. 
2.4 Survey of the Interactive Visualization Tools 
In this section, we provide a survey of 19 IVTs that are described in the chosen articles 
and use our proposed activity and task framework to analyze them. The survey includes 
an overview of the goal of the IVT, a brief description of its visualization, and an analysis 
of how sub-activities, tasks, and sub-tasks blend and combine to accomplish the tool's 
main higher-level activities of interpreting, predicting and, monitoring. A very 
important criterion to differentiate IVTs is whether they support activities that involve 
multiple patient records or exploration of an individual patient. We divide our survey into 
two different types of IVTs based on this criterion: population-based tools and single-
patient tools. Initially, studies were focused on single-patient tools, but since 2010, most 
of the IVTs are developed to support large numbers of patient records. Our survey 
includes more population-based tools, as it seems that these are more prevalent than 
single-patient tools. For the first type, we survey 14 tools, and, for the second type, we 
survey five tools. 
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Figure 2-3: Search results and how we selected the 24 articles that described 19 
IVTs. 
2.4.1 Population-Based Tools 
Population-based IVTs support data-driven activities that involve multiplicity of patient 
records in aggregate form and simultaneously. Although these types of tools display 
fewer details about a particular patient, they provide users with the ability to recognize 
patterns, detect anomalies, find desired records, and cluster and aggregate records into 
different groups. In this section, we survey fourteen population-based IVTs. 
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2.4.1.1 Lifelines2 
Lifelines2 (Wang et al., 2009, 2008) enables users to explore and analyze a set of 
temporal categorical patient records interactively. As shown in Figure 4, each record is 
represented by a horizontal strip containing patient ID and multiple events in patient 
history that occur at various times. Each event shows up as a color-coded triangle icon on 
a horizontal timeline. Lifelines2 allows the detection of temporal patterns and trends 
across EHRs to facilitate hypothesis generation and identify cause-and-effect 
relationships between patient records. 
This tool supports the activity of interpreting by allowing users to get a better 
understanding of clinical problems and discovering patients with interesting medical 
event patterns. It also supports monitoring by investigating the impact of hospital 
protocol changes in patient care. It allows for temporal ordering of event sequences, 
observing the distribution of temporal events, and locating records with particular event 
sequences. These tasks (ordering, observing, locating) are supported by sub-tasks such as 
ranking, aggregating, and identifying. 
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Figure 2-4: Lifelines2: Interactive visualization tool for temporal categorical data. 
Source: Image courtesy of the University of Maryland Human–Computer 
Interaction Lab, http://hcil.umd.edu. 
2.4.1.2 Lifeflow  
Lifeflow (Guerra Gómez et al., 2011; Wongsuphasawat et al., 2011) provides a visual 
summary of the exploration and analysis of event sequences in EHR data. While in 
Lifelines2, due to limited screen space, it is not possible to see all records simultaneously; 
Lifeflow gives users the ability to answer questions that require an overview of all the 
records. To convert from Lifelines2 view to Lifeflow, a data structure called “tree of 
sequences” is created by aggregating all the records. This structure is then converted into 
a Lifeflow view with each node representing an event bar. Figure 5 shows Lifeflow 
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visualization where all the records are vertically stacked on the horizontal timeline and all 
the events are represented using color-coded triangles.  
In this IVT, the sub-activities of exploring and overviewing medical events support the 
activity of interpreting, while analyzing aggregated event sequences for quality 
assurance supports the activity of monitoring. Recognizing patterns and temporal 
ordering of aggregated event sequences are two tasks that enable Lifeflow to support 
exploring, overviewing, and analyzing sub-activities. Finally, sub-tasks such as 
aggregating, identifying, and classifying work together to accomplish higher-level tasks. 
 
Figure 2-5: Lifeflow: Interactive visualization tool that provides an overview of 
event sequences. Source: Image courtesy of the University of Maryland Human–
Computer Interaction Lab, http://hcil.umd.edu. 
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2.4.1.3 Eventflow  
Eventflow (Monroe et al., 2013) provides users with the ability to query, explore, and 
visualize interval data interactively. It allows pattern recognition by visualizing events in 
both a timeline that displays all individual records and an aggregated overview that 
shows common and rare patterns. As displayed in Figure 6, all the records are shown on a 
scrollable timeline browser. On the horizontal timeline, point-based events are displayed 
as triangles, while interval events are represented by the connected rectangles. In the 
center, an aggregated display gives users an overview of all event sequences in EHR data. 
The aggregation method works exactly like the one in Lifeflow, but it has been extended 
to work for interval events in the Eventflow. All the records with the same event 
sequence are aggregated into a single bar and the average time between two events 
among the records in the group is represented by the horizontal gap between two bars. 
This tool supports interpreting by providing an overview of all event sequences found in 
the data and exploring medical events (point-based events as well as interval events). The 
overviewing and exploring sub-activities can be accomplished by recognizing temporal 
patterns and simplifying temporal event sequences. Monitoring can be accomplished by 
investigating aggregated event sequences. The investigating sub-activity is supported by 
detecting anomalies in the data. Eventflow supports predicting by learning new 
hypotheses where this sub-activity can be carried out by tasks such as specifying temporal 
patterns and simplifying temporal event sequences. Aggregating, identifying, classifying 
are the lowest-level sub-tasks for Eventflow. 
2.4.1.4 Caregiver 
Caregiver (Brodbeck et al., 2005) is an IVT that supports therapeutic decision making, 
intervention, and monitoring. As displayed in Figure 7, the tool has three different views 
where the upper view displays the duration and size of the patient groups that are chosen 
by physicians to receive interventions. A common timeline for each patient is shown in 
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the lower view of the chosen attributes. Caregiver allows users to create new cohorts 
from the search results based on a combination of values of any number of variables.  
In this tool, the activity of interpreting can be accomplished by discovering trends, 
critical incidents, and cause–effect relationships. Caregiver also supports predicting by 
allowing users to learn about the deterioration in the status of a disease. It supports these 
sub-activities (discovering and learning) by specifying temporal relationships and 
clustering. Specifying and clustering can be carried out by sub-tasks such as identifying, 
classifying, and ranking. 
 
Figure 2-6: Eventflow: Interactive visualization tool for analysis of event sequences 
for both point-based and interval events. Source: image courtesy of the University of 
Maryland Human–Computer Interaction Lab, http://hcil.umd.edu. 
2.4.1.5 CoCo 
CoCo (Malik et al., 2015, 2014) is an IVT for comparing cohorts of sequences of events 
recorded in EHRs. It provides users with overview and event-level statistics of the chosen 
dataset along with a list of available metrics to generate new hypotheses. It consists of a 
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file manager pane, a dataset statistics pane, an event legend, a list of available metrics, 
the main window, and options for filtering and sorting the results (as shown in Figure 8). 
The summary panel includes high-level statistics containing the total number of records 
and events in each record. 
CoCo supports the activity of interpreting by allowing users to explore and investigate 
two groups of temporal event sequences simultaneously. The activity of predicting can 
be accomplished by learning new hypotheses from the statistical analysis while 
comparing the event sequences (i.e., detecting differences among groups of patients). 
Ranking, classifying, and identifying are the lowest-level sub-tasks in CoCo. 
 
Figure 2-7: Caregiver: Interactive visualization tool for visualization of categorical 
and numerical data. Source: Image courtesy of Dominique Brodbeck. 
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2.4.1.6 Similan 
Similan (Wongsuphasawat, 2009) is a tool that provides users with the ability to discover 
and explore similar records in the temporal categorical dataset. Records are ranked by 
their similarity to a target record that can be either a reference record or a user's specified 
sequence of events. The similarity measure considers the transposition of events, 
addition, removal, and temporal differences of matching to estimate the similarity of 
temporal sequences. Simian lets users to visually compare the selected target with a set of 
records and rank those records based on the matching score, as shown in the left side 
middle panel in Figure 9.  
In this IVT, interpreting can be carried out by exploring and discovering similar records 
in temporal categorical data where these sub-activities themselves are supported by 
detecting (calculating similarity measure among records) and recognizing similarity 
among records. Predicting is accomplished by discovering patients with similar 
symptoms to a certain target patient. The sub-activity discovering can be carried out by 
tasks such as temporal ordering and dynamic query. Finally, sub-tasks such as ranking, 
identifying, and classifying work together to accomplish higher-level tasks. 
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Figure 2-8: CoCo: Interactive visualization tool for comparing cohorts of event 
sequences. Source: image courtesy of the University of Maryland Human–Computer 
Interaction Lab, http://hcil.umd.edu. 
2.4.1.7 Outflow 
Outflow (Wongsuphasawat and Gotz, 2012, 2011) is a graph-based visualization that 
shows the eventual outcome across the event sequences in patient records. It aggregates 
and displays event progression pathways and their corresponding properties, such as 
cardinality, outcomes, and timing. The tool allows users to interactively analyze the event 
sequences and detect their correlation with external factors (e.g., beyond the collection of 
event types that specify an event sequence). The tool is a state transition diagram, which 
is represented by a directed acyclic graph. The states (nodes) are unique combinations of 
patient symptoms that are mapped to rectangles, where the height of each rectangle is 
proportional to the number of patients. The graph is divided into different layers 
vertically, where layer i consists of all states in the graph with i symptoms. These layers 
are arranged from left to right, displaying patient history from past to future. Edges 
display transitions among symptoms where each edge encodes the number of patents that 
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are involved in the transition and the average time interval between different states. The 
end state that is represented by a trapezoid followed by a circle is used to mark points 
where the patient paths have ended. Finally, the color of the edges and end states 
represents the average outcome for the corresponding group of patients.  
 
Figure 2-9: Similan: interactive visualization tool for the exploration of similar 
records in the temporal categorical data. Source: image courtesy of the University of 
Maryland Human–Computer Interaction Lab, http://hcil.umd.edu. 
In this tool, sub-activities of exploring and overviewing event sequences work together to 
accomplish the activity of interpreting. Outflow also supports predicting by allowing 
users to discover the progression of temporal event sequences. The sub-activities of 
exploring, overviewing, and discovering can be accomplished by summarizing temporal 
event sequences, specifying temporal relationships, and detecting patterns from statistical 
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summaries. Finally, aggregating, identifying, and classifying are the lowest-level sub-
tasks. 
2.4.1.8 IPBC 
IPBC (Chittaro et al., 2003) (interactive parallel bar charts) is an interactive 3D 
visualization of temporal data. IPBC applies visual data mining to a real medical problem 
such as the management of multiple hemodialysis sessions. It provides users with the 
ability to make various decisions regarding such things as therapy, management, and 
medical research. Each time series is displayed as a 3D bar chart where one of the 
horizontal axes shows time and the vertical axis represents the value, as displayed in 
Figure 10. Lined up bar charts on the second horizontal axis enable users to view all the 
series simultaneously. 
IPBC supports interpreting by allowing users to explore patient data interactively. 
Monitoring can be carried out by evaluating the quality of care based on certain clinical 
parameters. The sub-activities of exploring and evaluating are supported by specifying 
temporal relationships and recognizing similar patterns where these tasks themselves can 
be accomplished by sub-tasks such as identifying, classifying, and ranking. 
2.4.1.9 Gravi++ 
Gravi++ (Hinum et al., 2005) allows users to explore and analyze multiple categorical 
variables using interactive visual clustering. This tool uses a spring-based layout to place 
both patient and variable icons across the visualization, where the value of a variable for 
a patient identifies the distance between that patient's icon and the variable’s icon. 
Gravi++ provides users with the ability to detect clusters since patients with similar 
values are placed together on screen. In order to visualize the exact values of each 
variable for each patient, the tool shows each patient’s value as a circle around variables. 
The patient icons are represented by spheres while the variable icons are encoded by 
squares. Moreover, the tool can encode different patient attributes using patient icons; for 
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instance, the size of the sphere can be mapped to the body mass index of the patient and 
its color can encode the patient’s gender or therapeutic outcome. 
 
Figure 2-10: IPBC: 3D visualization tool for analysis of numerical data from 
multiple hemodialysis sessions. Source: reprinted from Journal of Visual Languages 
& Computing, 14, Chittaro L, Combi C, Trapasso G, Data mining on temporal 
data: a visual approach and its clinical application to hemodialysis, 591-620, 
Copyright (2003), with permission from Elsevier. 
This tool supports the activity of interpreting by allowing users to explore patient data 
and discover clusters of similar patients. Monitoring can be accomplished by 
investigating the development of a patient after a certain treatment. The sub-activities of 
exploring, discovering, and investigating are supported by tasks such as recognizing 
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patterns and specifying temporal relationships. Finally, identifying and classifying are the 
lowest-level sub-tasks that are supported by the tool. 
2.4.1.10 PatternFinder 
PatternFinder (Fails et al., 2006) is a query-based tool for data visualization and visual 
query that can help users search and discover temporal patterns within multivariate 
categorical data. PatternFinder allows users to specify queries for temporal events with 
time span and value constraints and enables them to look for temporally ordered 
events/values/trends as well as the existence of events. Also, users can set a range of 
possible time spans among the events to specify how far apart the events are from each 
other. The tool has two main panels: the pattern design and query specification panel and 
the result visualization panel. The leftmost part of the pattern design panel is the 
Person/People panel that enables users to limit the types of patients by name, by choosing 
from a list of patients, or by typing a text string. Any modifications that are done in this 
panel are dynamic queries that lead to an immediate update of the results in the result 
visualization panel. The temporal panel that is placed to the right of the Person/People 
panel enables users to form temporal pattern queries by chaining the events together. 
Users are able to search for the presence of events, the temporal sequence of events (e.g., 
an emergency doctor's visit followed by a hospitalization), the temporal sequence of 
values (e.g., 200 or below cholesterol followed by 240 or higher), and the temporal value 
patterns (e.g., monotonically decreasing). The result visualization panel displays a 
graphical table of all the matches where each row shows a single pattern match for one 
patient. Pattern matches are represented as a timeline in a "ball-and-chain" visualization 
fashion where the event points are shown as circles and time spans are displayed by blue 
bars between the events. The color of the event point in the result visualization panel 
matches the color of the associated event in the query specification panel. All the events 
that match the query pattern specified by users are linked together by horizontal lines. 
In this tool, the activity of interpreting is supported by discovering patterns and exploring 
patient data dynamically, where these sub-activities themselves can be carried out by 
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tasks such as specifying temporal relationships and issuing dynamic queries. Identifying 
and ranking are the two low-level sub-tasks that work together to support the 
aforementioned tasks. 
2.4.1.11 TimeRider 
TimeRider (Rind et al., 2011a) offers an animated scatter plot to help users discover 
patterns in irregularly sampled patient data covering several time spans. As shown in 
Figure 11, time is represented by either traces or animation in TimeRider. Color, shape, 
and size of marks are used to encode up to three additional variables. Users can compare 
patient records of different time spans by synchronizing patients' age, calendar date, and 
the start and end of the treatment. 
 
Figure 2-11: TimeRider: Interactive visualization tool for pattern recognition in 
patient cohort data. Source: reprinted by permission from Springer Nature: 
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Springer, Ergonomics and Health Aspects of Work with Computers, Visually 
Exploring Multivariate Trends in Patient Cohorts Using Animated Scatter Plots, 
Rind A, Aigner W, Miksch S, et al., copyright (2011). 
This tool supports interpreting by allowing users to detect trends, clusters, and 
correlations and providing them with an overview to visually compare patient data in 
parallel. The sub-activities of detecting and overviewing can be carried out by tasks such 
as specifying temporal relationships, clustering, and recognizing patterns. Identifying and 
aligning are the sub-tasks that work together to support the aforementioned tasks. 
2.4.1.12 VISITORS 
VISITORS (Klimov et al., 2010) is an IVT that allows for exploration, analysis, and 
retrieval of raw temporal data. The tool uses raw numerical data (e.g., white blood cell 
counts) across time to derive temporal abstractions (e.g., durations of low, normal, or 
high blood-cell-count levels for patients). It then uses lower-level temporal abstractions 
in conjunction with raw data to generate higher-level abstractions. Finally, patient 
groups’ values are aggregated and displayed. Figure 12 shows this tool’s visualization 
environment, where raw numerical data is represented by line charts, whereas categorical 
data is displayed as tick marks or bars on a horizontal zoomable timeline. 
In this tool, the activity of interpreting is supported by exploring patient data in different 
temporal granularities. The sub-activity of exploring can be carried out by tasks such as 
specifying relationships, observing the distribution of aggregated values of a group of 
patients, and locating records based on specific time and value constraints. VISITORS 
supports the activity of monitoring by sub-activities, such as investigating treatment 
effects, clinical trial results, and quality of clinical management processes. The latter sub-
activity, investigating, can be carried out by the task of recognizing patterns as well as all 
the other tasks needed to support the activity of interpreting. Finally, aggregating, 
classifying, aligning, and identifying are the lowest-level sub-tasks that are supported by 
this tool. 
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Figure 2-12: VISITORS: Interactive visualization tool for the exploration of 
multiple patient records. (A) displays lists of patients. (B) displays a list of time 
intervals. (C) displays the data for a group of 58 patients over the current time 
interval. Panel 1 shows the white blood cell raw counts for the patients, while Panels 
2 and 3 display the states of monthly distribution of platelet and haemoglobin in 
higher abstraction, respectively. Abstractions are encoded in medical ontologies 
displayed in panels (D). Source: reprinted from Journal of Artificial Intelligence in 
Medicine, 49, Klimov D, Shahar Y, Taieb-Maimon M, Intelligent visualization and 
exploration of time-oriented data of multiple patients, 11-31., copyright (2010), with 
permission from Elsevier. 
2.4.1.13 Prima 
Prima (Gresh et al., 2002) is a population-based IVT that allows users to explore the 
categorical and numerical data by constructing different linked views. This helps users to 
not only understand the large set of patient records but also discover patterns and trends 
in the dataset. The aggregated window provides an overview of the categorical variables 
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by showing the proportions of patients in each category for those variables using stacked 
bar charts. This window enables users to filter patients by applying a color “brush”. It 
also displays correlations among different categorical variables through interactive 
coloring. Another view displays a histogram of numerical variables. The data can also be 
explored with a 2D scatter plot. Another view of the data is called multiple category 
tables. It shows the values of either a single variable or multiple categories. Finally, the 
tool incorporates the Kaplan–Meier curve to estimate the survival function from the 
patient data.  
Prima supports the activity of interpreting by allowing users to explore patient data 
interactively, where this sub-activity itself can be accomplished by recognizing patterns 
and specifying temporal relationships. Finally, aggregating and ranking are the lowest-
level sub-tasks that are supported by the tool. 
2.4.1.14 WBIVS 
WBIVS (Pieczkiewicz et al., 2007) is a web-based interactive tool that visualizes 
numerical and categorical variables for lung transplant home monitoring data. Numerical 
variables are displayed in line plots, while categorical variables are visualized in matrix 
plots. The tool visualizes ten variables in total. When a data point gets selected, all the 
other data points that belong to the same time period will get highlighted in the other 
charts. Moreover, users can find details about the last two chosen data points on the right 
part of the graph. 
This tool supports the interpreting activity by allowing users to explore patient data 
interactively and discover patterns. Monitoring is supported by investigating treatment 
effects. The exploring and discovering sub-activities can be accomplished by tasks such 
as specifying temporal relationships among data points and organizing data for pattern 
recognition. These tasks can be composed of lowest-level sub-tasks, such as identifying, 
classifying, and highlighting. 
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2.4.2 Single-Patient Tools 
Single-patient IVTs provide visualizations of one single-patient record at a time. These 
tools enable users to overview a given patient’s historical data, detect important events in 
the patient’s history, and recognize trends. In this section, we survey five single-patient 
IVTs. 
2.4.2.1 Midgaard 
Midgaard (Bade et al., 2004) allows for exploration of the intensive care units’ data at 
different levels of abstraction from overview to details. It uses visualizations to display 
numerical variables of treatment plans. It incorporates a complex semantic zoom method 
for numerical variables by calculating their categorical abstractions based on the 
available screen area and zoom level. Midgaard provides users with the ability to switch 
between different views such as a colored background, colored bars, area charts, or 
augmented line charts based on the level of details. The tool can progressively switches 
to a more detailed view to display all the individual data points when users zoom in or 
switch back to more compact graphical elements when they zoom out.  
Midgaard can also visualize medical treatment plans using colored bars where each bar 
can contain further bars displaying sub-plans. It allows users to navigate and zoom by 
interacting with two time axes that are placed below the visualization area. The bottom 
axis displays a temporal overview of the patient record while the middle axis allows users 
to see specific time intervals in more detail.  
The activity of interpreting is supported by exploring patient data at different levels of 
abstraction, where this sub-activity itself can be accomplished by tasks such as 
recognizing fluctuations in data. Identifying and classifying are the two sub-tasks that are 
supported by this tool. 
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2.4.2.2 MIVA 
MIVA (Faiola and Newlon, 2011) (Medical information visualization assistant) is a tool 
that transforms and organizes biometric data into temporal resolutions to provide 
healthcare providers with contextual knowledge. It allows users to prioritize and 
customize visualizations based on specific clinical problems. It visualizes the data using 
point plots to display temporal changes in numerical values, where each variable is 
represented by a separate plot, as shown in Figure 13. MIVA enables users to detect 
changes in multiple physiological data points over time for faster and more accurate 
diagnosis. Users can control the data source, time resolutions, and time periods to narrow 
down the assessment of a patient’s condition.  
 
Figure 2-13: MIVA: Interactive visualization tool to show the temporal change of 
numerical values where each variable is represented by an individual point plot. 
Source: image courtesy of Antony Faiola. 
This tool supports the activity of interpreting by enabling users to carry out sub-activities 
such as exploring longitudinal relationships in patient data where this sub-activity can be 
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accomplished by tasks such as specifying temporal relationships and recognizing patterns. 
At the level of sub-tasks, this tool supports identifying as well as classifying. 
2.4.2.3 VIE–VISU 
VIE–VISU (Horn et al., 2001) uses a set of glyphs to display changes in a patient's status 
over time in intensive care. Each glyph’s geometrical shape and color encodes categorical 
variables, while the numerical variables are represented by size of the glyph's elements. 
Every glyph can encode 15 variables that are classified by physiological systems. For 
instance, the respiratory parameters are mapped to a rectangle in the middle of the glyph; 
circulatory parameters are mapped to a triangle on top of the glyph, and the fluid balance 
parameters are shown by two smaller rectangles at the bottom of the glyph. By default, 
the tool displays 24 glyphs, one per hour.  
The activity of interpreting can be accomplished by overviewing a patient’s status, where 
this sub-activity is supported by tasks such as recognizing patterns. This tool supports 
monitoring by evaluating changes in patient’s status over time. The task of identifying 
temporal relationships supports the sub-activity of evaluating. Finally, aggregating and 
classifying are two sub-tasks that can be carried out by the tool. 
2.4.2.4 Lifelines 
Lifelines (Plaisant et al., 1998) offers a visualization environment to show patient history 
on a zoomable timeline, where a patient's medical record is displayed by a set of events 
and lines. Episodes and events in a patient record are represented by a set of multiple line 
segments as shown in Figure 14. Color can be used to encode the states of categorical 
variables. This IVT provides an overview of a patient history to recognize trends, specify 
important events, and detect omissions in data. 
The activity of interpreting is supported by understanding patient’s status where this sub-
activity itself can be carried out by tasks such as recognizing patterns and specifying 
temporal relationships. The tool supports monitoring by allowing users to carry out sub-
activities such as investigating trends and anomalies in patient data. The investigating 
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sub-activity is supported by outlining and summarizing the patient data. Finally, 
aggregating, classifying, and identifying are the sub-tasks that are supported by the tool. 
 
Figure 2-14: Lifelines: interactive visualization tool that displays patient’s medical 
histories on a timeline. Source: image courtesy of the University of Maryland 
Human–Computer Interaction Lab, http://hcil.umd.edu. 
2.4.2.5 VisuExplore 
VisuExplore (Pohl et al., 2011; Rind et al., 2011b) displays patient data in different views 
aligned with a horizontal timeline, where each view shows multiple variables. This IVT 
uses common visualization techniques that make it easy to use and learn. In this tool, 
numerical data are displayed using bar charts and line plots, whereas categorical data are 
represented using event charts and timeline charts, as shown in Figure 15. 
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Figure 2-15: VisuExplore: interactive visualization tool that displays patient data in 
various views on a timeline. Source: reprinted by permission from Springer Nature: 
Springer, Human–Computer Interaction, Patient Development at a Glance: An 
Evaluation of a Medical Data Visualization, Pohl M, Wiltner S, Rind A, et al., 
copyright (2011). 
In this tool, the activity of interpreting is supported by exploring temporal data of 
patients with chronic diseases, where this sub-activity can be carried out by tasks such as 
specifying temporal relationships. Finally, aligning and identifying are two sub-tasks that 
can be carried out by the tool. 
2.5 Discussion and Limitations 
In this paper, we have presented and proposed a framework to identify and analyze EHR-
data-driven tasks and activities in the context of IVTs—that is, all the activities, sub-
activities, tasks, and sub-tasks that are supported by EHR-based IVTs. Using a survey of 
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19 EHR-based IVTs, we demonstrate how these IVTs support activities by identifying 
the combination of sub-activities, tasks, and sub-tasks that work together to help users 
carry out the three higher-level activities as displayed in Table 3. Interpreting is 
supported by all IVTs surveyed in this paper. Eventflow, Similan, CoCo, Outflow, and 
Caregiver are the only IVTs that support predicting, whereas Lifelines2, Lifeflow, 
Eventflow, Gravi++, IPBC, TimeRider, VISITORS, WBIVS, VIE-VISU, Lifelines, 
CoCo, and Visu-Explore are the tools that facilitate monitoring. Going down from high-
level activities, recognizing patterns and specifying temporal relationships are the most 
common sub-activities that help users with the activity of interpreting in most of the 
IVTs. The existing EHR-based IVTs support predicting by giving users the ability to 
perform sub-activities such as learning new hypotheses, discovering patients with similar 
symptoms to a target patient, and detecting early deterioration of a disease. Finally, the 
most common sub-activities that facilitate monitoring are evaluating the quality of care 
and investigating the development of a patient's status after treatment. 
Our proposed framework can offer a number of benefits for designers, researchers, and 
evaluators of EHR-based IVTs. Firstly, the framework can help the designer to 
conceptualize activities, tasks, and sub-tasks of EHR-based IVTs systematically. 
Secondly, it can assist researchers in making sense of IVTs by providing them with all 
the activities that can be accomplished by carrying out different sets of sub-activities, 
tasks, and sub-tasks. Thirdly, this framework can be used by evaluators to identify the 
gaps in support of higher-level activities supported by existing IVTs. It appears that 
almost all existing IVTs focus on the activity of interpreting, while only a few of them 
support predicting despite the importance of this activity in supporting users to find the 
patients that are at high risk and identify the risk factors of various diseases. Also, some 
of the EHR-based IVTs do not pay enough attention to monitoring, even though this 
activity is beneficial in investigating the quality of clinical management processes. All 
these higher-level activities should be an integral part of a properly designed EHR-based 
IVT since healthcare providers use such tools to (1) better understand patients' condition, 
(2) anticipate the course of a specific disease, and (3) track patients' condition after 
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treatment. Most of the tools surveyed in this paper can only satisfy a certain aspect of 
users' needs. According to a recent survey in the US, 40% of the clinicians are not 
satisfied with the existing EHR-based system (EHRIntelligence, 2018). Therefore, a 
framework is needed to guide the designer of an IVT in choosing which activities, tasks, 
and sub-tasks the tool should support. Using questions such as, "What activities can users 
accomplish by executing a set of tasks?" or "What tasks should be supported to provide 
users with the ability to perform their activities?", we demonstrate how the proposed 
framework can be used by designers of EHR-based IVTs to systematically conceptualize 
and design the tasks and activities of such tools. Given the framework, all designers need 
to know is, which low-level sub-tasks, tasks, and sub-activities to select and how to blend 
and combine them to support higher-level activities and allow users to accomplish their 
overall goal. For instance, if a designer wants to design an IVT to monitor an infant's 
condition in the neonatal intensive care unit, they can choose different sets of sub-
activities, such as investigating the effect of a specific treatment or evaluating changes in 
infant's status over time. Then, the designer selects a combination of tasks such as the 
temporal ordering of event sequences or displaying the distribution of temporal events to 
support the chosen sub-activities. Finally, a set of sub-tasks, such as ranking, 
aggregating, and identifying, are chosen to support the selected tasks. 
We believe a successful EHR-based tool should be capable of doing more than just 
storing, retrieving, and exchanging patient data. It should support more complex 
activities, tasks, and sub-tasks to allow healthcare providers to accomplish their goals. 
Our proposed framework promises a new means for designers of EHR-based IVTs to 
understand the effectiveness of incorporating such activities, tasks, and sub-tasks in their 
tool. The use of our framework in EHR-based IVTs will also help physicians to make 
better treatment decisions and track changes in a patient's condition over time.  
This paper has three key limitations. First, we do not investigate the completeness and 
accuracy of the data sources that IVTs are using as our survey relies on the descriptions 
of the IVTs found in publications and video tutorials. Second, as the main goal of this 
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paper is the analysis of EHR-based IVTs, we exclude tools that are mainly dependent on 
statistical and machine learning methods. Finally, we do not consider commercial tools in 
this paper. This is because online descriptions of such tools do not systematically and 
thoroughly cover the features of these tools, i.e., their visualizations, interactions, and 
results.  
The findings of this paper will lead to the development of best practices for creating 
similar frameworks in other domains. A possible area of future research involves 
developing frameworks for visual analytics tools that incorporate automated analysis 
techniques along with interactive visualizations to support the increasingly large and 
complex datasets in EHRs.  
Table 2-3: Evaluation summary of the 19 existing tools based on the proposed 
framework. 
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Lifelines 2 
Sub-activity 
discovering, 
understanding,  
no investigating 
Tasks 
locating, observing, 
ordering 
n/a 
locating, 
observing, 
ordering 
Sub-tasks 
aggregating, identifying, 
ranking 
n/a 
aggregating, 
identifying, 
ranking 
Lifeflow 
Sub-activity exploring, overviewing no analyzing 
Tasks ordering, recognizing n/a 
ordering, 
recognizing 
Sub-tasks 
aggregating, classifying, 
identifying 
n/a 
aggregating, 
classifying, 
identifying 
Eventflow Sub-activity exploring, overviewing learning investigating 
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Tasks 
recognizing, 
summarizing 
specifying, 
summarizing 
detecting 
Sub-tasks 
aggregating, classifying, 
identifying 
aggregating, 
classifying, 
identifying  
aggregating, 
classifying, 
identifying 
Similan 
Sub-activity discovering, exploring discovering no 
Tasks detecting, recognizing ordering, querying n/a 
Sub-tasks 
identifying, classifying, 
ranking 
identifying, 
classifying, ranking 
n/a 
CoCo 
Sub-activity exploring learning investigating 
Tasks detecting detecting detecting 
Sub-tasks 
classifying, identifying, 
ranking 
identifying, 
classifying, ranking 
identifying, 
classifying, 
ranking 
Outflow 
Sub-activity exploring, overviewing discovering no 
Tasks 
detecting, specifying, 
summarizing 
detecting, 
specifying, 
summarizing 
n/a 
Sub-tasks 
aggregating, classifying, 
identifying 
aggregating, 
classifying, 
identifying 
n/a 
Caregiver 
Sub-activity discovering learning n/a 
Tasks specifying 
clustering, 
specifying 
n/a 
Sub-tasks 
classifying, identifying, 
ranking 
classifying, 
identifying, 
ranking 
n/a 
Gravi++ Sub-activity discovering, exploring no investigating 
48 
 
 
 
Tasks recognizing, specifying n/a 
recognizing, 
specifying 
Sub-tasks classifying, identifying n/a 
classifying, 
identifying 
IPBC 
Sub-activity exploring no evaluating 
Tasks recognizing, specifying n/a 
recognizing, 
specifying 
Sub-tasks 
classifying, identifying, 
ranking 
n/a 
classifying, 
identifying, 
ranking 
Pattern 
Finder 
Sub-activity discovering, exploring no no 
Tasks specifying, querying n/a n/a 
Sub-tasks identifying, ranking n/a n/a 
Prima 
Sub-activity exploring no no 
Tasks recognizing, specifying n/a n/a 
Sub-tasks aggregating, ranking n/a n/a 
Timerider 
Sub-activity detecting, overviewing no investigating 
Tasks 
clustering, recognizing, 
specifying 
n/a recognizing 
Sub-tasks aligning, identifying n/a n/a 
VISITORS 
Sub-activity exploring no investigating 
Tasks 
locating, observing, 
specifying 
n/a 
locating, 
observing, 
recognizing, 
specifying 
Sub-tasks 
aggregating, aligning, 
classifying 
n/a 
aggregating, 
aligning, 
classifying, 
identifying 
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WBIVS 
Sub-activity discovering, exploring no investigating 
Tasks organizing, specifying  n/a 
organizing, 
specifying 
Sub-tasks 
classifying, highlighting, 
identifying 
n/a 
classifying, 
highlighting, 
identifying 
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Midgard 
Sub-activity exploring no no 
Tasks recognizing n/a n/a 
Sub-tasks classifying, identifying 
  
MIVA 
Sub-activity exploring no no 
Tasks recognizing, specifying n/a n/a 
Sub-tasks classifying, identifying 
  
VIE-Visu 
Sub-activity overviewing no evaluating 
Tasks recognizing n/a specifying 
Sub-task aggregating,classifying n/a 
aggregating, 
classifying 
Lifelines 
Sub-activity understanding no investigating 
Tasks recognizing, specifying n/a 
outlining, 
summarizing 
Sub-tasks 
aggregating, classifying, 
identifying 
n/a 
aggregating, 
classifying, 
identifying 
VisuExplo
re 
Sub-activity exploring no evaluating 
Tasks specifying n/a recognizing 
Sub-tasks aligning, identifying n/a identifying 
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Chapter 3  
3 Multiple regression analysis and frequent itemset 
mining of electronic medical records: A visual analytics 
approach using VISA_M3R3 
This chapter has been published as S.S. Abdullah, N. Rostamzadeh, K. Sedig, A.X. Garg, 
and E. McArthur, “Multiple regression analysis and frequent itemset mining of electronic 
medical records: A visual analytics approach using VISA_M3R3” in the Data 
Journal, 5(2), 33; March 2020. We changed the format to match the general format of the 
dissertation. Figure, Table and Section numbers specified herein are relative to the 
chapter number. For example, “Table 1” corresponds to Table 3-1; “Figure 1” 
corresponds to Figure 3-1; and “Section 1.1” corresponds to Section 3.1.1. Moreover, 
when the term “paper”, “research”, or "work" is used, it refers to this specific chapter. 
3.1 Introduction 
As part of modernizing their operations, healthcare and medical organizations are 
adopting electronic medical records (EMRs) and deploying new information technology 
systems that generate, collect, digitize, and analyze their data (Caban and Gotz, 2015). 
With the development of EMRs and the extensive use of computerized provider order 
entry tools, patients’ medication profile data is now accessible and processable for 
secondary reuses (Abramson et al., 2011; Delamarre et al., 2015). The amount of 
prescription data available to clinical researchers, pharmaceutical scientists, and 
clinician-scientists continues to grow, creating an analyzable resource for generating 
insights that can help improve the healthcare system (Kamal, 2014; Murdoch and Detsky, 
2013). Healthcare providers use modern EMR-based systems to identify adverse drug 
events (Hannan, 1999; Honigman et al., 2001), study medication-medication interactions 
(Rinner et al., 2015), investigate medication effects on particular medical conditions 
(Gruchalla, 2000; Tandon et al., 2015), and ultimately prevent medication errors 
(Agrawal, 2009; Gildon et al., 2019; Singer and Duarte Fernandez, 2015).  
51 
 
 
 
A common problem in clinical medicine which may lead to development of acute kidney 
injury (AKI) is medication-induced nephrotoxicity (Assadi and Ghane Shahrbaf, 2015; 
Fusco et al., 2016; Khan et al., 2017). AKI can be defined as a sudden loss of kidney 
function over a short period of time (Porter et al., 2014; Nicholas M. Selby et al., 2012). 
The rate of medication-induced AKI can be as high as 60 percent (Gandhi et al., 2000; 
Kaufman et al., 1991; Nash et al., 2002; Schetz et al., 2005). Many prior studies have 
assessed the impact of individual nephrotoxic medications on AKI (Alexander et al., 
2017; Moffett and Goldstei, 2011; Ryan M. Rivosecchi et al., 2016). The combination of 
multiple medications can further increase the risk of AKI through synergistic or 
accumulative nephrotoxicity (Schetz et al., 2005). For each additional nephrotoxic 
medication, the chance of developing AKI may increase by 53 percent (Cartin-Ceba et 
al., 2012). Rivosecchi et al., through an exhaustive literature search, further emphasize 
the need for a comprehensive understanding of how medication combinations alter the 
risk of AKI (Ryan M. Rivosecchi et al., 2016). According to a Center for Disease Control 
report, as of 2017, there were more than 5,000 medications in the market and 1,000 
adverse medication effects known in the literature. So, for drug-drug interactions there 
may be 125 billion possible adverse medication effects between all possible pairs of 
medications (Collins, 2018; Zitnik et al., 2018). An individual clinical study is often 
required to test the nephrotoxicity of each medication or medication combination. 
Therefore, it is impossible to comprehensively assess medication-induced AKI through 
this number of clinical studies.  
Data analytics can offer a solution to this problem by employing algorithms, methods, 
and techniques from different fields, such as data mining, statistics, and machine learning 
(Han and Kamber, 2011). Data analytics is the investigation of raw data to gain both 
novel and deeper insights on associations within the data (Koh and Tan, 2005). There are 
several tools designed and developed in recent years that employ advanced machine 
learning techniques to improve drug-safety science, predict adverse drug reactions, and 
identify drug-drug interactions (Basile et al., 2019; Dey et al., 2018; Lysenko et al., 2018; 
Munsaka, 2017; Schmider et al., 2019; Vamathevan et al., 2019). While most clinical 
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machine learning tools are designed to incorporate large amounts of data, they are not 
capable of efficiently managing ill-defined problems that need human judgment. The 
main challenge of using machine learning techniques lies with their lack of 
interpretability and transparency, hence limiting their application in healthcare settings 
(Vamathevan et al., 2019).  
Interactive visualizations have the potential to address this challenge by providing a 
means to access the data at various levels of granularity and abstraction (Rind et al., 
2011b). They can be defined as computational systems that store and process data and 
use visual representations to amplify human cognition (Sedig and Parsons, 2016; Wilson, 
2014). Interactive visualizations allow users to explore the underlying data, modify 
representations, and change different visual elements to achieve their goals. In recent 
years, several EMR-based systems have been developed to interactively visualize patient 
prescription history (Ozturk et al., 2014), potential adverse medication events (Duke et 
al., 2010), and prescription behaviors (Van der Corput et al., 2014). Most of these 
systems only represent a limited number of attributes and relationships within the data 
(Faisal et al., 2013; Kosara and Miksch, 2002; Lavado et al., 2018; A Rind et al., 2011). 
When working with high-dimensional EMR data, it can be useful to analyze hidden, non-
explicit, and unknown relationships among all the data attributes (Lee and Yoon, 2017; 
Perer et al., 2015). One of the main issues with traditional data visualization systems is 
that they do not incorporate analytical processes, which are essential for recognizing 
hidden patterns and trends in the data. Therefore, interactive data visualization systems, 
alone and without data analytics components, fall short of satisfying the computational 
needs and requirements of users. 
While beneficial, both data analytics systems, with their advanced computational 
capabilities and interactive visualization systems, with powerful interaction and 
representation mechanisms, when used individually, prove inadequate in certain 
situations. The emergence of a type of computational system known as visual analytics 
(VA) has the potential to reduce the complexity of EMR data by combining the strengths 
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and alleviate the limitations of both aforementioned systems (Parsons et al., 2015; Saffer 
et al., 2004; A. F. Simpao et al., 2014). VA can improve the capabilities of users to 
perform complex data-driven tasks by analyzing EMRs in such a way that would be 
difficult or sometimes even impossible to do otherwise. Even though VA is suitable for 
different healthcare activities (e.g., prediction of diseases, exploration of patient history, 
and identification of adverse medication events), to date, healthcare environments lag 
behind other sectors in the development of such systems (Amarasingham et al., 2014; 
Caban and Gotz, 2015; Feng et al., 2019).  
The purpose of this study is to demonstrate how VA systems can be designed in a 
systematic way: 1) to examine the association between medications and AKI, in 
particular, and 2) to support other clinical investigations involving EMRs, in general. To 
this end, we present a novel system that we have developed, called VISA_M3R3—
VISual Analytics, VISA for Multiple Regression analyses and fRequent itemset Mining 
of electronic Medical Records, M3R3. VISA_M3R3 is intended to assist clinicians and 
healthcare researchers at the ICES-KDT (Kidney Dialysis and Transplantation), located 
in London, Ontario, Canada. We demonstrate VISA_M3R3 by investigating the process 
of identifying medications and medication combinations that associate with a higher risk 
of AKI using ICES health administrative data. To our knowledge, no prior VA system 
has been designed to examine how different medications affect kidney function and 
increase the risk of developing AKI. While few VA systems have been developed for 
other areas in healthcare (Basole et al., 2015; Bernard et al., 2015; Gotz et al., 2012; 
Huang et al., 2015; Klimov et al., 2015; Mittelstädt et al., 2014; Ninkov and Sedig, 2019; 
Perer et al., 2015; A. F. Simpao et al., 2014), VISA_M3R3 is novel in that it integrates 
multiple regression models (i.e., multivariable logistic regression), frequent itemset 
mining (i.e., Eclat algorithm), data visualization, and human-data interaction mechanisms 
in an integrated fashion. As such, the design concept of VISA_M3R3 can be generalized 
for the development of other EMR-based VA systems that apply multivariable regression 
and frequent itemset mining to gain novel and deep insights into massive clinical data 
that exist for different health conditions (e.g., diabetes and heart failure, to name a few). 
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The rest of this paper is organized as follows. Section 2 provides an overview of the 
terminological and conceptual background to understand the design of VISA_M3R3. 
Section 3 describes the methodology employed for the design of the proposed VA 
system. Section 4 presents VISA_M3R3 by providing a description of its structure, 
components, and results. Finally, Section 5 discusses the usefulness and limitations of the 
proposed system and some future areas of application. 
3.2 Background 
This section presents the necessary background concepts and terminology for 
understanding the design of VISA_M3R3. VA systems fuse the strengths of automated 
analysis and interactive visualizations to allow users to explore data interactively, identify 
patterns, apply filters, and manipulate data to achieve their goals. This process is more 
complicated than an automated internal analysis coupled with an external visualization to 
show the results. It is both data-driven and user-driven and requires re-computation when 
users manipulate data through visual representations. VA not only relies on 
computational techniques and analytics but also supports human-in-the-loop mechanisms 
that allow users to employ human judgment to reach evidence-based conclusions. To 
understand the concepts of VA, we discuss the spatial structure and different modules of 
VA systems in this section. 
3.2.1 Spatial Structure of Visual Analytics 
To conceptualize the spatial structure of VA, Sedig et al. (Sedig et al., 2012; Sedig and 
Parsons, 2016) proposed its processing load to be divided into at least 5 spaces: 
information space, computing space, representation space, interaction space, and mental 
space. The information space represents bodies of data that come from different sources. 
Data may come from abstract spaces (e.g., treatment plans) or concrete spaces (e.g., 
prescriptions). Data is then processed in the computing space, which may include (1) pre-
processing techniques such as data cleaning, filtering, fusion, integration, and 
normalization and (2) data processing and transformation techniques such as data mining, 
mathematical procedures, and statistical methods. Since the underlying processing is 
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carried out in the computing space, users of the VA system ideally do not need to be 
concerned with any computational work of this space. Resulting data items are then 
encoded into perceptible visual forms in the representation space. In order to achieve 
their goals through a visually perceptible interface, users can choose actions from a set of 
available options (i.e., the interaction space) to act upon existing visualizations in the 
representation space. Finally, the mental space refers to users perceiving and processing 
changes in the interface through carrying out mental operations such as apprehension, 
induction, deduction, judgment, and memory encoding. 
In healthcare settings, it is important for the designer to find a balanced distribution of the 
processing load among the above five spaces. VA systems can offer such a balanced 
distribution of processing load through a proper integration of advanced analytics 
techniques (i.e., data mining, statistics, and machine learning) with visual representations 
to facilitate high-level cognitive activities and tasks while at the same time allowing users 
to get more involved in interactive conversation with the data through its manipulation, 
analysis, and synthesis (D. Keim et al., 2010b; Ola and Sedig, 2018; Thomas and Cook, 
2006). 
3.2.2 Modules of Visual Analytics Systems 
The information processing load in a VA system is distributed between the user and the 
main components of the VA system—namely, the analytics and the interactive 
visualization modules (Cui, 2019; Jeong et al., 2015; D. Keim et al., 2010b; Ola and 
Sedig, 2014; Parsons and Sedig, 2014; Sedig and Parsons, 2013). The data analytics 
module encompasses the computing space and deals with the analysis of data from the 
information space. The interactive visualization module encompasses representation and 
interaction spaces. 
3.2.2.1 Data Analytics Module 
Human cognition has limitations when engaged in data-intensive mental tasks, especially 
when the data is large and complex (Green and Maciejewski, 2013; Ola and Sedig, 2014). 
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The analytics module of the VA system supports user cognition by carrying out most of 
the computational load. It provides users with the ability to make time-critical decisions 
by placing the majority of the processing load in the computing space. In a VA system, 
data analytics should not be solely controlled by the system. Instead, users should be 
involved in controlling the parameters, settings, and intermediary steps of the processing 
stage. The primary responsibility of the analytics module is to store, prepare, analyze, 
transform, and perform computerized analysis of the raw data. In the context of VA, the 
analytics process can be divided into three main stages: data pre-processing, data 
transformation, and data analysis (Ola and Sedig, 2014). 
The raw data from the information space gets processed in the pre-processing stage. Data 
often contains errors, exceptions, noise, and/or uncertainty. There are several possible 
reasons for having inaccurate data in EMRs. For instance, problems might arise from 
confusing data collection manual, faulty instruments, or incorrect data entry. The data 
analytics module might derive incorrect patterns if the data is noisy or erroneous. 
Therefore, it is very important to pre-process raw EMR data retrieved from a variety of 
sources. Data pre-processing includes cleaning, integration, and reduction (Han et al., 
2011). 
The pre-processed data is then transformed into forms appropriate for data analytics 
algorithms. The quality of information, knowledge, and insight extracted from a dataset 
can be improved by its transformation (Kusiak, 2001). Strategies for data transformation 
may include smoothing, attribute construction (i.e., feature generation), aggregation, 
normalization, and discretization (Han and Kamber, 2011). 
Finally, data analysis is the stage to uncover previously undetected relationships among 
data items and extract the implicit, previously unknown, and possibly useful information 
from data (Agrawal et al., 1993; Sahu et al., 2008). The data analysis process includes, 
but is not limited to, frequent itemset mining, regression, classification, and clustering. 
Usually, these techniques allow analysis of limited types of variables and do not support 
heterogeneous data (D. Keim et al., 2010b). VA systems overcome this limitation by 
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incorporating interactive visualizations and human reasoning in the decision-making 
loop. 
3.2.2.2 Interactive Visualization Module 
Interactive visualization is an integral part of VA for organizing data items in the 
information space and mapping them to visual structures. Interactive visual 
representations provide users with the ability to change and modify the displayed data 
and to guide the analysis process. This, in turn, will set off a chain of internal reactions 
that lead to the execution of additional data analysis processes. Interactive visualizations 
can potentially bridge the gap between the internal mental representation of the user and 
the external representations of the system by allowing the information processing load to 
be distributed between the user and the system. 
Design of visualizations is straightforward when dealing with simple tasks. As tasks 
require completion of one or more subtasks, they become more complex. As tasks 
become more complex, design becomes less apparent, particularly when dealing with 
massive amounts of heterogeneous data (Heer and Kandel, 2012; Sedig and Parsons, 
2013). To support complex, EMR-driven tasks, visualizations require some initial 
analysis (D. Keim et al., 2010b). For instance, the task of identifying high-risk 
medications for a certain medical condition includes sub-tasks such as finding association 
between the medical condition and medications (through data analysis), observing their 
relationships (through visual representations), and filtering medications that are 
associated with the medical condition (through analysis and visualization). Furthermore, 
because external structures of data affect how users perform tasks, another challenge 
involves determining how to organize a large number of data items in the visual 
representations. To support the performance of complex tasks, VA combines advanced, 
behind-the-scene analytics techniques with interactive external visualizations that 
organize data items (Kehrer and Hauser, 2013; Keim et al., 2008). 
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3.2.3 Visual Analytics and Analytical Reasoning 
User-triggered actions, consequent reactions, and discourse with information are essential 
in a VA system whose function is to facilitate users' analytical reasoning activities—
activities that refer to both rational and logical analysis of data as well as evaluation of 
results. Such activities also involve analogical, deductive, and inductive reasoning to 
reach conclusions (Sedig and Parsons, 2013), and emerge from a series of lower-level 
tasks (e.g., developing hypotheses or identifying relationships among data elements) 
(Heuer, 1999; Thomas and Cook, 2006). In order to reach a conclusion, some of these 
lower-level tasks take place in an iterative and non-linear manner depending on cognitive 
needs and overall goals of the user (Sedig and Parsons, 2013). Generally speaking, 
analytical reasoning can be viewed as transforming given data into information, 
knowledge, and insight (Gilhooly, 2004; Sedig and Parsons, 2013). This derived 
knowledge and insight serves as a foundation for other cognitive activities such as 
decision-making or problem-solving (Han et al., 2011; Leighton, 2004). 
EMRs contain large bodies of complex data, and, oftentimes, EMR-driven tasks are ill-
defined. Thus, users have to rely on their experience, knowledge, and judgement to 
perform complex activities (i.e., decision-making and problem-solving) in a healthcare 
setting (Varga and Varga, 2016). Human-in-the-loop mechanisms involving interaction 
with the visual and analytical modules of VA systems can thus help healthcare activities 
(Green and Maciejewski, 2013). 
3.3 Materials and Methods 
This section describes the methodology we have employed to design the proposed VA 
system, namely VISA_M3R3. For our EMR-based data, we use Ontario’s healthcare 
databases housed in the ICES facility to illustrate how VISA_M3R3 can be used to 
identify AKI-associated medications and medication combinations among older patients. 
In Section 3.1, we provide an overview of the design process and participants. We then 
describe data sources and cohort entry criteria in Sections 3.2 and 3.3, respectively. 
Section 3.4 explains the implementation details of our VA system. Finally, in Section 3.5, 
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we introduce the components of VISA_M3R3 and briefly describe how the overall 
system works, which is also discussed more extensively in Section 4. 
3.3.1 Design Process and Participants 
Healthcare tasks usually include both well- and ill-defined problems. The well-defined 
tasks have specific goals, clear expected solutions, and, oftentimes, a single solution path. 
On the contrary, ill-defined tasks do not have clear goals, expected solutions, or solution 
paths (Arifin et al., 2017).  
To help us understand how healthcare practitioners perform real-world tasks, and to help 
us conceptualize and design VISA_M3R3, we adopted a participatory design approach. 
Participatory design is a co-operative approach that involves all stakeholders (e.g., 
partners, end-users, or customers) in the design process to ensure the end product meets 
their needs (Muller, 2007).  A clinician-scientist, a statistician, an epidemiologist, data 
scientists, and computer scientists were involved in the design and evaluation process of 
VISA_M3R3. During the initial stage in the participatory design process, we realized that 
healthcare experts solve ill-defined problems in many different ways. It is difficult and 
sometimes impossible to determine a single correct problem-solving strategy (i.e., 
analytics and/or visualization techniques) for ill-defined tasks. Different techniques have 
their strengths and weaknesses, and there are different criteria to find out which technique 
is more appropriate for a specific problem. As such, we asked experts to provide us with 
1) a list of varying real-world, EMR-driven tasks that they perform, 2) analytics 
techniques they usually rely on to accomplish those tasks, 3) visualization techniques 
with which they are familiar, and 4) formative feedback on design decisions. In our 
collaboration with experts, we recognized two high-level tasks to consider in designing 
VISA_M3R3 system. 1) They would like to study the relationships between prescribed 
medications and AKI; 2) They would like to identify commonly prescribed medication 
combinations and understand the impact of different combinations on AKI. We were told 
that healthcare experts usually use different regression techniques to accomplish these 
types of tasks. Since the system has been designed to assist clinicians and healthcare 
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researchers at the ICES-KDT program, we decided to incorporate the analytical and 
visualization techniques with which they are more familiar. This was essential to build 
trust between the proposed system and its end-users. 
3.3.2 Data Sources 
For the particular version of VISA_M3R3, we are primarily interested in analyzing 
medications prescribed to older hospitalized patients in Ontario. Accordingly, we 
obtained patient characteristics, prescriptions, and hospital admission data from 5 health 
administrative databases. We used the Ontario Drug Benefit Program database to get 
medication use data. We acquired patient characteristics data from the Registered Persons 
Database, which contains demographic data on all Ontario residents who have ever been 
issued a health card. We obtained hospital admissions and emergency department (ED) 
visit data from the Canadian Institute for Health Information Discharge Abstract 
Database and National Ambulatory Care Reporting System, respectively. International 
Classification of Diseases, ninth (pre-2002), and tenth revision (post-2002) codes was 
used to identify the baseline comorbidities and incidence of AKI from ED visit and 
hospital admission data. 
3.3.3 Cohort Entry Criteria 
We developed a cohort of individuals aged 65 years or older who were admitted to 
hospital or who visited the ED between April 1, 2014 and March 31, 2016. The ED visit 
date or hospital admission date served as the index (cohort entry date). If an individual 
had multiple ED visits or hospital admissions, we selected the first incident. Individuals 
with an invalid healthcare number, age, and/or sex were excluded from the cohort. A 
120-day look-back window from the index date was used to capture the associated 
medication use data. We used a 5-year look-back window to identify relevant baseline 
comorbidities. 
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3.3.4 Implementation Details 
The current VISA_M3R3 system is implemented in HTML, JavaScript library D3, 
standard PHP programming language, and R packages. R was used to develop the 
Analytics module. Html and D3 were used to create various external representations in 
the Visualization module. The communication between these two modules is 
implemented using PHP and JavaScript.  
Most of the data analytics components were developed in R (version-3) because it 1) 
provides extensive support for carrying out data mining operations such as regression and 
frequent itemset mining, 2) is available in ICES workstations, 3) has a vast array of 
libraries, 4) is a platform-independent tool, 5) is an open-source tool, and 6) is constantly 
growing and providing updates whenever new features are available. 
We used D3 to implement external representations of the Visualization module because 
of the following reasons. 1) D3 offers a data-driven approach to help users attach their 
data to the DOM (Document Object Model) element. 2) It allows users to get access to 
full capabilities of modern web-browsers. 3) D3 uses a functional style that enables users 
to reuse JavaScript code and add functionalities. 4) It is compatible with other 
programming languages and platforms that have been used in this system. And 5) D3 is 
free and open-source software. 
3.3.5 Workflow 
As shown in Figure 1, VISA_M3R3 has three modules: Analytics, Visualization, and 
Interaction. The Analytics module is composed of two components: 1) single-medication 
analyzer and 2) multiple-medications analyzer. The Visualization module is composed of 
five views: 1) single-medication view, 2) multiple-medications view, 3) frequent-itemsets 
view, 4) covariates view, and 5) medication-hierarchy view. The Interaction module 
provides users with six main actions: 1) arranging, 2) drilling, 3) filtering, 4) searching, 
5) selecting, and 7) transforming. The basic workflow of the system is as follows. 
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First, an integrated dataset is created from different EMR databases stored at ICES. Next, 
the inclusion and exclusion criteria are applied to build the final cohort. The variables in 
the comorbidity and prescription data are then encoded and transformed into forms 
appropriate for analysis. After applying pre-processing techniques, we split the dataset 
into two groups. One contains the single medication data, and the other contains 
medication combination data; the latter is generated from the frequent itemset mining 
algorithm. We develop a number of multivariable regression models on both groups of 
data. The models are then validated through Bonferroni correction and mapped into 
respective visual representations. We developed five views to represent data items 
created from different analysis techniques. The output of the single-medication and 
multiple-medications analyzers are encoded into two scatter plots in the single-
medication and multiple-medications views, respectively. The frequent-itemsets view 
represents the result of the frequent itemset mining algorithm using a chord diagram. The 
covariates view allows users to control the information presented in other views though 
sliders. The medication-hierarchy view includes a data table to display additional 
information about data elements from the original dataset. Users are allowed to perform a 
number of actions on the visual representations to manipulate data items. For instance, 
users can highlight and/or filter out certain items and drill down into the details of the 
selected data elements in different views. 
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Figure 3-16: Workflow diagram of VISA_M3R3. Different colors are used to show 
the separation of the three main modules. 
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3.4 Design of VISA_M3R3 and Results 
In this section, we describe the three main components of VISA_M3R3 as well as some 
results. Section 4.1 (Analytics module) explains how the data is processed and offers a 
summary of its results. Section 4.2 (Visualization module) describes VISA_M3R3's 
interfaces and discusses how the system helps users in interpreting results. Finally, 
Section 4.3 (Interaction module) illustrates how users can interact with the displayed 
data. 
3.4.1 Analytics Module 
We use VISA_M3R3 to analyze ICES' EMRs to identify individual medications and 
medication combinations that are associated with AKI. Our system aims to facilitate 
understanding of relationships among medications, medication combinations, and AKI. 
The Analytics module of VISA_M3R3 performs an individual and group analysis using 
logistic regression and frequent itemset mining to achieve this goal. 
3.4.1.1 Single-Medication Analyzer   
Single-medication analyzer includes the regression models created to identify the 
association between each medication and AKI. In order to capture an accurate 
association, we include the demographic and comorbidity variables as potential 
covariates in the models. For demographics (i.e., the study of a population based on 
certain non-medical factors), we include the following variables in the models: age, sex, 
income quintile, rural location, and long-term care. For comorbidity (commonly defined 
as any distinct additional disease or condition that has existed during the clinical course 
of a patient who has the first disease or condition under observation), we include the 
following variables in the models: diabetes mellitus, hypertension, heart failure, coronary 
artery disease, cerebrovascular disease, peripheral vascular disease, chronic liver disease, 
chronic kidney disease, major cancers, and kidney stones. We obtain the medication 
prescription data from the Ontario Drug Benefit Program database. This database 
includes medication name, medication dose, date filled, and route-of-administration of 
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the prescriptions. We identify 595 different medications by analyzing prescriptions that 
have been filled 120 days before the index date. Thus, we create 595 binary variables to 
record the medication use data for each medication and each patient. We also gather the 
class and subclass information of these medications from the literature.  
We combine data from different sources into a single dataset. The combined dataset 
contains 5 demographic, 10 comorbidity, and 595 medication variables for each patient 
included in the cohort. In total, there are 926,005 unique patients in the dataset. Next, we 
apply the necessary pre-processing and transformation techniques on the combined 
dataset to make it ready for the regression analysis. We use the “glm” function in R 
packages to develop separate multivariable logistic regression models (Williams et al., 
1984) for each medication in the dataset. Thus, the regression formula includes AKI as 
the response variable and medication, demographics, and comorbidities as predictor 
variables. The “family” argument in the “glm” formula is set to “binomial”. We use the 
“summary” function to obtain the estimate, p-value, standard error, and z-score for each 
coefficient. In addition, the “confit” function is used to compute 95 percent confidence 
intervals and odds ratio.  
VISA_M3R3 provides users with the ability to compare regression models based on their 
odds ratios, confidence intervals, p-values, and standard errors. Odds ratio measures the 
association between medication and AKI. A high odds ratio for a specific medication 
indicates a stronger positive association between that medication and AKI. A list of 
statistically significant medications is created by filtering models based on the p-value of 
the medication variable’s coefficient. A small p-value indicates that it is unlikely that an 
observed relationship between the predictor (i.e., medication) and response variable (i.e., 
AKI) is due to chance. Out of 595, we find 55 medications that are strongly associated 
with AKI. In order to avoid false positives when comparing multiple independent models, 
we make the alpha value lower based on the Bonferroni correction to account for the 
number of comparisons being done. A p-value less than 8.4e-5 (divide 0.05 by 595) is 
considered to be statistically significant in this context. Next, we calculate the frequency 
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of each medication in the list. Data items produced through the single-medication 
analyzer include odds ratios, confidence intervals, p-values, standard errors, and usage 
frequencies of 55 medications. Users of VISA_M3R3 can explore and manipulate these 
data items to make sense of how an individual medication can affect AKI. Users’ 
sensemaking tasks include, but are not limited to, identifying medications with high odds 
ratio and lower p-value, understanding the comparative risk of medications, assessing the 
behavior of medication class or subclass, and exploring data items at various levels of 
abstraction. 
3.4.1.2 Multiple-Medications Analyzer   
In order to identify the medication combinations that are associated with AKI, we first 
prepare a dataset of frequently prescribed medications. Since we have 595 individual 
medications, the total number of combinations is a large number. Therefore, we use the 
Eclat algorithm (Agrawal et al., 1993) to obtain frequent combinations with a support of 
0.07%. Eclat is a frequent itemset mining algorithm that employs a depth-first search to 
discover groups of items that frequently occur in a transaction database. An itemset that 
appears in at least a pre-defined number of transactions is called a frequent itemset. At 
this stage, a total of 24,212 frequent itemsets (i.e., medication groups) are produced from 
595 individual medications. 
A number of binary variables are created to record the usage of the mediation groups. We 
set the value of a particular medication group for a patient when that patient has been 
dispensed all medications within the group within 120 days before the index date (at least 
once per medication). Next, we apply a multivariable logistic regression model on each 
medication group to identify potential accumulative nephrotoxicity. The formula includes 
group variables, individual medication variables that belong to the group, demographic 
variables, and comorbidities as predictors. Statistically significant medication groups are 
identified by filtering the models based on a Bonferroni-corrected alpha value (divide 
0.05 by the number of medication groups). We also calculate the usage frequency of 78 
medication groups that are found to be statistically significant.  
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In the multiple-medications analyzer, we employ a combination of frequent itemset 
mining and logistic regression to generate data items such as frequent medication 
combinations, statistically significant medication groups, p-values, odds ratios, 
confidence intervals, and standard errors. These data items allow users to understand the 
synergistic effect of a combination of different medications on AKI. Users’ sensemaking 
tasks include, but are not limited to, identifying medication groups with high impact on 
AKI, understanding the comparative risk of medications within a group, and exploring 
data items at various levels of abstraction. VISA_M3R3 organizes data items in different 
visual representations to allow users to perform these tasks. 
3.4.2 Visualization Module 
VISA_M3R3 (Figure 2) is composed of five main views: single-medication view, 
multiple-medications view, covariates view, medication-hierarchy view, and frequent-
itemsets view. These views are supported by a number of selection controls, such as 
search bar and collapsible tree structure. Each of these visualizations represents an 
important aspect of the Analytics module. In this section, we discuss how data items 
generated in the Analytics module are encoded as visual representations to allow users 
perform the activities and tasks mentioned in the previous section. 
3.4.2.1 Single-Medication View  
Single-medication view uses a scatter plot to represent the results of individual regression 
models for all the medications, as displayed in Figure 3. The generated scatter plot 
displays each model in proximity to each other based on their p-value and odds ratio. A 
linear scale is used for the vertical axis (odds ratio), whereas a log scale is used for the 
horizontal axis (p-value) since the p-value is exponential. Medications that are plotted 
closer together affect the risk of developing AKI in a similar manner. The regression 
model for each medication is encoded as a glyph where horizontal lines on both sides of 
each circle represent the confidence interval, and the vertical line shows the standard 
error of the model. The single-medication view enables users to identify high-risk 
medications that are associated with AKI and understand the comparative risk of these 
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medications. For instance, the glyph in the top-right corner with a p-value of 1e-45 and 
an odds ratio of 2.4 represents Metolazone. These values suggest that the odds of 
developing AKI for a patient using this medication are more than two times higher than a 
patient with similar conditions who is not using it. 
 
 
Figure 3-17: The Visualization module of VISA_M3R3 is composed of five views: 
(A) single-medication view, (B) multiple-medications view, (C) covariates view, (D) 
medication-hierarchy view, and (E) frequent-itemsets view. 
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Figure 3-18: Scatter plot of single-medication view. 
3.4.2.2 Multiple-Medications View  
The multiple-medications view, displayed in Figure 4, uses another scatter plot to 
represent the results of the regression analysis of groups that are created by the frequent 
itemset mining algorithm. Each glyph in this scatter plot encodes a medication group 
model. Similar to the single-medication view, horizontal lines on both sides of each circle 
in the glyph represent the confidence interval, and the vertical line shows the standard 
error of the model. We map the p-value and odds ratio to the x- and y-axis, respectively. 
The multiple-medications view provides users with the ability to detect medication 
groups that are associated with AKI. For instance, through frequent itemset mining 
analysis, we find that the pair of Gabapentin and Furosemide medications are frequently 
prescribed together. As shown in Figure 4, this pair appears to be associated with AKI 
with a p-value of 1e-26. 
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Figure 3-19: Scatterplot of multiple-medications view. 
3.4.2.3 Frequent-Itemsets View  
Frequent-itemsets view represents the result of the frequent itemset mining analysis by 
showing all possible combinations of the most frequent items using a chord diagram. As 
shown in Figure 5, medications are mapped to nodes along the circumference of the 
circle. Each node consists of an individual circle and a text field showing the name of the 
medication. Each chord (link) connects two nodes (medications) if they co-occur in the 
dataset within a certain timeframe. For instance, as shown in Figure 5, there are links 
between Moxifloxacin Hcl and three other medications (Furosemide, Allopurinol, and 
Amlodipine besylate) because these three medications have been prescribed with 
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Moxifloxacin Hcl more than a certain number of times (0.07 percent of the total 
population) within 120 days prior to the index date.  
The size of the circle of each node displays the frequency of the medication in the 
dataset. Higher usage frequency of a certain medication results in a larger radius for the 
circle representing that medication. This allows users to visually compare medications 
based on their use frequency. For instance, a relatively large radius of the circle 
representing Ramipril indicates that it is one of the frequently prescribed medications in 
Figure 5-B. 
The nodes that belong to the same subclass are placed close to each other separated by 
spaces. This enables users to visually identify the nodes that share common 
characteristics (i.e., belong to the same subclass). For instance, users can detect that 
Furosemide, Hydrochlorothiazide, Metolazone, Indapamide, and Chlorthalidone are all 
Diuretics; therefore, they are placed in the same group (Figure 5-A). The frequent-
itemsets view also reveals subclasses that are composed of a higher number of AKI-
associated medications. It can be observed from Figure 5 (C-1 and C-2) that there are two 
subclasses (Angiotensin and Beta-blockers) that contain six medications that are 
associated with AKI. 
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Figure 3-20: Chord diagram showing the results of the frequent itemset mining 
analysis in the frequent-itemsets view. 
3.4.2.4 Covariates View 
The covariates view is composed of several sliders that filter data items with respect to 
different covariates involved in the regression model. The number of sliders depends on 
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the number of covariates that are found to be statistically significant based on the result 
of the regression analysis. As displayed in Figure 6, six sliders are generated to create 
control for cancer, diabetes, hypertension, heart failure, coronary artery disease, and 
coronary liver disease.  
Each slider included in the covariates view has three components (a rectangle, vertical 
lines, and two arc-shaped handles). The rectangle contains the other two components in 
it. The length of the rectangle represents a linear or log scale, depending on the type of 
variable it is representing. A linear scale is used when the slider represents the odds ratio 
of a covariate. We use a log scale to represent the p-value of a covariate. All sliders are 
generated based on the p-value of the covariates. The vertical lines in the rectangles 
represent the regression models of both single-medication and multiple-medications 
analyzers. The placement of the line on the horizontal axis depends on the p-value or 
odds ratio of the covariate in the corresponding model. For instance, in the slider 
representing diabetes (second from the top in Figure 6), most of the models are densely 
clustered in the right corner. This indicates that diabetes has a high impact on the 
association between medications and AKI. Two arc-shaped handles are placed on both 
ends of the rectangle to allow users to choose a range of values on the horizontal axis. 
3.4.2.5 Medication-Hierarchy View 
The medication-hierarchy view contains a data table to provide a list of medications that 
have been selected through other views, as displayed in Figure 7. The table has three 
sortable columns for medications, subclasses, and higher-level classes. Each subclass 
contains a set of medications that share common chemical structures and mechanisms of 
action, and/or are used to treat similar diseases. A class contains medication subclasses 
that can be grouped together because of their similarity. 
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Figure 3-21: Six sliders representing different covariates in the covariates view. 
 
 
Figure 3-22: The medication-hierarchy view shows the list of medications and their 
classes and subclasses. 
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3.4.3 Interaction Module 
The Interaction module of VISA_M3R3 is intended to support human-in-the-loop 
processes of VA. Using the many interactions provided by this module, users can gain 
insight into the data and manipulate the incorporated data analysis techniques. In this 
section, we will explore these interactions and discuss how they assist users in identifying 
high-risk medications and understanding the association between medication groups and 
AKI. We describe interactions that can be performed in each of the views discussed in the 
previous section. These interactions not only affect displayed data at the selected view 
but also change the representation of the data in other views. 
3.4.3.1 Single-Medication View Interactions 
As shown in Figure 8, the glyphs representing regression models of individual 
medications are placed very close to each other in the scatter plot. It is sometimes 
difficult for users to distinguish between models when the glyphs are densely clustered. 
In order to address this issue, we use the Cartesian fisheye distortion technique on both 
axes of the scatter plot. Fisheye distortion enables users to zoom in on small areas of the 
plot without losing sense of its overall structure. Users can apply fisheye distortion by 
moving their mouse pointer over the grey rectangular areas on both axes of the scatter 
plot. Fisheye distortion magnifies the local region around the mouse continuously. Users 
have the ability to enable and disable the fisheye distortion action by clicking on the grey 
rectangular areas. The color of the rectangular area gets lighter when the fisheye 
distortion action is disabled. As shown in Figure 8, fisheye on the top-left scatter plot is 
disabled (light grey rectangles) and bottom-left scatter plot is enabled (relatively dark 
grey rectangles). 
The model selection interaction of the single-medication view affects all the other views. 
Using this interaction (Figure 8), users can highlight a single medication model 
throughout VISA_M3R3 in order to 1) determine positions of group models that include 
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the selected medication in the multiple-medications view, 2) detect the position of the 
selected medication in the covariates view, 3) observe the class and subclass of the 
selected medication in the medication-hierarchy view, and 4) identify other medications 
that are frequently prescribed with the selected medication in the frequent-itemsets view. 
The selected medication is highlighted using the red color in the top-left scatter plot in 
Figure 8. The glyphs representing corresponding groups in the bottom-left scatter plot, 
vertical lines representing the medication in the covariates view, and links between 
selected medication and other frequently used medications in the frequent-itemsets view 
are all highlighted using the amber color. The utility of this interaction is when users are 
interested in learning more about a medication that is strongly associated with AKI. They 
would select a glyph at the top-right corner of the scatter plot, whereupon VISA_M3R3 
would highlight and display the relevant information associated with that glyph. Another 
interaction supported by this view is hovered drilling. This interaction enables users to 
drill into scatter plot glyphs and get additional information about their corresponding 
model (Figure 3). 
 
Figure 3-23: Overview of interactions in the single-medication view. 
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3.4.3.2 Multiple-Medications View Interactions 
We designed the interactions of the multiple-medications view in a similar manner to the 
interactions of the single-medication view. The only difference is how we have designed 
the selection interaction. The group model selection interaction affects all the other 
views. Using this interaction (Figure 9), users can highlight a group model throughout the 
system in order to 1) identify the position of single models included in the selected group 
in the single-medication view, 2) determine the position of the selected group in the 
covariates view, 3) observe the class and subclass of medications included in the selected 
group in the medication-hierarchy view, and 4) highlight the nodes and links representing 
the group in the frequent-itemsets view. To maintain consistency across all views, the 
color scheme of the multiple-medications view is similar to the single-medication view. 
This interaction can be used when users want additional information about a specific 
group model; they can select the corresponding glyph and observe whether medications 
included in the selected group are associated with AKI individually in the single-
medication view. 
 
Figure 3-24: Overview of interactions in the multiple-medications view. 
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3.4.3.3 Covariates View Interactions 
The single-medication and multiple-medications analyzers produce a set of regression 
models. These models can be described by a certain number of common attributes (e.g., 
p-value and odds ratio of each covariate) because all of them include the same set of 
demographic and comorbidity variables as their covariates. The value of an attribute 
changes based on how each covariate affects the model. It is essential to understand the 
impact of covariates on both single and group models.  
Users can create complex queries composed of several simpler queries related to 
attributes of different covariates. In each simple query, users apply a filter to the models 
by selecting a specific range in each slider. Figure 10 shows an example of a complex 
query involving p-value of six covariates. Users can drag both ends of the given sliders to 
choose a certain range. The color of the range selector changes from green to red when a 
slider is active. The color of the vertical line representing the model changes from grey to 
amber when the corresponding model satisfies the criteria of the complex query. Also, 
the medication-hierarchy view displays the list of models that meet the criteria of the 
complex query. 
 
Figure 3-25: Overview of interactions in the covariates view. 
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In many situations, users struggle to choose appropriate ranges for the sliders. As a result, 
the query might produce an empty or a limited result set. In order to address this issue, 
we implemented a sensitivity encoding mechanism in VISA_M3R3 (Spence, 2002). The 
sliders are set to their maximum and minimum ranges by default. In this case, the color of 
the glyphs in both scatter plots is set to green because all models satisfy the query. The 
color of the glyph in the scatter plots encodes the number of simple queries its 
corresponding model satisfies in the covariates view, as shown in Table 1 and Figure 10. 
Table 3-4: Sensitivity encoding using color coding of glyphs. 
Number of 
satisfied 
filters 
Color of the 
glyphs 
6 Green 
5 Black 
4 Blue 
3 Cyan 
2 Purple 
1 Grey 
0 Yellow 
3.4.3.4 Frequent-Itemsets View Interactions 
The selection interaction of the frequent-itemsets view affects the single-medication 
view, covariates view, and medication-hierarchy view. Using this action (Figure 11), 
users can select a single medication from the chord diagram by clicking on its 
corresponding node in order to 1) identify other medications that are frequently 
prescribed with the selected medication in the frequent-itemsets view, 2) understand the 
association between the selected medication and AKI in the single-medication view, 3) 
determine the position of the selected medication in the covariates view, and 4) observe 
the class and subclass of the selected medication in the medication-hierarchy view. 
Figure 11 shows an example of this interaction. Selecting Moxifloxacin Hcl would 
highlight the links and the names of the other medications (i.e., Furosemide, Allopurinol, 
and Amlodipine besylate) that are frequently consumed with Moxifloxacin Hcl. 
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3.4.3.5 Medication-Hierarchy View Interactions  
Medication-hierarchy view supports two interactions as shown in Figure 12. Users can 
sort the table based on medication name, subclass, or class by clicking on the 
corresponding column header. For instance, if they click on “Medication”, medication 
names in the table get sorted alphabetically. They can also sort in the opposite order by 
clicking on the same header again. In addition, users can click on any row in the table to 
select the corresponding medication or medication groups. Selected medications get 
highlighted in all other views. 
 
Figure 3-26: Overview of interactions in the frequent-itemsets view. 
3.4.3.6 Selection Controls  
Selection controls include a search bar, a collapsible tree structure, and several buttons to 
control the information displayed in different views (top-right corner of Figure 12). If 
users are interested in learning about a specific medication, they can enter the name of 
that medication (or part of the name) in the search bar and the information related to that 
medication gets displayed in the medication-hierarchy view. Users can expand the tree 
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structure by clicking on the “+” icon at the top-right corner to get a menu of medication 
subclasses. Each item in the menu is linked to a checkbox. It is possible to limit data 
items displayed in other views by selecting these checkboxes. For instance, as shown in 
Figure 12, users have selected a number of subclasses such as Iron preparations, 
Vasodilator antihypertensive, and Antiemetics & Antinauseants in the collapsible tree 
structure to limit the number of data items shown in the scatter plots, data table, and 
chord diagram. 
 
Figure 3-27: Overview of interactions in the medication-hierarchy view and 
selection controls. 
3.5 Discussion 
In this paper, we have shown how VA systems can be designed to address the challenges 
of prescription data stored in EMRs in a systematic way. To achieve this, we have 
reported the development of VISA_M3R3, a VA system designed to assist medical 
researchers at ICES’ KDT program. VISA_M3R3 incorporates three main components: 
an Analytics module, made up of single-medication analyzer and multiple-medications 
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analyzer; a Visualization module, made up of five views: single-medication view, 
multiple-medications view, covariates view, frequent-itemsets view, and medication-
hierarchy view; and an Interaction module, made up of a set of different human-data 
interactions. VISA_M3R3 is unique in the manner in which it combines multivariable 
regression with Eclat to support underlying processing in the computing space and 
implements fisheye and sensitivity encoding to provide support for the representation and 
interaction spaces. It offers a balanced distribution of processing load through a proper 
integration of analytics techniques (i.e., regression and frequent itemset mining in the 
Analytics module) with visual representations (i.e., different interactive views in the 
Visualization module) to facilitate high-level cognitive tasks. Some of the main tasks 
commonly performed by researchers, and which VISA_M3R3 is designed to support, 
include: 1) compare multiple regression models, 2) understand the relationship between 
different predictors and a response variable, 3) identify the frequent itemsets from items 
of interest, and 4) interpret multivariable regression models. VISA_M3R3 is primarily 
designed as a research tool for the medical researchers at ICES’ KDT program, and it is 
up to them to decide how this system will be applied within the healthcare system. A 
number of training materials have been prepared to assist new users who are not familiar 
with the analytics and visualization techniques incorporated in VISA_M3R3 to use the 
system effectively. 
We have demonstrated how VISA_M3R3 can be used to detect AKI-associated 
medications among older patients who visited the hospital or emergency department in 
Ontario between 2014 to 2016 using ICES health administrative data. We have seen that 
VISA_M3R3 allows healthcare researchers to generate hypotheses, understand the 
relationships among data elements (e.g., medications and diseases), and recognize 
patterns and trends that would be otherwise difficult to identify. About 9% of all the 
medications that are prescribed to the older patients have been found to be associated 
with AKI. Using VISA_M3R3, we detect 55 medications (Furosemide, Allopurinol, 
Hydrochlorothiazide, Atorvastatin, Spironolactone, Olmesartan Medoxomil, to name a 
few) and 78 medication combinations (Furosemide & Oseltamivir Phosphate, Allopurinol 
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& Metolazone, Celecoxib & Quetiapine, and so on) that are associated with an increased 
risk of AKI. In general, medications belong to Angiotensin Receptor Blockers, Diuretics, 
Nonsteroidal Anti-inflammatory, and Xanthine Oxidase Inhibitors classes are found to be 
strongly associated with AKI. Moreover, some combinations of medication classes such 
as Anti-inflammatory & Antidepressants and Diuretics & Antiviral Agents have been 
identified with the evidence for increased risk of developing AKI. The lists of 
medications and medication combinations have been reviewed by a nephrologist to 
validate the results. Most of these medications are already known to be nephrotoxic in the 
existing literature, which confirms the accuracy of our findings through VISA_M3R3 
(Chao et al., 2015; Kwok M. Ho and Power, 2010; Perez-Ruiz, 2017; Pierson-
Marchandise et al., 2017; Verdoodt et al., 2018; Wu et al., 2014). 
In terms of the extensibility and scalability of VISA_M3R3, we have designed it in a 
modular way so that it can easily accept new data sources, data types, and analysis 
techniques. VISA_M3R3 can be used to investigate many other clinical problems, such 
as identifying risk factors associated with hypertension, and understanding the 
relationship between dietary habits and diabetes. To test the applicability of the system in 
different healthcare areas, we have used VISA_M3R3 to detect hospital admission codes 
(i.e., reasons for hospitalization) that are associated with AKI using healthcare utilization 
database housed at ICES. We detected 8,543 itemsets by analyzing the hospital admission 
codes that co-occur frequently. Using VISA_M3R3 to analyze this data, 185 individual 
codes and 215 group codes are found to be statistically significant. The top few reasons 
for hospitalization (representing admission codes associated with AKI) include 1) 
Essential hypertension, 2) Malignant neoplasm of bladder, 3) Non-follicular (diffuse) 
lymphoma, 4) Mycosis fungoides, 5) Iron deficiency anemia, and 6) Chronic obstructive 
pulmonary disease. This result also aligns with what has already been known from the 
literature, which more generally and comprehensively proves the efficacy of 
VISA_M3R3's design (Anderson et al., 2010; Da’as et al., 2001; Kandler et al., 2014; 
Malbrain et al., 1994; Martines et al., 2013). 
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There are four key limitations to the development of VISA_M3R3. The first one is that it 
reports the regression analysis result of the group models but does not consider how 
individual items within the group are affecting the outcome. For instance, in the study 
with medications, VISA_M3R3 reveals that the combination of Furosemide and 
Metoprolol increases the risk of AKI. However, it does not explain the additive risk of 
using Metoprolol with or without Furosemide and vice versa. This issue can be resolved 
by incorporating a stratified analysis on each item available in at least one group. The 
second limitation is that, even though we have had a participatory design and medical 
experts have evaluated VISA_M3R3 and have found it very useful and usable, we have 
not conducted any formal experimental usability studies to evaluate its performance, nor 
the efficacy of its human-data discourse mechanisms. The third one is that VISA_M3R3 
incorporates a limited number of analytics techniques. Although there are more advanced 
machine learning algorithms in the literature, we decided to design the system based on 
techniques that are more interpretable to our end-users (i.e., clinicians and healthcare 
researchers). Fourth, the preparation of the dataset for VISA_M3R3 could be labor-
intensive in some situations, depending on the data source and problem at hand. 
However, there are a number of readily available libraries and packages available to 
assist users with the data cut and preparative work. 
3.6 Conclusion 
The purpose of this study is to demonstrate how VA systems can be designed in a 
systematic way to support EMR-driven tasks and investigation of different clinical 
problems. We report the development of a VA system (called VISA_M3R3) and 
demonstrate how it can be used to help medical practitioners and researchers identify 
medications and medication combinations that associate with a higher risk of AKI. 
VISA_M3R3's novelty stems from its design: it incorporates multivariable regression, 
frequent itemset mining, data visualization, and human-data interaction mechanisms in an 
integrated fashion to support ill-defined, complex EMR-driven tasks. Using 
VISA_M3R3, we analyzed ICES health administrative data. Through this analysis, 55 
medications and 78 medication groups, strongly associated with AKI, were identified. 
85 
 
 
 
Although, through clinical studies, a number of these AKI-associated medications and 
medication groups are known by medical researchers, some of them have never been 
studied before. VISA_M3R3 can alert and raise physicians' awareness of such potentially 
AKI-associated medications. This, in turn, can prompt healthcare providers to conduct 
further clinical investigations to improve healthcare research outcomes. Finally, 
VISA_M3R3's design concepts are generalizable. They can be used to systematically 
develop any VA system whose goal is to support medical tasks involving analysis of 
EMR data using multiple regression models and frequent itemset mining. Applications of 
such VA systems can lead to the emergence of best practices for developing similar VA 
systems in other medical domains. 
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Chapter 4  
4 Machine Learning for Identifying Medication-Associated 
Acute Kidney Injury   
This chapter has been published as S.S. Abdullah, N. Rostamzadeh, K. Sedig, D. J. 
Lizotte, A.X. Garg, and E. McArthur, “Machine Learning for Identifying Medication-
Associated Acute Kidney Injury” in the Health Section of the Informatics 
Journal, Volume 7; May 2020. We changed the format to match the general format of the 
dissertation. Figure, Table, and Section numbers specified herein are relative to the 
chapter number. For example, “Table 1” corresponds to Table 4-1; “Figure 1” 
corresponds to Figure 4-1; and “Section 1.1” corresponds to Section 4.1.1. Moreover, 
when the term “paper”, “research”, or "work" is used, it refers to this specific chapter. 
4.1 Introduction 
Acute kidney injury (AKI), defined as a sudden loss of kidney function over a short 
period of time, affects approximately 10% of patients admitted to hospitals worldwide 
(Porter et al., 2014; Selby et al., 2012). It is associated with increased mortality, 
morbidity, and estimated incremental health care costs of more than $200 million in 
Canada annually (Collister et al., 2017). Medication-induced nephrotoxicity is very 
common in clinical practice. It accounts for 19% of cases of AKI in a hospital setting 
(Collister et al., 2017; Gandhi et al., 2000; Kaufman et al., 1991; Miyahara, 1978; Nash et 
al., 2002; Uchino et al., 2005) and is associated with increased healthcare expenditure 
(Choudhury and Ahmed, 2006; Collister et al., 2017). For instance, using the medication 
utilization data in Canada for 2013, Morgan et al. (2016) have reported an estimated 
healthcare cost of $419 million due to inappropriate prescriptions (Morgan et al., 2016). 
Over the last two decades, the incidence rate of AKI has increased in Canada (Liu et al., 
2010; Mehrabadi et al., 2014), the United States (Nadkarni et al., 2016; Xue et al., 2006), 
and the United Kingdom (Kolhe et al., 2016). The increasing occurrence of AKI is 
related to the changing spectrum of diseases. There is a growing body of evidence 
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showing that patients with multiple comorbidities and extrarenal complications are at a 
higher risk of developing AKI (Mehta et al., 2004; Siddiqui et al., 2012). For instance, 
Aikar et al. (Waikar et al., 2006) have shown that the high comorbidity rate, measured by 
the Deyo-Charlson comorbidity index, is associated with AKI. In a study of 681 AKI 
patients who are admitted to the intensive care unit, the occurrence of comorbid 
conditions is high: 37% have coronary artery disease, 30% have chronic kidney disease, 
29% have diabetes mellitus, and 21% have chronic liver disease (Mehta et al., 2004). As 
a patient's number of comorbid conditions grow, there is a rise in associated 
hospitalizations, physician visits, prescriptions, and expenses (Zulman et al., 2014), 
ultimately leading to an increase in medication intake. Patients admitted to hospitals, 
particularly critically ill patients with multiple comorbidities, often take several 
medications, with up to 25% of these medications having nephrotoxic potential 
(Choudhury and Ahmed, 2006). A study in 2005 has revealed that out of 7 million 
adverse medication event reports, 2.7% include an incidence of AKI, of which 16% are 
known nephrotoxins, 18% are possible nephrotoxins, and the rest are new potential 
nephrotoxins (Uchino et al., 2005). 
 The use of nephrotoxic medications is associated with 16-25% of all AKI cases in the 
adult population (Pannu and Nadim, 2008; Uchino et al., 2005). Few studies have been 
conducted to identify medications that are commonly associated with AKI. Most of these 
studies have been limited in assessing the impact of known nephrotoxic medications 
(Alexander et al., 2017; Moffett and Goldstei, 2011; Rivosecchi et al., 2016). In addition, 
information on medication combinations that can cause AKI lacks in the literature. It is 
important to identify those combinations because a combination of multiple nephrotoxins 
may result in synergistic or accumulative nephrotoxicity, thus increasing the chance of 
renal failure (Schetz et al., 2005). For example, the risk of developing AKI increases by 
53% for each additional nephrotoxic medication used by a patient (Cartin-Ceba et al., 
2012). Hence, it is important to identify not only nephrotoxic medications but also 
medication combinations that affect the risk of AKI. Rivosecchi et al., through an 
exhaustive literature search, further emphasize the need for a comprehensive 
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understanding of how medication combinations alter the risk of AKI (Rivosecchi et al., 
2016). According to a CDC report in 2017, there are about 1,000 known adverse 
medication effects and 5,000 medications available in the pharmacies (FastStats - 
Therapeutic Drug Use), making for approximately 125 billion possible adverse 
medication effects between all possible pairs of medications (Zitnik et al., 2018). Thus, it 
is impossible to assess medication-induced AKI through this number of clinical trials 
comprehensively. Moreover, conducting a trial to determine whether to prescribe or not 
prescribe a potentially harmful combination would likely never receive research ethics 
board approval. 
Data analysis has the potential to address this challenge by employing methods and 
techniques from different fields, such as data mining, statistics, and machine learning to 
accomplish various data-driven tasks (Han and Kamber, 2011). It can be used to 
investigate clinical data to gain both novel and deep insights to help healthcare providers 
examine medication-induced nephrotoxicity. Recently, several studies have been 
conducted to identify drug-drug interactions, improve drug-safety science, and predict 
adverse drug reactions using machine learning techniques (Vamathevan et al., 2019). For 
instance, Kandasamy et al. (2015) have developed a prediction model to identify drug-
induced nephrotoxicity using human induced pluripotent stem cells and random forest 
(Kandasamy et al., 2015). In addition, Dey et al. (2018) have presented a deep learning 
framework to predict adverse drug reactions and detect molecular substructures 
associated with them (Dey et al., 2018). An automatic method of processing adverse 
event reports using artificial intelligence and robotics is presented in (Schmider et al., 
2019). Lysenko et al. (2018) have incorporated Mashup (Cho et al., 2016) and a gradient-
boosted tree to predict drug toxicity using biological network data (Lysenko et al., 2018). 
Although these studies are designed to deal with large bodies of data to solve different 
medication-related problems, the relationship between medications and AKI has not been 
studied before through automated data analysis. Automated data analysis techniques 
allow an incorporation of large quantities of data that creates an opportunity to include 
additional information to more comprehensively study individual medications and their 
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combinations. It is essential to consider comorbidities while studying the effect of 
medications since it is not clear whether the underlying comorbidities or medications 
increase the risk of developing AKI. In addition to comorbidity data, demographics data 
such as age, sex, and region, are also considered as risk factors for AKI (K. D. Liu et al., 
2019; Siew et al., 2016). Therefore, any complete study that investigates nephrotoxic 
medications or combinations should include demographic and comorbidity data in the 
analysis. Up until now, there is a lack of well-designed studies that consider demographic 
and comorbidity data while assessing the risk of developing AKI with the use of single or 
multiple medications. Even though the identification of nephrotoxic medications is 
crucial for improved patient care, it has not been studied thoroughly through machine 
learning techniques. 
 The purpose of this study is to identify individual medications associated with AKI in 
hospitalized patients using an automated machine learning approach. We also identify 
AKI-associated medication combinations and investigate whether the use of multiple 
medications results in multiplicative effects on the risk of developing AKI. Finally, we 
investigate how our findings are consistent with data in the existing literature. Our study 
differs from other studies in three ways: (1) we consider all the frequently used 
medications in the study, whether they have been known to be nephrotoxic or not; (2) we 
use a frequent itemset mining algorithm to identify frequent medication combinations and 
multivariable logistic regression to investigate the association between medication 
combinations and AKI; and (3) we incorporate the patient's demographic and 
comorbidity features as potential covariates in the regression models. 
4.2 Materials and Methods 
This section describes the methodology we have employed to conduct the study. We 
describe the design process, study setting, workflow, data sources, cohort entry criteria, 
input features, outcome, analysis processes, and tools. 
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4.2.1 Design Process and Participants 
To help us understand how healthcare providers perform automated analysis, and to help 
us conceptualize and design our study, we adopted a participatory design method. It is a 
co-operative method that involves all stakeholders (e.g., designers, intermediary-users, 
and end-users) in the design process to ensure the output of the analysis meets their needs 
(Muller, 2007). A statistician, a clinician, an epidemiologist, and several computer 
scientists were involved in the design and evaluation process of this study. During the 
initial stage in the designing process, we realized that healthcare providers usually 
perform medication-safety related studies in many ways. It is difficult to determine a 
single correct analytics technique for these tasks because different techniques have their 
strengths and weaknesses. As such, we interviewed healthcare experts to identify the 
data-driven tasks and analytics techniques with which they are familiar. We identified 
four data-driven tasks to consider in designing this study through our collaboration with 
healthcare experts at the ICES-KDT (ICES - an independent, non-profit, world-leading 
research organization that uses population-based health and social data to produce 
knowledge on a broad range of healthcare issues; KDT - Kidney Dialysis and 
Transplantation program), located in London, Ontario, Canada. 1) Studying the 
relationships between prescribed medications and AKI. 2) Identifying commonly 
prescribed medication combinations to older patients. 3) Examining the effect of a 
medication combination on AKI. 4) Investigating if a certain medication is associated 
with an increased risk of developing AKI when used with another medication. We came 
to know that healthcare experts usually rely on different regression techniques to 
accomplish such tasks. Thus, we decided to employ multivariable regression in this 
study. We also invited healthcare experts to provide us with formative feedback on 
design decisions and results. 
4.2.2 Design and Setting 
We performed a population-based retrospective cohort study in older adults from April 
2014 to March 2016 in Ontario, Canada, using administrative health databases located at 
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ICES. These datasets were linked using unique encoded identifiers and analyzed at ICES. 
The use of data in this project was authorized under section 45 of Ontario’s Personal 
Health Information Protection Act, which does not require review by a Research Ethics 
Board. 
Ontario has a population of approximately 13 million residents with universal access to 
hospital care and physician services, including 1.9 million people aged 65 years or older 
who have universal prescription drug coverage (14% of the population). We suppressed 
our results in cells with five or fewer patients to comply with privacy regulations and 
minimize the chance of re-identification of patients. 
4.2.3 Workflow 
Figure 1 illustrates the basic workflow of the study presented in this paper. In the first 
stage, we created an integrated dataset from different health administrative databases 
stored at ICES. The data sources are explained in Section 2.4. Next, we applied the 
inclusion and exclusion criteria presented in Section 2.5 to build the final cohort. The 
demographic and comorbidity features were then encoded and transformed into 
appropriate forms for analysis in Section 2.6. Section 2.7 describes the outcome (i.e., 
AKI) and how we identified the incidence of AKI. A brief description of the cohort is 
presented in Section 2.8. After that, we performed individual and combination analysis, 
which are discussed in Section 2.9 and 2.10, respectively. The results from both analyses 
were then validated and presented in Tables 2 and 3. 
4.2.4 Data Sources 
We ascertained patient characteristics, drug prescriptions, and outcome data from 5 
health administrative databases (Appendix A). The datasets were linked using unique, 
encoded identifiers derived from health card numbers, and patient-level data were 
analyzed at ICES. We obtained vital statistics from the Ontario Registered Persons 
Database, which contains demographic data on all Ontario residents who have ever been 
issued a health card. We used the Ontario Drug Benefit Program database to identify 
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prescription drug use. This database contains highly accurate records of all outpatient 
prescriptions dispensed to older patients, with an error rate of less than 1% (Levy et al., 
2003). We identified hospital admissions, baseline comorbidity data, and emergency 
department visits from the National Ambulatory Care Reporting System (ED visits) and 
the Canadian Institute for Health Information Discharge Abstract Database 
(hospitalizations). We used the International Classification of Diseases, tenth revision 
(post-2002) codes to assess baseline comorbidities. Baseline comorbidity data were also 
obtained from the Ontario Health Insurance Plan database, which includes claims for 
physician services. Coding definitions for comorbidity data are represented in Appendix 
B. 
 
Figure 4-28: Workflow diagram of the study presented in this paper. Different 
colours are used to show the separation of three main parts (pre-processing, 
individual analysis and combination analysis). 
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4.2.5 Cohort Entry Criteria 
We identified a cohort of individuals aged 65 years or older who were admitted to 
hospital or visited the emergency department (ED) between 1st April 2014 and 31st 
March 2016. The ED visit date or hospital admission date served as the index or cohort 
entry date. If an individual had multiple ED visits or hospital admissions, we selected the 
first incident. Individuals with invalid data regarding the health card number, age, and sex 
were excluded. We also exclude: (1) patients who previously received dialysis or a 
kidney transplant as AKI is often no longer relevant once a patient develops end-stage 
kidney disease (diagnosis codes for exclusion criteria are shown in Appendix C); and (2) 
patients who left the hospital against medical advice or without being seen by a 
physician.  
4.2.6 Baseline Covariates 
There were a total of 5 demographic, 10 comorbidity, and 595 medication features in the 
cohort, which serve as input for the analysis. Demographic information included age, sex, 
residency status (urban and rural), long term care, and socioeconomic status (income 
quintile according to Statistics Canada). We used a 5-year look-back window to identify 
relevant baseline comorbidities, including diabetes mellitus, hypertension, heart failure, 
coronary artery disease, cerebrovascular disease, peripheral vascular disease, chronic 
liver disease, chronic kidney disease, major cancers, and kidney stones.  
All of the features in the cohort were categorical. We converted the comorbidity features 
into binary forms. For instance, if a patient had a particular comorbid condition, its 
corresponding value was taken as "1." We set the value for sex and residency status 
features if a patient was male and resided in urban areas. The income feature took an 
integer value ranged between 1 to 5 to represent the income quintile of a particular 
patient. All these features from different data sources were integrated using the encoded 
identifiers derived by ICES. Finally, the features in the cohort were transformed into a 
format and scale that were suitable for the analysis. For each feature in the cohort, we 
recorded the last value before the index date. Thus, we aggregated multiple values (rows) 
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of a single feature into one by considering the latest values of that feature for each 
patient. 
4.2.7 Outcome: Identification of AKI 
AKI was the outcome variable for all the regression models in this study. We identified 
the incidence of AKI in the first visit to the ED or hospital admission between 1st April 
2014 and 31st March 2016. The incidence of AKI was captured using the National 
Ambulatory Care Reporting System and the Canadian Institute for Health Information 
Discharge Abstract Database based on the International Classification of Diseases (ICD), 
Tenth Revision (ICD-10-CA) "N17" diagnostic codes. We considered the first incidence 
in case of multiple episodes of AKI for a patient. We set the value of the outcome 
variable if a patient was diagnosed with AKI. We recorded the first incidence of AKI in 
case there were multiple episodes.  
4.2.8 Cohort Characteristics 
A total of 924,533 participants were included in the derivation cohort, of which 25,084 
(2.7%) had AKI during their hospital or ED encounter. Selected characteristics of this 
cohort are shown in Table 1. The mean age was 70 years, and 56% were women. Sixteen 
percent of the patients resided in rural areas, and 6% of them were in long term care. The 
pre-existing comorbidities were hypertension (88%), diabetes (38%), coronary artery 
disease (25%), major cancer (16%), heart failure (14%), cerebrovascular disease (3%), 
peripheral vascular disease (2%), chronic liver disease (4%), chronic kidney disease 
(9%), and kidney stones (1%). 
Table 4-5: Baseline characteristics of patients admitted to the hospital or who visited 
the emergency department (ED). 
Characteristics Patients admitted to hospital or visited ED 
 Total Patients AKI  No AKI  
Cohort size 924,533 25084 (3%) 899449 (97%) 
Age, yr, mean (SD)  
65 to <70 192,678 2522 (1.3%) 190156 (98.7%) 
70 to <80 382,989 7946 (2.1%) 375043 (97.9%) 
80 to <90 274,842 10370 (3.8%) 264472 (96.2%) 
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>=90 74,024 4246 (5.7%) 69778 (94.3%) 
Women 516,175 12139 (2.4%) 504036 (97.6%) 
Year of cohort entry (index date)  
2014-2015 605,244 16689 (2.8%) 588555 (97.2%) 
2015-2016 319,289 8395 (2.6%) 310894 (97.4%) 
Rural residence 151,323 2097 (1.4%) 149226 (98.6%) 
Long-term care 43,351 3118 (7.2%) 40233 (92.8%) 
Income Quintile  
1 180,227 5466 (3%) 5466 (3%) 
2 192,686 5515 (2.9%) 5515 (2.9%) 
3 182,957 4909 (2.7%) 4909 (2.7%) 
4 186,407 4829 (2.6%) 4829 (2.6%) 
5 182,256 4365 (2.4%) 4365 (2.4%) 
Comorbid conditions  
Hypertension 814,604 24209 (3%) 790395 (97%) 
Diabetes 358,472 13837 (3.9%) 344635 (96.1%) 
Heart failure 125,136 7623 (6.1%) 117513 (93.9%) 
Coronary artery disease 239,437 8392 (3.5%) 231045 (96.5%) 
Chronic liver disease 33,359 1245 (3.7%) 32114 (96.3%) 
Cancer 145,286 4253 (2.9%) 141033 (97.1%) 
Chronic kidney disease 86,442 7759 (9%) 78683 (91%) 
Kidney stones 12,457 391 (3.1%) 12066 (96.9%) 
Peripheral vascular disease 13,197 660 (5%) 12537 (95%) 
Cerebrovascular disease 25,835 1180 (4.6%) 24655 (95.4%) 
4.2.9 Individual Medication Analysis 
We identified a total of 595 unique medications prescribed to about 1 million patients in 
the Ontario Drug Benefit Program database. The database includes medication name, 
medication dose, date filled, and route-of-administration of the prescriptions. We 
generated 595 binary features to record the use data for each medication and each patient. 
We set the value of a specific medication feature for a patient when the medication was 
administered to that patient in the 120 days prior to hospital presentation. When patients 
take a drug, it affects them differently based on body composition and metabolism. 
However, most physicians are not able to consider all of these factors when prescribing a 
medication. Thus, to investigate the association between medications and AKI, we 
intended to identify signals that affect a large population. If a particular signal is common 
in a large number of people (i.e., a population of one million patients), then the 
possibility of the existence of an association is very high. Our goal was to identify 
potential interactions that are not yet understood or perhaps known. We considered this as 
an information retrieval problem, such that our models were designed to discover the 
possible relationships between each medication and AKI. We developed a multivariable 
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logistic regression model to predict AKI based on the demographic, comorbidity, and 
medication data and observed the attribute representing medication to understand the 
relationships between a particular medication and AKI. Logistic regression is a special 
type of regression technique used to predict the outcome of a binary dependent feature 
from one or several predictors. We developed separate regression models for each 
individual medication (i.e., 595 models). For each model, the regression coefficient and 
p-value of the medication attribute were analyzed to identify potential associations. It is 
important to mention that formal clinical studies are required to confirm such 
interactions. The study was designed to assist healthcare experts at the ICES-KDT 
program in choosing potential candidates for their future drug-safety studies.     
The "glm" function in R packages was employed to implement multivariable logistic 
regression models (Williams et al., 1984). Model covariates included demographic 
features and baseline comorbidities. Thus, the formula in R included AKI as the response 
and comorbidities, demographics, and medication as predictor variables. The value for 
the "family" argument in the "glm" function was set to "binomial." We used the 
"summary" function to get the estimate, p-value, z-score, and standard error for each 
coefficient in the model. In addition, the "confit" function was used to compute the 
confidence interval and odds ratio. 
In order to avoid type I error in comparing multiple independent regression models, we 
lowered the alpha value based on the Bonferroni correction to account for the number of 
comparisons being performed. We considered a Bonferroni-corrected p-value less than 
8.4e-5 (divided 0.05 by the number of individual medications) as statistically significant 
for regression models with each medication. 
4.2.10 Medication Combination Analysis 
In order to identify the medication combinations that are associated with AKI, we first 
prepared the medication combinations data. Since the number of individual medications 
is 595, the total number of combinations is a large number. Hence, we used a data mining 
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technique named Eclat (Agrawal et al., 1993) to select the frequent combinations that 
included prescription data of at least 0.07% of the total number of prescriptions. Eclat is a 
frequent itemset mining algorithm that uses a depth-first search to discover groups of 
items that frequently occur in a transaction database. An itemset that appears in at least a 
pre-defined number of transactions is called a frequent itemset.  Each frequent 
medication combination was annotated with its support. The support of a medication 
combination was how many times it appeared in the medication database 
We only included combinations of two medications in this analysis and identified 7,748 
unique medication combinations. Then, we created binary features to record the presence 
of these combinations. We set the value of a specific combination feature for a patient 
when that patient had been dispensed all medications within the combination in the 120-
day period before the index date. Similar to the individual medication analysis, we 
applied a multivariable logistic regression on each medication combination. The baseline 
covariates, such as demographics and comorbidities, and medication combination 
features were included as potential covariates in the models. We developed separate 
regression models for each medication combinations identified using frequent itemset 
mining analysis (i.e., 7,748 models). The regression coefficient and p-value of the 
medication combination attribute were analyzed to identify combinations that are 
associated with AKI. We then performed a stratified analysis to examine potential 
medication-medications interactions further. We created a subset of medication 
combinations based on their significance in the regression models. Statistically 
significant combinations were detected by filtering the regression models based on a 
Bonferroni-corrected alpha value, 6.5e-6 (divided 0.05 by the number of medication 
combinations). 
Stratified analyses were conducted on each medication available in one or more 
combinations in the above subset. To do this, we created a list of unique medications (i.e., 
base medications) from the chosen subset of medication combinations. Then for each 
medication in the list, we identified the other medication that holds a combination with 
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the base medication. In the next stage, we prepared two sub-cohorts. The first one 
includes both medications in the combination (base and other), and the second one 
excludes the other medication in the combination. Finally, we applied multivariable 
logistic regression on each sub-cohort that included the combination and/or base 
medication feature along with the baseline covariates. The same process was followed for 
each medication available on the list. 
In this analysis, for each unique medication combination, we obtained two models for the 
sub-cohorts. In order to help us to assess how the other medication affects the outcome of 
the base medication, we compared the odds ratio of the combination attribute in the first 
model with the odds ratio of the base medication attribute in the second model. We tested 
the significance of all models in the stratified analysis using a Bonferroni-corrected alpha 
value. We calculated the percentage change in odds ratios to report the result of this 
analysis. 
4.2.11 Tools and Technologies 
SAS was used to cut and prepare the dataset because ICES administrative databases were 
stored in the SAS server (“SAS Enterprise BI Server,” n.d.). In addition, we used R 
packages (“RStudio | Open source & professional software for data science teams,” n.d.) 
to conduct the necessary statistical and machine learning analyses in this study. R was 
chosen because it 1) provides widespread support for carrying out data mining operations 
such as frequent itemset mining and multivariable regression, 2) is available on the ICES 
workstations, 3) has a rich array of libraries, 4) is platform-independent and open-source, 
and 5) is continuously growing and providing updates with new features. 
4.3 Results 
This section describes the results of the study. The results are divided into two 
subsections. The results of the individual medication analysis and medication 
combination analysis are discussed in Subsection 3.1 and 3.2, respectively.  
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4.3.1 Individual Medication and AKI 
Some of the commonly prescribed medications in the 120 days before the ED visit were 
Atorvastatin Calcium (24%), Rosuvastatin Calcium (22%), Hydrochlorothiazide (20%), 
Amlodipine Besylate (19%), and Metformin Hcl (16%). A binary logistic regression 
model was fit to each medication, where demographic and comorbidity features were 
included as potential risk factors in the model to test the research hypothesis regarding 
the relationship between the likelihood of developing AKI and specific medications. 
Table 2 shows the full list of medications with their p-values, odds ratios, confidence 
intervals, and standard errors. The medication classes are shown in brackets with 
medication names. We sorted medications based on the odds ratio of the medication 
feature in each model. Out of 595 medications, 55 of them were found to be strongly 
associated with AKI (i.e., statistically significant after Bonferroni correction). Among 
these 55 medications, six of them were Diuretics, four were Beta-blockers, three of them 
belonged to Oral Anti-Glycemic, three of them were Prostatic Hyperplasia medications, 
and the rest of them belonged to 33 other medication classes.  
Among demographics, age, sex, residency status, and long-term care attributes have 
shown statistically significant relationships with the probability of AKI. The fitted 
models revealed that keeping all other attributes constant, the odds of getting diagnosed 
with AKI for males over females varied between 1.35 to 1.38. The odds for older age 
groups (i.e., 80 to <90 and >=90) was higher. The odds for rural residents were 24-28% 
lower than the odds for urban residents. Similarly, the odds for patients in long term care 
were 41-45% higher. By analyzing the comorbidity attributes in the models, we identified 
that AKI was more likely to be associated with chronic kidney disease, hypertension, 
diabetes, and heart failure, and chronic liver disease. Among these attributes, chronic 
kidney disease, hypertension, and diabetes have shown very strong associations. The 
average odds ratios for chronic kidney disease, hypertension, and diabetes patients were 
1.81, 1.64 and,1.41, respectively. 
100 
 
 
 
4.3.2 Medication Combinations and AKI 
A medication combination was chosen for this analysis if it has been used by at least 700 
patients during the study period using the eclat algorithm. The most frequent medication 
combinations were Amlodipine Besylate-and-Atorvastatin Calcium (7%), Atorvastatin 
Calcium-and-Metformin Hcl (6%), Atorvastatin Calcium-and-Ramipril (5%), 
Amlodipine Besylate-and-Hydrochlorothiazide (5%), Atorvastatin Calcium-and-
Hydrochlorothiazide (5%), Metformin Hcl-and-Rosuvastatin Calcium (5%), and 
Hydrochlorothiazide-and-Rosuvastatin Calcium (4%). 
In the next stage, we applied multivariable logistic regression on each selected 
combination. We filtered the combinations based on the p-value of the medication feature 
in each model. We found 78 combinations that were found to be strongly associated with 
AKI among 7,748 combinations. Then, we performed a stratified analysis on the strongly 
associated combinations and reported the percentage change in the odds ratio. We 
identified 37 cases where a second medication is associated with increasing the risk of 
developing AKI when used with another medication. Table 3 contains a filtered list of 
combinations with a percentage change of more than 40%. 
Table 3 shows the medication names with classes, odds ratios of models with and without 
the second medication, and percentage change in odds ratios. In the stratified analysis, we 
found 16 and 27 distinct classes representing the first (Base Medication column) and 
second (Other Medication in Combination column) medications, respectively. The 
percentage change in odds ratio had increased by 80% when Indapamide was used with 
Clavulanic acid potassium or Amoxicillin. The combination of Allopurinol with 
Venlafaxine Hcl or Morphine Sulfate was associated with a possible increase in the odds 
of 55%. The odds of getting diagnosed with AKI increases if Alprazolam, Trandolapril, 
Metformin, Clonidine Hcl, Acetaminophen & Oxycodone Hcl, or Cefuroxime Axetil is 
used in combination with Furosemide. When Celecoxib, Pregabalin, or Atenolol was 
used with one of the Antipsychotic medications (Quetiapine), the average change in odds 
ratio was about 65%. It is interesting to note that Celecoxib (Anti-Inflammatory) was not 
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found to be associated with AKI (Table 2) when used individually but appeared to be 
AKI-associated when used with Mirtazapine (Antipsychotic) or Quetiapine Fumarate 
(Antidepressants). 
The relationship between AKI and potential covariates (i.e., demographics and 
comorbidities) in the combination models resembled the relationship of individual 
models. By analyzing the regression coefficients of the combination models, we 
identified patients with AKI were more likely to be men, resided in urban areas, lived in 
long-term care, had chronic kidney disease, hypertension, diabetes, and heart failure. AKI 
was less likely to be associated with income quintile, peripheral vascular disease, chronic 
liver disease, and cerebrovascular disease. 
Table 4-6: List of the individual medications sorted based on their odds 
ratios. 
Medication P-value Odds ratio (OR) Std. error OR’s 95% CI 
Sunitinib Malate (Antineoplastic Miscellaneous) 1.6e-09 4.59 0.25 2.72 - 7.37 
Lenalidomide (Immunosuppressive Agents) 9.4e-17 3.58 0.15 2.62 - 4.79 
Abiraterone Acetate (Not Identified) 1.7e-10 2.61 0.15 1.92 - 3.48 
Metolazone (Diuretics) 1.3e-60 2.38 0.05 2.14 - 2.63 
Cyclosporine (Immunosuppressive Agents) 4.0e-06 2.18 0.17 1.54 - 3 
Megestrol Acetate (Progesteron Analogues) 2.6e-07 2.08 0.14 1.56 - 2.72 
Lithium Carbonate (Antimanic Agents) 4.7e-12 2.04 0.1 1.66 - 2.48 
Atropine Sulfate & Diphenoxylate Hcl (Antidiarrhea) 3.4e-10 2 0.11 1.6 - 2.46 
Furosemide (Diuretics) 2.6e-133 1.93 0.02 1.87 - 2 
Prochlorperazine Maleate (Antiemetics And Antinauseants) 9.1e-26 1.93 0.06 1.7 - 2.17 
Spironolactone (Diuretics (Potassium-Sparing)) 2.6e-112 1.87 0.03 1.77 - 1.97 
Methyldopa (Centrally Acting Antiadrenergic) 4.9e-06 1.84 0.13 1.4 - 2.37 
Hydralazine Hcl (Vasodilator Antihypertensive Drugs) 1.5e-26 1.76 0.05 1.58 - 1.95 
Dexamethasone (Corticosteroids, Plain) 2.4e-19 1.74 0.06 1.54 - 1.96 
Ondansetron Hcl (Antiemetics And Antinauseants) 9.1e-13 1.69 0.07 1.46 - 1.94 
Clonidine Hcl (Centrally Acting Antiadrenergic) 3.9e-06 1.69 0.09 1.4 - 2.02 
Allopurinol (Xanthine Oxidase Inhibitor) 1.2e-81 1.51 0.02 1.45 - 1.57 
Linagliptin (Unclassified Therapeutic Agents) 4.1e-24 1.5 0.04 1.38 - 1.62 
Loperamide (Antidiarrhea) 1.4e-09 1.47 0.06 1.29 - 1.66 
Glyburide (Oral Anti-Glycemic) 1.3e-12 1.46 0.04 1.34 - 1.58 
Chlorthalidone (Diuretics) 1.2e-18 1.42 0.06 1.25 - 1.59 
Atenolol (Beta Blockers) 1.23e-08 1.4 0.02 1.06 - 1.47 
Acetylsalicylic Acid & Dipyridamole (Adenosine Diphosphate Inhibitors) 2.9e-07 1.36 0.06 1.21 - 1.53 
Olmesartan Medoxomil (Angiotensin Ii Antagonist) 7.9e-13 1.35 0.04 1.24 - 1.46 
Iron Ferrous Fumarate (Iron Preparations) 1.9e-39 1.34 0.02 1.29 - 1.4 
Quetiapine Fumarate (Antipsychotic Agents) 4.4e-06 1.34 0.03 1.26 - 1.43 
Nortriptyline Hcl (Tricyclic Antidepressant) 7.2e-19 1.34 0.06 1.18 - 1.51 
Mirtazapine (Antidepressants: Miscellaneous) 2.1e-15 1.33 0.04 1.24 - 1.43 
Iron Ferrous Gluconate (Iron Preparations) 8.2e-16 1.33 0.04 1.24 - 1.43 
Terazosin (Alpha Adrenergic Blocking Agents) 1.5e-07 1.33 0.05 1.19 - 1.48 
Olanzapine (Antipsychotic Agents) 8.5e-07 1.33 0.06 1.18 - 1.48 
Fenofibrate (Antilipemic: Fibrates) 3.6e-08 1.32 0.05 1.19 - 1.46 
Carvedilol (Beta-Blockers) 5.1e-09 1.31 0.05 1.19 - 1.43 
Doxazosin Mesylate (Alpha Adrenergic Blocking Agents) 6.6e-07 1.3 0.05 1.17 - 1.43 
Folic Acid (Vitamin B Complex) 6.9e-09 1.28 0.04 1.18 - 1.39 
Trimethoprim (Sulfonamides, Trimetroprim And Combination) 8.5e-12 1.27 0.03 1.19 - 1.36 
Indapamide (Diuretics) 3.9e-08 1.26 0.03 1.19 - 1.33 
Sulfamethoxazole (Anti-Bacterial Sulfonamide) 2.1e-14 1.26 0.03 1.18 - 1.35 
Moxifloxacin Hcl (Fluoroquinolones) 1.8e-10 1.24 0.04 1.15 - 1.34 
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Nifedipine (Calcium Blockers) 3.3e-06 1.21 0.03 1.14 - 1.28 
Lisinopril (Ace Inhibitors) 5.1e-06 1.21 0.04 1.12 - 1.31 
Gabapentin (Gamma-Aminobutyric Acid (Gaba) Derivatives) 7.6e-09 1.2 0.03 1.13 - 1.27 
Oseltamivir Phosphate (Antiviral Agents - Influenza Virus Specific) 1.1e-10 1.2 0.04 1.11 - 1.3 
Metoprolol (Beta-Blockers) 6.4e-11 1.19 0.03 1.12 - 1.25 
Donepezil Hcl (Cholinesterase Inhibitors) 1.9e-08 1.18 0.03 1.11 - 1.25 
Gliclazide (Oral Anti-Glycemic) 3.7e-11 1.17 0.03 1.12 - 1.23 
Hydrochlorothiazide (Diuretics) 1.9e-18 1.16 0.02 1.12 - 1.2 
Metoprolol Tartrate (Beta-Blockers) 1.7e-21 1.16 0.02 1.11 - 1.21 
Amlodipine Besylate (Calcium Blockers) 2.4e-06 1.15 0.02 1.12 - 1.19 
Valsartan (Angiotensin Ii Antagonist) 3.1e-11 1.15 0.03 1.09 - 1.21 
Digoxin (Digitalis Preparations) 1.85e-06 1.15 0.03 1.09 - 1.22 
Bisoprolol Fumarate (Beta-Blockers) 9.9e-08 1.14 0.02 1.1 - 1.18 
Senna (Cathartics and Laxatives) 1.7e-09 1.14 0.02 1.08 - 1.19 
Ramipril (Ace Inhibitors) 9.7e-15 1.13 0.02 1.09 - 1.17 
Metformin Hcl (Oral Anti-Glycemic) 1.8e-11 1.1 0.02 1.06 - 1.14 
Table 4-7: List of the medication combinations sorted based on their 
percentage change in odds ratios. 
Base Medication Other Medication in Comb. 
Base Odds 
Ratio 
Comb Odds 
Ratio 
%Chg in 
Odds Ratio 
Indapamide (Diuretics) Clavulanic Acid Potassium (Penicillins) 1.24 2.22 79.00 
Indapamide (Diuretics) Amoxicillin (Penicillins) 1.24 2.21 78.27 
Furosemide (Diuretics) Alprazolam (Benzodiazepine Derivatives) 1.86 3.27 75.86 
Donepezil Hcl (Cholinesterase 
Inhibitors) 
Indapamide (Diuretics) 1.16 2.00 72.77 
Mirtazapine (Antidepressants: 
Miscellaneous) 
Celecoxib (Non-Steroidal Anti-Inflammatory: Non-
Asa Base) 
1.31 2.27 72.41 
Quetiapine Fumarate (Antipsychotic 
Agents) 
Celecoxib (Non-Steroidal Anti-Inflammatory: Non-
Asa Base) 
1.32 2.26 70.79 
Nortriptyline Hcl (Tricyclic 
Antidepressant) 
Acetaminophen & Oxycodone Hcl (Analgesics And 
Antipyretics: Miscellaneous) 
1.27 2.13 67.49 
Doxazosin Mesylate (Alpha 
Adrenergic Blocking Agents) 
Perindopril Tert.Butylamine (Ace Inhibitors) 1.22 2.02 66.03 
Metoprolol Tartrate (Beta-Blockers) Amitriptyline Hcl (Tricyclic Antidepressant) 1.15 1.90 65.96 
Iron Ferrous Fumarate (Iron 
Preparations) 
Bupropion Hcl (Antidepressants) 1.33 2.21 65.63 
Nortriptyline Hcl (Tricyclic 
Antidepressant) 
Lorazepam (Benzodiazepine Derivatives) 1.25 2.06 64.85 
Furosemide (Diuretics) Trandolapril (Ace Inhibitors) 1.86 3.01 61.77 
Indapamide (Diuretics) Donepezil Hcl (Cholinesterase Inhibitors) 1.24 2.00 61.77 
Allopurinol (Xanthine Oxidase 
Inhibitor) 
Venlafaxine Hcl (Selective Serotonin Reuptake 
Inhibitors - Other) 
1.49 2.41 61.65 
Terazosin (Alpha Adrenergic Blocking 
Agents) 
Irbesartan (Angiotensin Ii Antagonist) 1.27 2.03 59.84 
Fenofibrate (Antilipemic: Fibrates) Candesartan Cilexetil (Angiotensin Ii Antagonist) 1.27 2.02 58.17 
Terazosin (Alpha Adrenergic Blocking 
Agents) 
Pantoprazole Sodium (Proton Pump Inhibitors) 1.25 1.97 57.23 
Lithium Carbonate (Antimanic 
Agents) 
Atorvastatin Calcium (Antilipemic: Statins) 1.84 2.86 55.79 
Spironolactone (Diuretics (Potassium-
Sparing)) 
Clonazepam (Benzodiazepine Derivatives) 1.85 2.81 52.26 
Allopurinol (Xanthine Oxidase 
Inhibitor) 
Morphine Sulfate (Narcotics: Opiate Agonists) 1.50 2.26 50.77 
Iron Ferrous Fumarate (Iron 
Preparations) 
Meloxicam (Non-Steroidal Anti-Inflammatory: Non-
Asa Base) 
1.33 2.01 50.75 
Folic Acid (Vitamin B Complex) Hydrochlorothiazide (Diuretics) 1.22 1.82 49.59 
Dexamethasone (Corticosteroids, 
Plain) 
Gabapentin (Gamma-Aminobutyric Acid (Gaba) 
Derivatives) 
1.67 2.49 49.42 
Quetiapine Fumarate (Antipsychotic 
Agents) 
Pregabalin (Anticonvulsants: Miscellaneous) 1.32 1.95 47.67 
Dexamethasone (Corticosteroids, 
Plain) 
Ramipril (Ace Inhibitors) 1.69 2.48 46.97 
Metoprolol (Beta-Blockers) Omeprazole (Proton Pump Inhibitors) 1.17 1.71 46.70 
Ondansetron Hcl (Antiemetics And 
Antinauseants) 
Ranitidine Hcl (Histamine H2 Receptor Antagonist) 1.62 2.37 46.49 
Furosemide (Diuretics) Metformin (Oral Anti-Glycemics) 1.86 2.69 44.56 
Quetiapine Fumarate (Antipsychotic 
Agents) 
Atenolol (Beta-Blockers) 1.32 1.90 43.70 
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Iron Ferrous Fumarate (Iron 
Preparations) 
Metformin (Oral Anti-Glycemics) 1.34 1.91 43.05 
Spironolactone (Diuretics (Potassium-
Sparing)) 
Candesartan Cilexetil (Angiotensin Ii Antagonist) 1.84 2.62 42.47 
Spironolactone (Diuretics (Potassium-
Sparing)) 
Enalapril Sodium (Ace Inhibitors) 1.86 2.61 40.83 
Furosemide (Diuretics) 
Acetaminophen & Oxycodone Hcl (Analgesics and 
Antipyretics: Miscellaneous) 
1.85 2.60 40.35 
Spironolactone (Diuretics (Potassium-
Sparing)) 
Dabigatran Etexilate (Anticoagulants Miscellaneous) 1.85 2.60 40.22 
Furosemide (Diuretics) Clonidine Hcl (Centrally Acting Antiadrenergic) 1.86 2.61 40.11 
Furosemide (Diuretics) Cefuroxime Axetil (Cephalosporin) 1.86 2.61 40.02 
4.4 Discussion 
In this study, we demonstrated how machine learning techniques could help with the 
identification of potentially nephrotoxic medications using administrative health 
databases housed in ICES. Nephrotoxic medications are responsible for about 20% of 
episodes of AKI, and the rate of medication-induced nephrotoxicity leading to AKI 
among older patients is approximately 66% (Kohli et al., 2000; Peres and da Cunha, 
2013). We have presented methods for identifying medications and medication 
combinations that are associated with AKI using regression and frequent itemset mining 
algorithms. We found that 9% of all the prescribed medications were possibly associated 
with AKI by analyzing the medication data of one million older patients included in our 
study. Our analysis identified Angiotensin II Receptor Blockers, Antibacterial Agents, 
Diuretics, Iron Preparations, Nonsteroidal Anti-inflammatory Drugs, and Xanthine 
Oxidase Inhibitors as medication classes that were significantly associated with AKI. In a 
recent study of the French national pharmacovigilance database, Pierson-Marchandise et 
al. (2017) found that the majority of cases of medication-induced AKI were related to 
Antibacterial Agents, Antineoplastic Agents, Diuretics, Anti-inflammatory Drugs, and 
agents acting on the Renin-angiotensin system (Pierson-Marchandise et al., 2017). A 
similar conclusion was reached by a study of nursing home residents where Ace 
Inhibitors, Angiotensin II receptor Blockers, Antibiotics, and Diuretics were identified as 
the primary medication classes responsible for developing AKI.  
Our study aimed to investigate how individual medication analysis results were 
consistent with what has been found in previous studies. We first reviewed the results 
with a nephrologist and learned that most of the statistically significant medications 
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(Table 2) were already known to be associated with AKI, which confirmed the accuracy 
of our findings. We also conducted an electronic literature search to find the research 
papers that studied the relationships between these medications and AKI. To ensure that 
relevant papers were not missed in our search, we used a relatively large set of keywords. 
We used two sets of keywords. The first set represented the medication, and the second 
was concerned with AKI. For the second set, we used the following terms: "AKI", "acute 
kidney injury", " acute renal failure", "acute phosphate nephropathy", "acute prerenal 
failure", and "anuria". All the studies included in this literature search were published 
from 1995 till 2019. We found evidence through the literature search that confirmed the 
association between 38 individual medications (among 55 statistically significant 
medications) and AKI, which more comprehensively proved the efficacy of our study.  
To explain the results of individual medication analysis, we divided the identified 
medications into two main groups— known and likely-confounded. The medications that 
belong to the first group were already known to be associated with AKI. The 
relationships between AKI and these medications have previously been studied in the 
literature. The likely-confounded group contained medications that were not yet proven 
to be AKI-inducing. They were used to treat conditions that are associated with AKI, 
included in studies with kidney function, or not studied before. There is a lack of 
evidence regarding the association between AKI and some of these medications, such as 
Prochlorperazine Maleate and Terazosin. The complete list of medications that are 
divided into these groups is shown in Table 4. Out of 55 medications, there were 38 
medications in the known group and 17 medications in the likely-confounded group. The 
key finding of the individual medication analysis was the list of medications included in 
the likely-confounded group. These medications can be suitable candidates for clinical 
drug-safety studies to investigate this potential association. 
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Table 4-8: The list of statistically significant medications from individual analysis 
divided into three groups. 
Known Likely-confounded 
Furosemide(Bove et al., 2018; K. M. Ho and Power, 2010) Hydralazine Hcl(Sari, 2019) 
Allopurinol (Alirezaei et al., 2017; Perez-Ruiz, 2017) Ondansetron Hcl(Aamdal, 1992) 
Amlodipine(Pierson-Marchandise et al., 2017; Saruta et al., 1995) Lithium Carbonate(Sari, 2019) 
Hydrochlorothiazide (Pierson-Marchandise et al., 2017). Bisoprolol Fumarate(J. Liu et al., 2019) 
Iron Ferrous Fumarate (Leaf and Swinkels, 2016) Abiraterone Acetate(Neyra et al., 2015) 
Spironolactone(Juncos and Juncos, 2016) Sunitinib Malate(Jha et al., 2013) 
Bisoprolol(Pierson-Marchandise et al., 2017) Carvedilol(Dupont, 1992) 
Atenolol(Fleet et al., 2014) Donepezil Hcl(Erbayraktar et al., 2017) 
Metoprolol (Fleet et al., 2014) Acetylsalicylic Acid (Sari, 2019) 
Valsartan(Lopau et al., 2001) Mirtazapine(Dev et al., 2014) 
Indapamide(Pierson-Marchandise et al., 2017). Loperamide(Mackowski et al., 2015) 
Nifedipine(Mishima et al., 2017) Doxazosin Mesylate(Mori et al., 2001) 
Iron Ferrous Gluconate(Leaf and Swinkels, 2016) Senna(Vanderperren et al., 2005) 
Quetiapine(Yamada et al., 2018) 
Megestrol Acetate(Boccanfuso et al., 
2000; Rammohan et al., 2005) 
Gabapentin (Miller and Price, 2009) Nortriptyline(Dawlilng et al., 1981) 
Linagliptin(Nandikanti et al., 2016) Terazosin 
Glyburide (McCoy et al., 2010) Prochlorperazine Maleate 
Lenalidomide(Lipson et al., 2010) 
 
Trimethoprim(Pierson-Marchandise et al., 2017). 
Olmesartan Medoxomil(Georgaki-Angelaki et al., 2009) 
Ramipril(Pierson-Marchandise et al., 2017). 
Gliclazide(Pierson-Marchandise et al., 2017). 
Atropine Sulfate (Pierson-Marchandise et al., 2017). 
Folic Acid(Gupta et al., 2012) 
Chlorthalidone(Peskoe et al., 1978) 
Clonidine Hcl(Allison, 2015) 
Fenofibrate(Pierson-Marchandise et al., 2017). 
Dipyridamole(Puri et al., 2016) 
Olanzapine(Hwang et al., 2014) 
Digoxin(Pierson-Marchandise et al., 2017).  
Lisinopril(Pierson-Marchandise et al., 2017). 
Methyldopa(Perazella, 2015) 
Oseltamivir Phosphate(Watanabe et al., 2014) 
Metolazone(Sean M. Bagshaw et al., 2007; Rp, 2019; Shulenberger et al., 
2016) 
Cyclosporine(Bennett, 2013) 
Dexamethasone(Jacob et al., 2015; Kumar et al., 2009) 
Moxifloxacin Hcl(Bird et al., 2013) 
Sulfamethoxazole(Pierson-Marchandise et al., 2017) 
Through the medication combination analysis, we found that out of 25 thousand patients 
with AKI in our dataset, about 85% were prescribed multiple medications within 120 
days prior to the index date. The incidence rate of developing AKI is usually higher 
among patients who are prescribed multiple medications. For instance, in a study of 
38,782 adverse drug reaction events, out of 1,254 reported AKI cases, about 66% 
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included two or more concomitantly prescribed medications (Pierson-Marchandise et al., 
2017). Another study suggested that there were statistically significant associations 
between the duration of simultaneous medication use and the development of AKI 
(Chang et al., 2012). Similarly, a study of Taiwan's National Health Insurance system 
showed that the concurrent use of certain medication classes (such as Diuretics, Beta 
Blockers, Calcium Channel Blockers, Alpha Blockers, Ace Inhibitors, Digoxin, and 
Platelet Aggregation Inhibitors) was strongly associated with the development of AKI 
(Chao et al., 2015). In order to compare our findings with the existing literature, we 
discussed the results of medication combination analysis using medication classes since 
most of the previous studies presented their results this way. As shown in Table 3, some 
of the AKI-associated combinations are Alpha Adrenergic Blocking Agents-and-Ace 
Inhibitors, Corticosteroids-and-Ace Inhibitors, Diuretics-and-Ace Inhibitors, Potassium-
Sparing Diuretics -and-Ace Inhibitors, Diuretics-and-Analgesics and Antipyretics, 
Tricyclic Antidepressant-and-Analgesics and Antipyretics, Alpha Adrenergic Blocking 
Agents-and-Angiotensin II Antagonist, and Antilipemic: Fibrates-and-Angiotensin II 
Antagonist. We have identified that using a combination of Diuretics with some specific 
medication classes are associated with increasing the risk of developing AKI. In line with 
our findings, the effect of using Diuretics with Renin Angiotensin Aldosterone System 
Agents, Ace inhibitors, or Penicillin on AKI has been investigated in several research 
studies (Adhiyaman et al., 2001; Audia et al., 2008; Fournier et al., 2014, 2012; Loboz 
and Shenfield, 2005; Steinhäuslin et al., 1993; Wu et al., 2014). 
In order to verify the results of the medication combination analysis, we compared our 
findings with a recent study (Rivosecchi et al., 2016). In their study, Rivosecchi et al. 
identified 76 unique combinations of medication classes that were associated with AKI 
by assessing 2,139 citations. Overall, 73.7% of selected medication classes were 
categorized as very low quality, 15.8% were of low quality, and 10.5% were considered 
medium quality. We found that our results are consistent with the studies included in this 
literature review. It is important to note that there were 19 medications in our study that 
were not statistically significant individually but were found to be strongly associated 
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with AKI when used with another medication (Table 2 and Table 3). There are also a few 
combinations of medication classes in our study, such as Antipsychotic Agents and Anti-
inflammatory, Diuretics and Xanthine Oxidase Inhibitor, to name a few, which have been 
studied individually but there is a lack of evidence in the literature on how these 
combinations are associated with AKI (Dixit et al., 2010; Gois et al., 2016; Jiang et al., 
2017; Karajala et al., 2009; Zhang et al., 2017). Clinical drug-safety studies need to be 
conducted to confirm these medication-medication interactions. 
The main strength of the study presented in this paper was its exhaustive analysis of 
medication usage patterns of the one million hospitalized patients within a 120-day look-
back window. It is noteworthy that all the patients were elderly (65 years or older), 
suffering from multiple diseases and taking several potentially nephrotoxic medications. 
We included most of the frequently prescribed medications and investigated all possible 
combinations among these medications in our study. Next, to assess the true impact of 
medications on AKI, we incorporated the patients' demographic and comorbidity features 
as covariates in the regression analysis. In addition, we performed a stratified analysis to 
investigate the synergistic effect of medication combinations on AKI, which made our 
study more comprehensive and unique in comparison to other studies. To our knowledge, 
this study introduced a novel analysis technique by integrating frequent itemset mining, 
regression, and stratification to identify medications and combinations that can 
potentially be associated with AKI.  
This research also demonstrates how machine learning can be used to address a well-
known problem in the medical domain. It highlights what needs to be considered when 
designing studies that are intended to incorporate machine learning techniques to support 
data-driven tasks using health administrative datasets. 
4.5 Limitations 
Our study has some limitations. First, our results can only be generalized to the elderly, 
as we only had complete medication data on those aged 65 and older. Second, our study 
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population might have included clinically unstable patients who were admitted to the 
hospital or emergency department. This could be a confounding factor as clinically 
unstable patients are more likely to take multiple concomitant medications, increasing 
their chances of developing AKI. Third, our findings can only be generalized to the 
population of Ontario since the models were derived and validated in cohorts from 
hospitals in Ontario. Lastly, there could be multiple reasons for which a patient is 
prescribed with medication, and these reasons may lead to the development of AKI rather 
than the medication itself. The study was designed to assist healthcare researchers at the 
ICES-KDT program in identifying potential candidates for their future medication-safety 
studies. This is not a confirmatory analysis, and proper clinical studies are required to 
confirm the findings. 
4.6 Conclusion 
Medication-induced nephrotoxicity is one of the major causes of AKI worldwide. In the 
present study of the ICES database, we identify the individual medications and 
medication combinations that are potentially associated with AKI by applying a 
combination of regression and frequent itemset mining techniques to this field for the 
first time. We have shown that our results are consistent with previous studies throughout 
this paper. Although most of the medications that we identify are already known to be 
associated with AKI, some of them have not been thoroughly studied yet. Our findings 
would raise awareness to conduct clinical research on these potentially nephrotoxic 
medications. Attention should be directed at avoiding nephrotoxic treatments when an at-
risk situation is identified to reduce the chance of patients developing AKI. This requires 
not only careful monitoring by prescribers but also comprehensive studies on these 
medications. Ongoing research in this field might provide us with more reliable methods 
in the detection of potentially nephrotoxic medications and their combinations, thus 
allowing timely intervention to prevent AKI. This research will help machine learning 
researchers to understand what needs to be considered when designing studies that are 
intended to incorporate machine learning methods to accomplish various data-driven 
tasks using healthcare datasets. 
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Chapter 5  
5 Visual Analytics for Dimension Reduction and Cluster 
Analysis of High Dimensional Electronic Health 
Records 
This chapter has been published as S.S. Abdullah, N. Rostamzadeh, K. Sedig, A.X. Garg, 
and E. McArthur, “Visual Analytics for Dimension Reduction and Cluster Analysis of 
High Dimensional Electronic Health Records” in the Health Section of the Informatics 
Journal, Volume 7; May 2020. We changed the format to match the general format of the 
dissertation. Figure, Table, and Section numbers specified herein are relative to the 
chapter number. For example, “Table 1” corresponds to Table 5-1; “Figure 1” 
corresponds to Figure 5-1; and “Section 1.1” corresponds to Section 5.1.1. Moreover, 
when the term “paper”, “research”, or "work" is used, it refers to this specific chapter. 
5.1 Introduction 
The increasing use of EHR-based (Electronic Health Record) systems in healthcare has 
resulted in generating data at an unprecedented rate in recent years (Caban and Gotz, 
2015; Murdoch and Detsky, 2013). EHR data includes, but is not limited to, medical and 
demographic records, healthcare administrative records, and results of laboratory tests 
(Cowie et al., 2017). The complex, diverse, and growing information available in EHRs 
creates promising opportunities for the healthcare providers to drastically improve the 
healthcare system (Kamal, 2014; Murdoch and Detsky, 2013). It is often challenging for 
healthcare providers to keep pace with the large volumes of heterogeneous data stored in 
EHRs (Rind et al., 2019). Automated data analysis techniques based on data mining and 
machine learning hold great promise to fulfill the computational requirements of EHRs 
(Marlin et al., 2012; Wetzel, 2001). There are currently a variety of efforts underway to 
organize, analyze, and interpret EHRs using unsupervised machine learning techniques 
such as clustering (Estiri et al., 2019; Foguet-Boreu et al., 2015; Haraty et al., 2015; 
Khalid et al., 2018; Liao et al., 2016; Marlin et al., 2012).  
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Cluster analysis (CA) can be used to discover hidden patterns in EHRs by grouping 
entities (e.g., patients, medications) with similar features into homogenous groups (i.e., 
clusters) while increasing heterogeneity across different groups (Dilts et al., 1995; 
McLachlan, 1992). It divides data into meaningful, useful, and natural groups without 
prior knowledge of the labels or nature of the groupings. With the large amount of 
unlabeled data stored in EHRs, CA has the potential to characterize medical records into 
meaningful groupings. Several studies have been conducted that employ different 
clustering techniques to identify multimorbidity patterns (Foguet-Boreu et al., 2015), 
implausible clinical observations (Estiri et al., 2019), and risk factors for a disease (Doust 
and Walsh, 2011). Despite the effectiveness of using CA in analyzing EHRs, it suffers 
from a problem which has been referred to as the “curse of dimensionality”. This 
problem arises when the dataset is high-dimensional (i.e., has more than 1000 features), a 
very common occurance in EHRs (Ruan et al., 2019). In such situations, the output of CA 
is not reproducible and meaningful since variances among data elements become sparse 
and large (Adachi, 2017; Ronan et al., 2016). One solution is to employ dimensionality 
reduction (DR) techniques that can potentially reduce the number of features to a 
manageable size before using CA (Mitsuhiro and Yadohisa, 2015). 
DR refers to the transformation of the original high-dimensional dataset into a new 
dataset with reduced dimensionality without loss of much information (Siwek et al., 
2013). DR techniques are developed based on the idea that most high-dimensional 
datasets contain overlapping information (Wilke, 2019). DR techniques can be used to 
improve the performance of CA by removing multicollinearity and creating a small-
volume dataset. Many recent studies have combined techniques from both CA and DR to 
find similarity among data elements and form meaningful groups (Wenskovitch et al., 
2018). Despite the fact that a combination of DR and CA can result in efficient 
processing time and better interpretability, a number of complicated decisions need to be 
made when using techniques from both families (i.e., CA and DR) (Sembiring et al., 
2011). For instance, when applying CA, it is important to consider which technique and 
distance measure to use, which features and samples to include, and what granularity to 
111 
 
 
 
seek (Demiralp, 2017). Similarly, one needs to determine the optimal values for the 
configuration parameters when using a DR technique (Halpern et al., 2012). 
Consequently, combining these techniques results in more complicated problems. Given 
a wide range of techniques for DR and CA, determining which combination of techniques 
of CA and DR techniques leads to the desired results is not straightforward (Wenskovitch 
et al., 2018). Moreover, the intermediary steps of the analysis processes of CA and DR 
are often hidden from users, making it difficult to choose optimal values for the 
configuration parameters (Yoo et al., 2012). Therefore, one of the challenges of using 
these techniques lies with their lack of transparency and interpretability, hence limiting 
their application in EHR-based systems. 
In order to address this issue, analysis processes can be made accessible to users through 
interactive visualizations. Interactive visualizations provide users with an overview of the 
data while at the same time enabling them to access, restructure, and modify the amount 
and form of displayed information (D. A. Keim et al., 2010; Thomas and Cook, 2005). 
They allow exploration of the visualized data to answer user-initiated queries (Sedig and 
Parsons, 2013). In recent years, several EHR-based visualization systems have been 
developed to support healthcare providers in performing various user-driven activities 
(Rind et al., 2011b). Although users are often good at visually perceiving the overall 
structure of the data, it is difficult for them to extract meaningful patterns from 
visualization systems when the data is large and high-dimensional. Most of these systems 
can only represent a limited number of features within the data due to the limited real 
estate space on display devices (Aimone et al., 2013; Faisal et al., 2013; Kosara and 
Miksch, 2002; Lavado et al., 2018). Another issue with visualization systems is that they 
do not incorporate analytical processes, hence falling short in fulfilling the computational 
demands of EHRs. Thus, an integrated approach may be needed in which automated 
analysis techniques (i.e., DR and CA) and user interfaces that facilitate interaction with 
visualizations of data (i.e., interactive visualizations) are coupled together.  
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Visual analytics fuses the strengths of analysis techniques and interactive visualizations 
to allow users to explore data interactively, identify patterns, apply filters, and manipulate 
data as required to achieve their goals (Parsons et al., 2015; Saffer et al., 2004; A. F. 
Simpao et al., 2014). This process is more complicated than an automated internal 
analysis coupled with an external visual representation to show the results of the analysis. 
It is both data-driven and user-driven and requires re-computation when users manipulate 
the data through the visual interface (Ola and Sedig, 2014).  
The purpose of this study is to demonstrate how visual analytics systems can be designed 
in a systematic way to analyze the large-scale high-dimensional data in EHRs. To this 
end, we present a novel system that we have developed, called VALENCIA—Visual 
Analytics for Cluster Analysis and Dimension Reduction of High Dimensional Electronic 
Health Records. VALENCIA is intended to assist healthcare providers at ICES-KDT 
(ICES - an independent, non-profit, world-leading research organization that uses 
population-based health and social data to produce knowledge on a broad range of 
healthcare issues; KDT - Kidney Dialysis and Transplantation program), located in 
London, Ontario, Canada. This visual analytics system allows users to choose from 
multiple DR and CA techniques with different configuration parameters, combine these 
techniques, and compare analysis results through interactive visualizations. We 
demonstrate the usefulness of this system by investigating the process of analyzing the 
health administrative data housed at ICES to gain novel and deep insights into the data 
and tasks at hand while at the same time identifying the most appropriate combination of 
analysis techniques. While few visual analytics systems have been developed for 
different areas in healthcare (Choo et al., 2013; Demiralp, 2017; Klimov et al., 2015; 
Ninkov and Sedig, 2019; Stasko et al., 2008; Wise, 1999), VALENCIA is novel in that it 
integrates a number of DR and CA techniques, real-time analytics, data visualization, and 
human-data interaction mechanisms in a systematic way. As such, the design concepts of 
VALENCIA can be generalized for the development of other visual analytics systems 
that deal with high-dimensional datasets in other domains (e.g., insurance, finance, and 
bioinformatics, to name a few). 
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The rest of this paper is organized as follows. Section 2 provides an overview of the 
conceptual and terminological background to understand the design of VALENCIA. 
Section 3 briefly describes other visual analytics systems that are related to VALENCIA. 
Section 4 explains the methodology employed for the design of the proposed system by 
describing its structure and components. Section 5 presents a usage scenario of 
VALENCIA to illustrate the usefulness of the system. Finally, Section 6 discusses 
conclusions and some future areas of application. 
5.2 Background 
This section presents the necessary terminology and concepts for understanding the 
design of VALENCIA. First, we describe the components of visual analytics. Afterwards, 
we briefly describe the processes of DR and CA. Finally, the healthcare stakeholders 
subsection introduces intended users of the system. 
5.2.1 Visual Analytics 
Visual analytics combines advanced analytics techniques with visual representations to 
analyze, synthesize, and facilitate high-level cognitive activities while allowing users to 
get more involved in discourse with the data (D. A. Keim et al., 2010; Thomas and Cook, 
2006). The information processing load of visual analytics is distributed between users 
and the main components of the system—namely, the analytics and interactive 
visualization engines (Cui, 2019; Jeong et al., 2015; D. Keim et al., 2010b; Ola and 
Sedig, 2014; Parsons and Sedig, 2014; Sedig and Parsons, 2013). The analytics engine 
deals with the analysis of the data and carries out most of the computational load. The 
interactive visualization engine incorporates visual representations to amplify human 
cognition when working with the data (Sears and Jacko, 2007; Sedig and Parsons, 2016). 
Human cognition is limited when confronted with data-intensive tasks, especially when 
the data is high-dimensional and complex (Green and Maciejewski, 2013; Ola and Sedig, 
2014). The analytics engine of the system incorporates techniques from different fields 
such as statistics, machine learning, and data mining to support human cognition in such 
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situations. Although the analytics engine carries out the majority of the computational 
load of the system, users are responsible for controlling the configuration parameters and 
internal steps of the analysis. The main responsibility of the analytics engine is to store, 
pre-process, transform, and analyze the data. This process can be divided into three 
stages: data pre-processing, data transformation, and data analysis (Ola and Sedig, 2014). 
The pre-processing stage is responsible for preparing raw data from different sources, 
which includes procedures such as cleaning, integration, and reduction (Han et al., 2011). 
Next, in the transformation stage, the pre-processed data is transformed into forms 
suitable for analysis (Kusiak, 2001). The transformation stage includes procedures such 
as smoothing, aggregation, feature generation, discretization, and normalization (Han and 
Kamber, 2011). Finally, in the data analysis stage, various statistical and machine 
learning techniques are applied to the transformed data to discover hidden patterns among 
data items and extract implicit, novel, and useful information (Agrawal et al., 1993; Sahu 
et al., 2008). Most of these techniques are intended for users with significant experience 
and do not allow proper exploration of the intermediary steps and computed results. 
Visual analytics addresses these issues by incorporating interactive visualization in the 
human-in-the-loop process.  
The interactive visualization engine provides users with the ability to change the 
displayed data, filter the subset of the information displayed, tune the configuration 
parameters of the analysis techniques, and control the intermediary steps of the analytics 
engine. This, in turn, sets off a chain of reactions that will result in the execution of 
additional data analysis processes. Despite the benefits of interactive visualizations in 
enhancing the cognitive needs of users, they prove inadequate when faced with problems 
requiring heavy computations (Ola and Sedig, 2014). Another challenge is to determine 
how to organize a large number of data items in visual representations, especially when 
the data is high-dimensional. Therefore, an integrated approach that combines data 
analysis with interactive visualizations through visual analytics is more suitable for a 
comprehensive exploration of high-dimensional EHR data (Kehrer and Hauser, 2013; 
Keim et al., 2008). 
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5.2.2 Dimension Reduction 
Most of the high-dimensional EHR datasets consist of multiple correlated features that 
offer overlapping data (e.g., most of the diabetes patients use similar medications). DR 
techniques can be used on such datasets to reduce dimensions without losing much 
information. This has long been one of the leading research topics in statistics, data 
mining, and machine learning (Sorzano et al., 2014). In addition to data analysis, DR 
techniques have been widely used in visualization research due to their ability to 
represent high-dimensional datasets in a low-dimensional space (Cook et al., 2007, p. 1; 
Fujiwara et al., 2020; Hege et al., 2009; Xin Geng et al., 2005). For instance, it is possible 
to transform a high-dimensional comorbidity dataset into a dataset with reduced 
dimensions to represent it in a scatter plot where relative positions among coordinates 
indicate the pairwise relationships among the transformed dimensions. 
 There are many DR techniques in the literature. Each DR technique has its own set of 
parameters, optimization criteria, and behaviours, which in turn affects data types and 
tasks that the technique supports. Different DR techniques should be represented using 
different types of visual representations because the internal mechanisms of these 
techniques are dissimilar. DR techniques can be broadly categorized into two groups: 
supervised and unsupervised (Cunningham, 2008). Most of the unsupervised DR 
techniques only consider the pairwise relationships among data items. Thus, the 
generated lower-dimensional projection can be represented in a cartesian-coordinate-
based visualization. On the other hand, supervised techniques take into account additional 
information about the cluster structure of the data items. Therefore, supervised DR 
techniques require the class labels associated with cluster structure to obtain a low-
dimensional projection of the original data. 
 In many existing visual analytics systems, DR techniques have been used as a 
preprocessing step to prepare the data for traditional machine learning methods that work 
well with a lower number of features (Mitsuhiro and Yadohisa, 2015; Obaid et al., 2019; 
Yan et al., 2006). A number of DR techniques are incorporated in our proposed system to 
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help users understand the high-dimensional EHR data better and prepare the data for CA. 
Since the cluster structure and/or class labels are not available at the initial stage, we only 
incorporate unsupervised DR techniques in VALENCIA. 
5.2.3 Cluster Analysis 
CA can be instrumental in retrieving the cluster structure information from the 
transformed dimensions. It is a machine learning method that partitions data items with 
similar characteristics into groups called clusters. When CA is applied on a dataset 
containing comorbidities data, it creates different patient groups/clusters each having 
similar comorbid conditions. The groups formed by CA offer valuable insights into the 
data. In the above example, if a patient with an unknown comorbidity profile belongs to a 
cluster where diabetes and hypertension are common, there is a high chance for that 
patient to have those conditions. Moreover, CA results can be used to create an additional 
categorical feature to improve the performance of the data mining methods. Furthermore, 
CA has the potential to add significant value to visual analytics systems by offering a 
visual understanding of natural groupings of data items in the dataset (Choo et al., 2013; 
Demiralp, 2017). 
The overall goal of CA is to determine the similarity between data items. There are 
different ways to measure similarity. Accordingly, CA techniques can be divided into 
four categories: connectivity, centroid, distribution, and density techniques 
(Kameshwaran and Malarvizhi, 2014). When data items are placed in a data space, 
connectivity techniques assume that items closer to each other exhibit more similarity 
than items that are farther away. Centroid techniques determine the similarity of data 
items by measuring closeness to the centroids using an iterative approach. Distribution 
techniques are based on the assumption that all data items in the same cluster share a 
common distribution (e.g., normal, gaussian, to name a few). Finally, density-based 
techniques analyze the density of the data items in a data space and group different 
density regions into clusters.  
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Each CA technique has its own set of configuration parameters, optimization criteria, and 
behaviours, which affects its performance for different datasets. Our goal in the design of 
VALENCIA is to assist users explore high-dimensional EHR data from different 
perspectives and identify the best CA technique that fits their needs. Thus, we incorporate 
at least one CA technique from each category (i.e., connectivity, centroid, distribution, 
and density) in our proposed system. 
5.2.4 Healthcare Stakeholders 
For the purposes of this study, we characterize stakeholders as those people who are 
integrally involved in the healthcare system to provide different services, such as medical 
practitioners, clinical researchers, and so on. With the growth of healthcare organizations, 
the interrelationship among healthcare stakeholders is getting complex (Davis, 2019). 
Irrespective of their field of expertise, stakeholders interact with EHRs at some level to 
perform numerous tasks to achieve novel healthcare solutions. For instance, medical 
practitioners use the historic treatment plan data to forecast the progress of treatments 
(Soyiri and Reidpath, 2013), or clinical researchers develop frameworks to discover 
temporal knowledge from healthcare administrative data (Klimov et al., 2015). To 
support complex, data-driven tasks, EHR data require some initial analysis to allow 
healthcare stakeholders to get insight into the distribution of the data and understand 
relationships among data items. The initial analysis may include preprocessing and 
compression of high-dimensional data to make it ready for other machine learning and 
statistical methods. Because of their lack of support for interactive visualizations, 
particularly when dealing with high-dimensional data, it is often difficult to do the above-
mentioned task with conventional data analysis systems (i.e., R, SAS, Weka, to name a 
few). VALENCIA is designed to assist healthcare stakeholders at the ICES-KDT 
program (i.e., clinicians, scientists, epidemiologists, and analysts) to be able to explore 
and analyze healthcare administrative data housed at ICES. 
118 
 
 
 
5.3 Related work 
In this section, we discuss some of the available visual analytics systems. There are not 
too many EHR-based systems that adopt DR and/or CA techniques. Thus, we include any 
visual analytics systems that incorporate DR and/or CA techniques in this section. In 
addition, we provide a brief overview of visual analytics systems that are designed for 
EHRs, whether they are tied to DR/CA or not. This section is divided into four parts: 
ones using DR, CA, both DR and CA, and EHR. 
5.3.1 DR-Based Visual Analytics Systems 
GGobi19 (Cook et al., 2007) is a visual analytics system that uses a DR technique called 
grand tour (Asimov, 1985) to represent encoded high-dimensional data. The advantage of 
this technique in comparison with other DR techniques is that it supports exploration of 
the high-dimensional space by allowing users to continuously modify the basis vectors 
into which data items are mapped. However, the grand tour technique can only be used 
when the data is not very high-dimensional. Because of this limitation, the application of 
GGobi19 is restricted when dealing with a very large number of dimensions which is 
often the case in EHRs. Another visual analytics system that uses a DR technique 
(specifically, PCA) to represent high-dimensional data is iPCA (Hege et al., 2009). The 
use of DR on high-dimensional data often results in significant information loss. iPCA 
offers a solution to this problem by introducing the idea of reducing the dimensions to an 
intermediary size and visualizing them using parallel coordinates plot. Thus, iPCA allows 
exploration of reduced dimensional data without loss of much information from the 
original dataset. It can also help users get a better understanding of the role of the reduced 
dimensions by visualizing the PCA basis vectors. Praxis (Cavallo and Demiralp, 2018) is 
another system that allows users to change the input and output of DR techniques 
dynamically and observe these changes through interactive visualizations. Praxis 
implements PCA and a number of autoencoder-based DR techniques. TimeCluster (Ali et 
al., 2019) is another system that incorporates DR, deep convolutional auto-encoder, 
scatter plot, and time-series graph to analyze large time-series data. It allows users to 
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compare the results of multiple DR techniques visually. Although most of these systems 
are designed to assist users in exploring high-dimensional data using DR, they only 
include a limited number of DR techniques. Moreover, some of these systems, such as 
GGobi19 and iPCA do not support exploration of very high-dimensional data because 
they visualize the features of the original data along with the results of DR. 
5.3.2 CA-Based Visual Analytics Systems 
The Hierarchical Clustering Explorer (HCE) (Seo and Shneiderman, 2003) allows users 
to explore the results of CA of gene expression data using dendrograms and heatmaps. 
Although it enables users to visually compare the results of CA, it only supports 
hierarchical clustering techniques. Similar to the HCE, Matchmaker (Lex et al., 2010) 
allows users to arrange and compare multiple clusters simultaneously using heatmaps and 
parallel coordinates. It shows raw data along with the clustering results. ClusterSculptor 
(Nam et al., 2007) is a visual analytics system that uses k-means as the clustering engine 
to aid users in the derivation of classification hierarchies. Although it allows users to tune 
the configuration parameters through an interactive visual interface, it does not support 
any other clustering techniques. iGPSe (Ding et al., 2014) is another system that is 
designed to visually compare the results of clustering of different expression data types 
using parallel sets. It allows users to investigate which features are shared between 
multiple clusters from two different CA techniques. Both iGPSe and HCE have 
interpretability problems for large datasets because of having too many crossing lines. 
CComViz (Zhou et al., 2009) resolves this issue by rearranging clusters and their items to 
minimize visual clutter between features. XCluSim (L’Yi et al., 2015) also supports the 
comparison of several CA results of gene expression datasets using a force-directed 
layout, dendrogram, and parallel sets. XCluSim offers a better understanding of the 
characteristics of each CA technique and its parameters along with results. Although 
most of the abovementioned visual analytics systems are designed to compare multiple 
CA results, they often suffer from lack of interpretability when dealing with large 
datasets. A combination of the CA with DR can resolve this issue, especially when the 
data is high-dimensional. 
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5.3.3 DR and CA-Based Visual Analytics Systems 
IN-SPIRE (Wise, 1999) is a visual analytics system for processing text documents; it 
incorporates both CA, DR, and interactive visualizations. It uses a bag-of-words model to 
encode the documents as high-dimensional vectors and then applies k-means with a 
specific number of clusters. Although it is equipped to deal with a large amount of data, it 
offers only a limited number of interactions to alter the analysis techniques and their 
configurations. Another system that utilizes both CA and DR for analyzing documents 
and their entities is Jigsaw (Stasko et al., 2008). To reduce the number of keywords in the 
vocabulary, Jigsaw implements an automatic named-entity extraction technique. It then 
uses k-means to display related documents and their keywords through visualization. 
Similar to IN-SPIRE, Jigsaw supports a limited number of interactions and does not 
allow users to change the CA technique. Testbed (Choo et al., 2013) is another system 
that addresses these limitations by incorporating seventeen DR and four CA techniques to 
analyze large-scale high-dimensional datasets. It allows users to apply any combinations 
of these techniques to visually compare their results. Another system for interactive 
exploration of high-dimensional data is Clustrophile (Demiralp, 2017); this system 
incorporates six DR and two CA techniques. It allows users to tune different 
configuration parameters and observe the changes through several interactive 
visualizations such as a heatmap and a scatter plot. Despite the advantages, both Testbed 
and Clustrophile allow users to apply clustering on the original dataset, which can be 
very high-dimensional. Some CA and visualization techniques may not perform well in 
those situations due to the “curse of dimensionality”. 
5.3.4 EHR-Based Visual Analytics Systems 
MatrixFlow (Perer and Sun, 2012) is a visual analytics system that assists users in 
discovering subtle temporal patterns across patient cohorts stored in EHRs. It integrates 
an advanced network modeling framework (i.e., Orion (Heer and Perer, 2014)) with 
interactive visualizations to represent networks of clinical events as a temporal flow of 
matrices. Another visual analytics system is VisualDecisionLinc (Mane et al., 2012) that 
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facilitates the interpretation of large amounts of clinical data by providing overviews of 
treatment options and patient outcomes in an interactive dashboard. It enables clinicians 
to identify patient subpopulations that share similar medical characteristics to help them 
in the decision-making process. Simpao et al. (Simpao et al., 2015) developed a 
dashboard to facilitate the monitoring of medication alerts in EHRs to reduce irrelevant 
alerts and improve medication safety. It assists clinicians in exploring not only 
medication alerts but also alert types and patient characteristics. Visual Temporal 
Analysis Laboratory (ViTA-Lab) (Klimov et al., 2015) is an interactive and data-driven 
framework that is designed for the investigation of temporal clinical data. It combines 
query-driven visualizations with longitudinal data mining techniques to assist users in 
discovering temporal patterns within time-oriented clinical data. Another visual analytics 
system is Care Pathway Explorer (Perer et al., 2015) that enables users to discover 
common clinical event sequences and helps them to study how these event sequences are 
associated with patient outcomes. In order to achieve this, it integrates a frequent 
sequence mining technique with an interactive user interface. PHENOTREE (Baytas et 
al., 2016) allows interactive exploration of patient cohorts and interpretation of 
hierarchical phenotypes by integrating sparse principal component analysis with an 
interactive visual interface. VISA_M3R3 (Abdullah et al., 2020) is a recent visual 
analytics system that incorporates multiple regression, frequent itemset mining, and 
interactive visualization to assist users in the identification of nephrotoxic medications 
using EHRs. Although most of these systems incorporate complex visualization and 
enable users to interactively explore EHR data, they only include a limited number of 
analytics techniques. Moreover, some of these systems do not allow users to access and 
modify the analytics engine through visualization, which is an essential aspect of visual 
analytics. 
5.4 Methods 
This section describes the methodology we have employed to design the proposed visual 
analytics system, namely VALENCIA. In Section 4.1, we provide an overview of the 
design process and participants. We then describe task analysis and design criteria in 
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Sections 4.2. Then, in Section 4.3, we introduce the components of VALENCIA and 
briefly describe how the overall system works, also discussed more extensively in 
Section 4.4, 4.5, and 4.6. Finally, Section 4.7 outlines the implementation details of 
VALENCIA. 
5.4.1 Design Process and Participants 
Healthcare stakeholders usually deal with both well- and ill-defined tasks to solve various 
research problems. The well-defined tasks have clear expected solutions, specific goals, 
and, oftentimes, a single solution path. Unlike well-defined tasks, ill-defined tasks do not 
have a solution path (Varga and Varga, 2016). To help us understand how healthcare 
stakeholders perform real-world tasks, and to help us conceptualize and design 
VALENCIA, we adopted a participatory design approach. It is a co-operative approach 
that involves all stakeholders in the design process to ensure the output meets their 
requirements (Leighton, 2004). The system was primarily designed to assist the 
healthcare experts at the ICES-KDT program located in London, Ontario, Canada. A 
clinician-scientist, an epidemiologist, a data scientist, and two computer scientists were 
involved in the conceptualization, design, and evaluation process. They were from the 
computer science and epidemiology department of Western University. Participants were 
identified and contacted through the ICES-KDT. During the primary stage of the design 
process, we discerned that exploring EHR through DR, CA, and interactive visualization 
is not a straightforward task. It is often difficult to understand which analytics technique 
produces the desired result for a given dataset, which visualization technique is more 
suitable for the analysis results, or which interaction techniques are more appropriate to 
meet the requirements of the user. It becomes an ill-defined problem when analytics and 
interactive visualizations are combined in a VA system. In order to make appropriate 
design decisions, we interviewed healthcare experts in our team (i.e., a clinician-scientist 
and epidemiologist) to understand 1) data-driven tasks they perform with EHRs 2) 
analytics techniques they rely on to accomplish those tasks, and 3) visualizations with 
which they are familiar. We negotiated with healthcare experts the possibility of using 
several semi-structured interviews, which allowed new concepts to be brought up during 
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the process. We conducted these interviews in person at the ICES-KDT center. Typical 
stakeholders of the system are involved in assessing and suggesting features towards 
similar systems regularly. In our collaboration with experts, we first finalized the 
analytics techniques that could allow them to accomplish data-driven tasks they would 
like to perform with the system. We then created several horizontal prototypes to narrow 
down the visualization design possibilities and selected appropriate visualization 
techniques for the data, analytics, and users. We performed formative evaluations 
continuously at every stage of the design and development process. This process was 
essential to build trust between the proposed system and its end-users. 
5.4.2 Task Analysis and Design Criteria 
In our collaboration with the healthcare stakeholders, we recognized four high-level tasks 
to consider in designing VALENCIA. 
5.4.2.1 Displaying an Overview of the Data 
Users would like to explore the features of the dataset so that they can decide which 
features to incorporate in the analysis. For instance, they would like to see frequencies of 
distinct categories for the categorical variables. Since some analysis techniques work best 
with specific data types, it is important to understand the characteristics of the features 
and their distributions. 
5.4.2.2 Allowing Iteration Over DR Techniques 
Choosing the appropriate DR technique is not a straightforward task. Users have to make 
several decisions such as which technique to use, which values for the configuration 
parameters are appropriate, and how many transformed dimensions to retain, to name a 
few. After the initial selection, users would like to refine their decisions in an iterative 
manner. 
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5.4.2.3 Allowing Iteration Over CA Techniques 
Users would like to explore the data using different CA techniques with various 
parameter settings. They want to investigate how the clusters are formed and verify the 
results. Users would like to refine their decisions by going through the CA process 
iteratively. 
5.4.2.4 Facilitating Reasoning about DR and CA 
Users often would like to understand which features of the dataset are affecting the 
transformed dimensions, which dimensions are essential in identifying a given cluster, 
and how different selections of features, dimensions, techniques, and/or parameters 
influence the results. Since clustering is performed on the transformed data, users would 
like to know the summary statistics of different features and identify which feature 
groups or features are more important within each cluster. 
5.4.3 Workflow 
As shown in Figure 1, VALENCIA has two modules: the analytics engine and the 
interactive visualization engine. The analytics engine is composed of two components: 1) 
DR engine and 2) CA engine. The interactive visualization engine is composed of two 
views: 1) DR view, and 2) CA view. The DR view has four subviews: 1) raw-data 
subview, 2) projected-features subview, 3) association subview, and 4) variance subview; 
it supports eight interactions: selecting, drilling, filtering, annotating, arranging, 
searching, and transforming. The CA view is composed of three subviews: 1) hierarchical 
subview, 2) frequency subview, and 3) projected-observation subview; it supports six 
interactions: selecting, drilling, filtering, arranging, searching, and transforming. 
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Figure 5-29: Basic workflow of VALENCIA. The backgrounds of the components 
are color-coded to show the similarity between processes.    
The basic workflow of VALENCIA is as follows. Once the data is loaded, it gets 
preprocessed and encoded via the default encoding scheme. Users can then interactively 
explore the dataset through the raw-data subview to choose their features of interest. 
Next, upon selection of the DR technique and configuration parameters, the subset of the 
data containing the chosen features is analyzed in the DR engine. The system updates the 
projected-features, association, and variance subviews when the data items are generated 
in the DR engine. Users can observe representation of the categories of different features 
in proximity to each other based on their values in the projected dimensions through the 
projected-features subview. The association subview allows users to understand which 
features are most significantly associated with different dimensions. Users can observe 
the amount of variation retained by each projected dimension from the variance subview. 
This subview also allows users to select the dimensions to be analyzed through the CA 
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engine. Users can observe the hierarchical structure of the CA result through the 
hierarchical subview. After selecting the dimensions, when users click the submit button, 
they get to the CA view. Upon selection of the CA technique and configuration 
parameters, the CA engine generates data items to be represented in the hierarchical, 
frequency, and projected-observation subviews. The frequency subview displays the 
distribution of features in each subset of the data selected through the hierarchical 
subview. The projected observation subview allows users to explore the positions of the 
observations in the dataset with respect to the projected dimensions. The association 
subview is shared between both the DR and CA views; however, the data in this subview 
gets filtered in the CA view based on the selection through the variance subview. Finally, 
users can export the output of the analysis using the export button in the CA view.  
5.4.4 Encoding and Preprocessing 
VALENCIA accepts input files in the JSON (JavaScript Object Notation) format and 
enables output to be exported in the same format. It has a built-in preprocessing 
procedure to encode the categorical features. The system enables users to select multiple 
features within a group (e.g., diabetes and hypertension in comorbidities group), all 
features of a group (e.g., all comorbidities or medications) or all features in all groups. A 
collapsible tree structure is implemented to support this operation in VALENCIA. The 
subset of the data containing selected features are then transferred to the analytics engine 
for further processing. 
5.4.5 Analytics Engine 
The analytics engine of VALENCIA has two main components: 1) the DR engine (a sub-
engine of the analytics engine) that transforms the EHR data from the high-dimensional 
space to a space of lower dimensions, and 2) the CA engine (a sub-engine of the analytics 
engine) that organizes objects in low-dimensional space into meaningful groups whose 
members share similar characteristics in some way. Several techniques belonging to both 
families are incorporated in VALENCIA. Users are able to analyze the inputted dataset 
using DR, CA, or a combination of both techniques. Some studies in the literature have 
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identified several limitations of combining some specific DR and CA techniques (e.g., 
(Arabie, 1994; De Soete and Carroll, 1994; Mitsuhiro and Yadohisa, 2015; Rocci et al., 
2011; Timmerman et al., 2010; Vichi and Kiers, 2001)). For instance, DR techniques that 
rely on probability distribution (e.g., t-distributed stochastic neighbour embeddings) are 
not suitable for distance or density-based CA techniques. VALENCIA overcomes these 
limitations by providing users with the ability to choose a combination from a number of 
DR and CA techniques and verify the results of the analysis with both original and low-
dimensional data through interactive visualizations. This analysis process is iterative, 
which allows users to go through any number of combinations until an optimal solution is 
found.  
5.4.5.1 DR Engine 
In analytical activities, it is often challenging for users to choose a DR technique among 
an abundance of available algorithms. There is no single solution to the problem of 
recognizing which technique is appropriate for a particular dataset. The choice of a DR 
technique primarily depends on the nature of the data. It also depends on the domain 
knowledge of users and the problem at hand. Linear DR techniques such as 
correspondence analysis (Hirschfeld, 1935), classical multidimensional scaling (CMDS) 
(Torgerson, 1958), principal component analysis (PCA) (F.R.S, 1901; Hotelling, 1933), 
multiple correspondence analysis (MCA) (Greenacre and Blasius, 2006), and multiple 
factor analysis (MFA) (Escofier and Pagès, 1994) are better at representing the global 
structure of the data. On the other hand, nonlinear techniques such as t-Stochastic 
neighbour embedding techniques (t-SNE) (Maaten and Hinton, 2008) and nonmetric 
multidimensional scaling (NMDS) (Kruskal, 1964; Shepard, 1962) are better at 
representing and preserving local interactions. VALENCIA incorporates eight linear and 
nonlinear DR techniques to allow users to analyze high-dimensional EHR data. Some of 
the well-known DR techniques that are implemented in VALENCIA include PCA, MCA, 
MFA, and t-SNE.  
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PCA uses variance to obtain principal components (i.e., orthogonal vectors) in the feature 
space that accounts for the maximum variance in the data. Although PCA is originally 
designed for continuous features, a special version of PCA, categorical principal 
component analysis (princals), can be used for categorical features (De Leeuw, 2005; 
Gifi, 1990). VALENCIA uses R libraries "PCA" and "princals" to implement PCA. On 
the other hand, MCA is a correspondence analysis technique for compressing and 
visualizing datasets with multiple categorical features. It is a generalization of PCA when 
the features to be analyzed are categorical instead of continuous (Abdi and Williams, 
2010). To implement MCA, VALENCIA uses the "MCA" function from the 
"FactoMineR" package in R. In addition, MFA is a multivariate analysis technique to 
summarize or visualize complex datasets where observations are described by multiple 
sets of features structured into different groups. The distance between observations is 
defined based on the contribution of all active groups. To implement this technique, we 
use the "MFA" function in the "FactoMineR" package in R.  
Unlike PCA, t-SNE is a nonlinear dimensionality reduction technique that can deal with 
more complex patterns in multidimensional space (Maaten and Hinton, 2008). It relies on 
the probability distribution of observations in the high-dimensional space to calculate the 
probability in the corresponding low-dimensional space. This technique is implemented 
using the "Rtsne'' package in VALENCIA. NMDS is another nonlinear dimensionality 
reduction technique that uses rank-orders to collapse data from high-dimensional space 
into a limited number of dimensions. VALENCIA uses the "vegan" package to 
implement NMDS. 
Determining the suitable number of new dimensions in the lower-dimensional space is a 
challenging task. The optimal number of dimensions to keep for CA mainly depends on 
the dataset. Users are often interested in particular signals in the dataset, and the choice of 
dimensions also depends on whether the signal of interest is captured within the 
dimensions in the reduced space. Thus, choosing the appropriate dimensions is crucial in 
VALENCIA because the DR engine is used to prepare the data for CA. It is also 
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important to reduce the number of dimensions to an appropriate size because of the 
limitation of the screen space, especially when users want to visually explore the high-
dimensional data. For instance, in the case of principal component analysis with a high-
dimensional dataset, the first two or three principal components may describe a small 
fraction of variance of the dataset and/or may not capture the variation of interest (i.e., the 
signal of interest can be a confounding factor). In those situations, users may need to 
explore higher-order components through visualization and select a combination of low- 
and higher-order components to preserve the desired variance. VALENCIA allows users 
to explore the projected dimensions produced through different DR techniques using 
interactive visualizations. Users have the ability to adjust not only the number of 
dimensions but also different configuration parameters of a particular DR technique. It is 
important for users to find the optimal values of configuration parameters to get their 
desired results from the DR engine. Some arguments are adjusted automatically by the 
system based on the type of features in the dataset. The data items for the visual 
representations are produced based on the values of different arguments in the DR 
engine. 
5.4.5.2 CA Engine 
It is often difficult to interpret and visualize the results of CA when the data is high-
dimensional. To address this issue, VALENCIA employs DR techniques to lower the 
dimension from possibly thousands to a manageable size, making it possible not only to 
apply different CA techniques on the projected data but also to incorporate different 
visualization techniques. It also offers the flexibility of analyzing a dataset containing 
mixed features because some CA techniques might not work well in such situations 
(Mitsuhiro and Yadohisa, 2015). Similar to DR, there is no single CA technique that suits 
every dataset and/or problem. Moreover, the configuration parameters of CA techniques 
need to be adjusted for different problems to find an optimal solution. There are several 
CA algorithms in the literature, and new algorithms are often introduced to solve 
different problems. Many of these algorithms are problem- and data-specific. Since there 
is no globally optimal CA technique, VALENCIA incorporates a number of CA 
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techniques from different methods (i.e., connectivity, centroid, distribution, and density) 
that work together with a number of DR techniques. Through the integration of DR and 
CA, it allows users to identify patterns and groups in low-dimensional space and discover 
knowledge in multidimensional data.  
One of the widely used CA techniques is k-means (Hartigan and Wong, 1979; Jain, 
2010), a centroid-based method that partitions the data into clusters. It defines clusters in 
such a way that the total within-cluster (i.e., intra-cluster) variation is minimized. In 
general, this algorithm first selects k observations as initial centers or centroids from the 
dataset. Then, all remaining observations are assigned to their closest centroid using a 
distance function. Next, the new mean value of each cluster and its centroid are 
calculated. All the observations are reassigned based on the updated cluster means. These 
steps are repeated until convergence is achieved. To implement this technique in 
VALENCIA, we use the "kmeans" function in the "stats" package in R. 
Unlike k-means, hierarchical clustering (Nielsen, 2016) does not require users to specify 
the number of clusters initially. It comes in two forms: agglomerative and divisive 
(Rokach and Maimon, 2005). Agglomerative clustering works in a "bottom-up" manner. 
Observations are initially considered as single clusters, and similar clusters are then 
combined to create new clusters with multiple observations. This process is repeated until 
all observations are grouped in a single cluster. On the contrary, divisive clustering works 
in a "top-down" manner where observations are combined or divided based on a 
similarity measure. We use the "dist()" function in R to compute distances between 
observations. Agglomerative and divisive techniques are implemented using "hclust()” in 
“stats" and “diana()” in “cluster” packages, respectively, to generate hierarchical trees in 
VALENCIA. 
The density-based clustering (Ester et al., 1996) can be used to identify clusters of 
different sizes and shapes from the data. Each cluster must contain a minimum number of 
observations. It seeks the regions in the data space that have a high density of 
observations, which are separated by low-density regions. VALENCIA uses the "dbscan" 
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function in the "fpc" package in R to provide support for density-based clustering. Users 
can define the radius of the neighbourhood around an observation by choosing "eps" 
argument and the minimum number of observations within a specified radius using 
"MinPts" argument.  
Model-based clustering (Fraley and Raftery, 2002) assumes that the data is generated by 
an original model and tries to recover that model based on certain criteria. The recovered 
model is then used to define the clusters. Unlike other techniques mentioned above, 
model-based techniques implement a soft assignment, where each observation is assigned 
with a probability of belonging to a cluster. One of the well-known criteria to determine 
the model parameters is maximum likelihood. VALENCIA uses the "mclust" package in 
R to provide support for model-based clustering. This package uses maximum likelihood 
to fit different models, which can be compared based on their Bayesian information 
criterion score.  
There are several ways to assess the quality of CA, each of which has limitations relating 
to the subjective quality of individual evaluations (Feldman and Sanger, 2007). 
VALENCIA allows users to develop a feedback loop with the system through a series of 
interactions. Users adjust different configuration parameters to observe their effects on 
features of interest to evaluate the performance of a particular CA technique. In order to 
find the optimal CA technique for a dataset, users can try several configuration settings. 
For example, when working with k-means, the "centers" argument can be modified to 
control the number of initial cluster centroids, and "iter.max" can be tuned to regulate the 
maximum number of iterations. While users have the flexibility to adjust some 
arguments, many arguments are adjusted automatically by the system. Despite the 
ubiquitous use of DR and CA techniques in the literature, their combination can be 
difficult to interpret, especially in relation to the features of the original dataset. To 
overcome this issue, the data items produced through the CA engine are made available 
to users through a number of visualizations. These visualizations represent the 
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distribution of clustered observations in both high- and low-dimensional space, allowing 
users to verify the results and avoid misinterpretation. 
5.4.6 Interactive Visualization Engine 
VALENCIA is composed of two main views: DR and CA. The DR view is composed of 
4 subviews: raw-data, projected-features, association, and variance. The CA view is 
composed of 3 subviews: hierarchical, frequency, and projected-observations. These 
views are supported by several selection controls, such as collapsible tree structure, drop-
down menu, search bar, and checkbox. Each of these views represents an important 
aspect of the analytics engine. In this section, we describe how data items generated in 
the analytics engine are mapped onto visual representations to allow healthcare 
stakeholders to achieve the tasks mentioned in Section 4.2. 
5.4.6.1 DR View 
The components in the DR view allow healthcare stakeholders to import raw data, 
explore features, select features of interest, apply DR techniques, adjust configuration 
parameters, analyze DR results, and generate data items for the CA engine. This section 
describes four main subviews of the DR view (Figure 2). 
5.4.6.1.1 Raw-data Subview 
The raw-data subview is composed of a collapsible tree structure, bar chart, and data 
table. Upon selection of an input file, VALENCIA maps the hierarchical features of the 
preprocessed data into a collapsible tree structure. Users can expand the tree structure 
multiple times by clicking on the “+” icon in each level; this reveals groupings of the 
features in that level. The lowest level of the tree contains the actual feature names.  
The grouping or feature name at each level of the tree structure has a checkbox, allowing 
users to select not only a specific feature but also a group of features. The list of selected 
features and relevant information is shown in a data table. Moreover, users can hover the 
mouse over any feature in the tree structure to see the distribution of that feature through 
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a bar chart. The data table and bar chart are on the right side of the tree structure, as seen 
in the top-middle section of Figure 2. 
 
Figure 5-30: The DR view containing (A) raw-data subview, (B) projected-features 
subview, (C) association subview, and (D) variance subview. 
5.4.6.1.2 Projected-Features Subview 
The projected-features subview includes a scatter plot, collapsible tree structure, search 
bar, and several drop-down menus. Initially, users select a DR technique, relevant 
configuration parameters, and the number of projected dimensions to engage with the DR 
engine. Upon these selections, the coordinates of the chosen features (selected through 
the raw-data subview) are mapped onto a scatter plot. The scatter plot displays glyphs 
representing categories of each feature in proximity to each other based on their values in 
the projected dimensions. All the categories of a specific feature are encoded with the 
same color and all the features belonging to the same group are represented by a specific 
shape (e.g., triangle, rectangle, star, to name a few). Each category can also be 
represented by its corresponding label. Both the glyph and label can be turned on/off via 
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two separate checkboxes. In the scatter plot, a linear scale is used for both horizontal and 
vertical axes to represent the selected dimensions. Users can interactively adjust the 
dimensions corresponding to the axes via two drop-down menus. The displayed 
information in the scatter plot can be filtered using a collapsible tree structure. This tree 
structure shows the list of chosen features through the raw-data subview. It allows users 
to select features of interest to observe their positions in the scatter plot. The tree 
structure is accompanied by a search bar that enables users to look for a specific group 
and/or feature.  
Users can click on a glyph representing a category of a specific feature to observe the 
position of other glyphs and labels belonging to that feature. This interaction filters out 
all other glyphs to make it easy for users to investigate the feature of interest. Users can 
drill the glyphs for additional information by hovering the mouse over them. It is 
sometimes difficult for users to distinguish between glyphs when they are densely 
clustered in the scatter plot. In order to address this issue, VALENCIA provides scrolling 
to allow users to zoom in/out on the scatter plot. While zooming, users may wish to see 
glyphs that are not visible in the visual representation of the scatter plot. In such 
situations, users can navigate through the scatter plot by selecting any region within the 
representation (with the mouse) and dragging it to the desired location. These interactions 
are useful for exploring high-dimensional and heavily-categorized datasets. 
5.4.6.1.3 Association Subview 
Once the DR technique is applied, the correlation coefficient between each feature and 
projected dimension is shown in a heatmap in the association subview. The heatmap 
visualizes the magnitude and direction of the correlations through variations in coloring. 
It allows users to cross-examine multivariate data, through placing features in the 
columns and projected dimensions in the rows. Users can identify patterns by examining 
variance across multiple features and dimensions through this subview. They can also 
detect similarities between both features and dimensions and observe if any correlations 
exist between them. Only the significantly correlated (i.e., filtered by p-value) 
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coefficients are included in the heatmap, leaving the unassociated cells empty. Each cell 
in the heatmap contains a color-coded numerical value representing the relationship 
between the feature and dimension in the connecting row and column. The color-coding 
is based on a color scale that blends from one particular color to another, to show the 
difference between low and high values. In order to assist users in interpreting the 
heatmap, a legend is included in the association subview. The legend contains a gradient 
scale, which is created by blending dark brown and navy blue.  
Users can sort the heatmap based on either a feature or dimension by clicking on the 
corresponding row or column header. This allows users to observe which dimensions best 
represent each feature and how different features affect each dimension. Users can drill to 
obtain the actual value of the coefficient by hovering the mouse over the corresponding 
cell. Users may face difficulty while exploring this subview because of the limited screen 
space, especially when the dataset is high-dimensional. To address this issue, 
VALENCIA supports selecting any region of the subview with the mouse (left-click) and 
dragging it to the desired position. It also allows users to zoom in/out on the heatmap by 
scrolling the mouse within the region specified for this subview. These interactions make 
it possible for users to observe all the elements of the heatmap and investigate features of 
interest more closely. 
5.4.6.1.4 Variance Subview 
The variance subview includes a line-column chart and checkboxes that correspond to 
each projected dimension. The line-column chart combines a line graph and column chart 
by using a common x-axis. The column chart encodes each projected dimension in a 
vertical bar, allowing users to compare the proportion of variance retained by that 
dimension using the eigenvalues measure. The line chart encodes the cumulative 
percentage, obtained by adding the successive variances to calculate the running total. 
This subview supports drilling (mouse over) by displaying both actual and cumulative 
variance. Users can select a dimension by clicking on its corresponding checkbox. This 
allows users to choose a subset of projected dimensions so that it can be analyzed with 
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the CA engine. In practice, users tend to look for a minimum number of projected 
dimensions that cover maximum variance in the dataset. 
5.4.6.2 CA View 
The components in this view allow users to apply different CA techniques, adjust 
configuration parameters, analyze the output, and export the final result (Figure 3). This 
view shares a common subview (i.e., association subview) with the DR view. The three 
main subviews of the CA view are described in this section. 
 
Figure 5-31: The CA view containing (A) association subview, (B) projected-
observations subview (C) hierarchical subview, and (D) frequency subview. 
5.4.6.2.1 Hierarchical Subview 
Upon selection of a CA technique and relevant configuration parameters, the hierarchical 
structure of the clustered data is displayed in a zoomable treemap in the hierarchical 
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subview. The space in the visual representation of the treemap is divided into nested 
rectangles. The set of rectangles in the first, second, and third levels represents clusters, 
groups within a particular cluster, and features within a particular group, respectively. 
There are several algorithms in the literature that can be used to determine the size of the 
rectangles in a treemap. VALENCIA determines the size of the rectangles based on the 
impact of each feature on a particular cluster. The algorithm to compute the size is 
presented in Procedure 1. For hierarchies, the size of a rectangle that contains other 
rectangles is determined by the sum of areas of the contained rectangles. All the 
rectangles representing groups and features within a cluster are encoded with the same 
color. VALENCIA automatically assigns colors to different clusters. The sets of 
rectangles in the first and second levels are transparent, showing the contained rectangles 
in the background. The varying sizes, colors, and nested structures of the rectangles allow 
users to identify patterns that would be difficult to detect otherwise. 
Procedure 5-1: Compute the size of the rectangles  (1) 
Require: Raw dataset with cluster labels (2) 
compute the number of features in each group in number_of_groupfeatures [] (3) 
compute max_groupfeatures = maximum value in number_of_groupfeatures [] (4) 
compute frequency of each feature in the dataset (5) 
divide the dataset based on each cluster (6) 
for each cluster C in the dataset (7) 
   for each feature F in the dataset (8) 
 compute relative frequencies of feature F in cluster C (9) 
 feature_weight = (relative frequencies / frequency [F]) * 100 (10) 
 adjusted_feature_weight [C,F] = (max_groupfeatures / number_of_groupfeatures [F]) * 
feature_weight 
(11) 
return adjusted_feature_weight [][] (12) 
Initially, the set of rectangles belonging to the first level (i.e., clusters) is visible in the 
representation of the treemap. Users can navigate through the rectangles in different 
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levels by clicking on a rectangle representing a cluster or group. The top-left corner of 
the treemap contains a button and navigation links. The button allows users to get back to 
the previous level from particular levels (i.e., second or third). The navigation links get 
updated dynamically as users navigate through the treemap. These links allow users to 
jump into any level by clicking on them. Users can hover the mouse over a rectangle to 
bring out the label of the corresponding rectangle. When a rectangle is hovered, it 
becomes highlighted (black) to help users understand which rectangle will be selected if 
they click on it. 
5.4.6.2.2 Frequency Subview 
The frequency subview includes a parallel set, collapsible tree structure, search bar, and 
checkbox. Parallel Sets (Kosara, 2010) is a visualization technique that is developed 
mainly for interpreting categorical data. For each feature or cluster, horizontal bars are 
displayed for possible categories in the frequency subview. The width of the bar encodes 
the frequency (i.e., number of matches) of that category. Starting with the first feature, 
each of its corresponding categories is connected to the categories of the next feature, 
which reveals how that category is subdivided. This subdivision process gets repeated 
recursively, which creates a tree of “ribbons”. The relationship between horizontal bars 
and ribbons helps users understand the distribution of combinations of categories. The 
horizontal bars and ribbons are color-coded based on the categories of the first feature. 
VALENCIA assigns colors to different categories automatically to make sure they are 
visually distinguishable. 
The data items displayed in the parallel sets can be controlled through a collapsible tree 
structure and an interaction with the treemap in the hierarchical subview. Users can select 
checkboxes of features in the collapsible tree structure to include them in the parallel sets. 
Features are organized into groups to make them easy to find. A search bar is also 
included to find a specific feature. The interaction with the tree structure helps users to 
investigate the distribution of features of interest in different clusters. The displayed 
information in the parallel sets can also be controlled by selecting a rectangle 
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representing a cluster, group, or feature in the treemap. Initially, a common set of features 
along with clusters are shown in the parallel sets for the entire dataset. As users interact 
with the treemap, the subset of data belonging to the contained rectangles in the treemap 
is shown in the parallel sets. For instance, if users click on a rectangle representing a 
cluster in the treemap, only the data items belonging to that cluster are displayed in the 
parallel sets. This process continues until users reach the last level in the treemap. 
Whenever users interact with either the tree structure or the treemap, the parallel sets gets 
updated based on the latest interaction. 
To get additional information, users can move their mouse over the components of the 
parallel sets to highlight them and bring out tooltips. The tooltip of each horizontal bar 
displays the frequency and percentage (as a fraction of the entire dataset) of its 
corresponding category. When users move their mouse over a horizontal bar, all the bars 
and ribbons connected to that particular bar get highlighted. The tooltip of a ribbon 
displays the combination of criteria (categories) that the ribbon represents along with the 
frequency and relative percentage. When users hover over a ribbon, all other connected 
ribbons get highlighted. Users can drag any features and categories to reorder them. The 
mouse pointer changes to help users understand which components are draggable. The 
features and categories can be dragged vertically and horizontally, respectively. This 
helps users to rearrange components of the parallel set and choose which feature should 
be used to color the ribbons. 
5.4.6.2.3 Projected-Observations Subview 
Projected-observations subview includes a scatter plot matrix and histograms. The 
scatterplot matrix is used to show the projected observation from the DR and CA 
analyses. It can be seen as a collection of scatterplots organized into a matrix where each 
scatterplot displays the relationship between a pair of projected dimensions. While each 
off-diagonal cell in the matrix maps a pair of distinct dimensions, there is no logical 
mapping for the diagonal cells. Therefore, VALENCIA incorporates histograms in the 
diagonal cells of the matrix. Histograms plot the frequency of observations in each 
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projected dimension. The observations are color-coded based on their corresponding 
cluster. The same color scheme is used for both the treemap, scatter plot matrix, and 
parallel sets. The scatter plot matrix helps users determine the linear correlation between 
multiple dimensions and detect patterns in the distribution of the clustered observations 
using projected dimensions. Users can observe each histogram to visually detect the 
median, outlier, and distribution (e.g., normal, skewed, to name a few) of the 
observations.  
When users apply brushing to select a region in any scatter plot, all observations outside 
the brushed region get grayed out in the scatter plot matrix. This interaction helps users 
investigate a set of observations in the region of interest. The mouse pointer changes 
when users move the mouse over any region that can be brushed. Several buttons are 
generated to filter observations displayed in the scatter plots and histograms. The number 
of buttons depends on the number of clusters. Each button and its corresponding cluster 
share the same color to help users understand the mapping. These buttons can be turned 
on/off by clicking on them. Each button can be used to filter observations of its 
corresponding cluster. 
5.4.7 Implementation Details 
The VALENCIA system is implemented using standard PHP programming language, R 
packages, JavaScript library D3, Ajax, JavaScript library jQuery, SAS, and standard 
HTML. D3, jQuery and HTML were used to develop the front end of the system, which 
includes all the external representations (i.e., interactive visualization engine). A number 
of packages in R were used to develop the analytics engine of the system. Since ICES 
data is stored in the SAS server, we used SAS to cut the data and integrate data from 
different sources. The communication between analytics and visualization engines is 
implemented using AJAX and PHP. 
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We used R to develop the components of the analytics engine because it 1) offers various 
packages to perform DR and CA, 2) is a platform-independent open-source tool, and 3) is 
available in the ICES working environment. 
We chose D3 to develop various external representations mainly because it 1) offers a 
data-driven approach to attach data to the Document Object Model elements. 2) provides 
users with the ability to get access to the full capabilities of modern web-browsers, 3) is 
an open-source library, and 4) is compatible with other programming languages that have 
been used in our system. 
5.5 Usage Scenario 
In this section, we demonstrate how VALENCIA can assist healthcare stakeholders at the 
ICES-KDT program in the investigation and exploration of high-dimensional EHR data. 
The datasets include demographics, comorbidities, hospital admission codes, medication 
profiles, and procedures, all linked using unique identifiers derived from health card 
numbers. We describe multiple scenarios to demonstrate how intended users perform 
numerous tasks to achieve their goals in finding appropriate DR and/or CA techniques 
and optimal configuration settings. Throughout this process, users get an overall 
understanding of relationships among data items in the EHRs. 
5.5.1 Data Sources 
We ascertained patient characteristics, drug prescription, and healthcare utilization data 
from 5 health administrative databases housed at ICES. We obtained vital statistics from 
the Ontario Registered Persons Database that contains demographic data on all residents 
of the Province of Ontario who have a valid health card. We used the Ontario Drug 
Benefit program database to get the prescription drug use data. This database records all 
outpatient prescriptions dispensed to patients aged 65 years or older, with a very low 
error rate (Levy et al., 2003). We ascertained hospital admission, procedure, baseline 
comorbidity, and emergency department visit data from the National Ambulatory Care 
Reporting System (i.e., ED visits) and the Canadian Institute for Health Information 
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Discharge Abstract Database (i.e., hospitalizations). Baseline comorbidity data were also 
obtained from the Ontario Health Insurance Plan database, containing claims data for 
physician services. 
5.5.2 Cohort Creation 
For this analysis, we created a cohort of patients who visited an ED or hospital between 
April 1st, 2014 and March 31st, 2016. The hospital admission date or ED visit date 
served as the cohort entry date (i.e., index date). If a patient had multiple hospital 
admissions or ED visits, we chose the first incident. Patient records with invalid data 
regarding age, sex, and health-care number were excluded from the cohort. We captured 
the hospital admission diagnosis and procedural information on the index date. We 
applied a 5-year look-back window to obtain relevant baseline comorbidity data and 120 
days look-back window to obtain prescription data. We used the International 
Classification of Diseases, tenth revision (post-2002) codes to identify baseline 
comorbidities. 
5.5.3 Cohort Description 
There were a total of 47 unique features and about 1 million patients in the cohort. The 
results of the analysis are suppressed to comply with the privacy regulations for reducing 
the possibility of patient reidentification. Therefore, the data points shown in the 
projected-observation subview are suppressed in cells with five or fewer patients. The 
cohort includes eleven comorbidities—namely, acute kidney injury, cerebrovascular 
disease, chronic kidney disease, chronic liver disease, coronary artery disease, diabetes 
mellitus, heart failure, hypertension, kidney stones, major cancers, and peripheral 
vascular disease. It contains four demographics features, including age, sex, income 
quintile, and location.  There are thirteen features representing drug classes of ACE-
inhibitors, alpha-adrenergic blocking agents, angiotensin II receptor blockers, beta-
blockers, calcium blockers, potassium-sparing diuretics, other diuretics, antipsychotic 
agents, fluoroquinolones, macrolides, immunosuppressive agents, nonsteroidal anti-
inflammatory agents, and oral anti-glymetics. The cohort contains three features to 
143 
 
 
 
represent the procedures—namely, angiograms, angioplasty stent, and transluminal 
angioplasty. Finally, it contains sixteen hospital admission diagnosis codes, including 
fluid disorders, delirium, atrial fibrillation, mycoplasma, anemia, valve disorders, femur 
fracture, chronic ischemia, volume depletion, paralytic ileus, chronic pulmonary, 
septicemia, abnormal function, hyperplasia of prostate, dementia, and glomerular 
disorders. 
All the patients in the cohort are aged over 64 years, and the mean age is 70 years. About 
56% of the patients are female, and 16% are from rural locations. The pre-existing 
comorbidities are hypertension (88%), diabetes (38%), coronary artery disease (25%), 
heart failure (14%), major cancer (16%), chronic kidney disease (9%), cerebrovascular 
disease (3%), peripheral vascular disease (2%), and kidney stones (1%). Some of the 
commonly prescribed drug classes are ace-inhibitors or angiotensin II receptor blockers 
(60%) and diuretics (57%). The most frequent diagnosis codes associated with AKI were 
chronic pulmonary (3%), atrial fibrillation (3%), chronic anaemia (2%), and ischaemic 
(2%). 
5.5.4 Case Study 
VALENCIA can be used in an iterative manner. This allows users to move freely among 
different stages, skipping some stages if needed, especially after going through the 
process of choosing a DR or CA technique once. In this study, we explain the process of 
using the system in a sequential manner to make it easier for readers to follow.  
First, users import the data file by clicking on the “Browse Files” button in the DR view. 
The data file gets preprocessed by the system automatically.  
Intended users can be interested in selecting a number of features from different feature 
groups. The imported dataset has five feature groups (i.e., demographics, comorbidities, 
hospital admission codes, procedures, and medications). Let us assume that a user 
analyzes the features using the raw-data subview and chooses fifteen features from 
hospital admission codes, twelve features from medications, and all features from 
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procedures, demographics, and comorbidities through the collapsible tree structure 
(Figure 4-A). As shown in Figure 4-B, the user has the option to observe the description 
of each feature while choosing them. The selected features are displayed in a scrollable 
data table for verification as shown in Figure 4-C. 
 
Figure 5-32: The raw-data subview containing (A) collapsible tree structure, (B) bar 
chart, and (C) data table. 
The user has the option to choose the DR technique and set the configuration parameters 
for that technique. Let us assume that the user selects “MCA” as the DR technique and 
sets the method and number of dimensions to “indicator” and “6”, respectively. The DR 
engine then automatically sets indices for quantitative and categorical supplementary 
features. Upon these selections, the DR engine applies the selected technique with the 
specified configurations on the chosen features. 
   
(A) (B) (C) 
Figure 5-33: Showing an overview of the projected-features subview, which includes 
(A) all glyphs with respect to dimensions one and two, (B) some selected glyphs and 
labels with regard to dimensions three and four, and (C) all the glyphs and labels 
representing age upon drilling. 
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Then, VALENCIA updates the projected-features, association, and variance subviews 
when the data items are generated. As shown in Figure 5-A, the projected-features 
subview displays the coordinates of features relative to the dimensions. The first two 
dimensions (i.e., dimension one and two) are shown by default as axes of the scatter plot. 
In Figure 5-B, the user can change the X- and Y-axes from default to dimensions three 
and four. Initially, the scatter plot displays all the glyphs corresponding to all feature 
categories. As shown in Table 1, the shapes of the glyphs are chosen automatically by the 
system based on different groups of features such as comorbidities, demographics, and so 
on. The user is interested in investigating a few specific features, and thus they select age 
from demographics, diabetes mellitus and hypertension from comorbidities, and anemia 
from the hospital admission codes using the collapsible tree structure in the projected-
features subview (Figure 5-B). Since the glyphs displayed in the scatter plot belong to 
different groups (i.e., demographics, comorbidities, and admission codes), they are 
encoded by different shapes and colors. However, all the categories belonging to a 
feature (e.g., male and female categories for feature sex) are represented by the same 
shape and color. The user selects the checkbox to observe the label of each glyph in 
Figure 5-B. They click on the glyph representing age to observe the position of other 
glyphs and labels (i.e., different categories of age) belonging to that feature (Figure 5-C). 
Table 5-9: Showing the shapes of the glyphs based on different groups of features. 
Group Shape 
Demographics      (Plus) 
Comorbidities ★ (Star) 
Hospital admission codes ▲ (Triangle) 
Procedures ■ (Rectangle) 
Medications ♦ (Diamond) 
Although the chosen features in Figure 5-B contribute to the definition of dimension four, 
they are not well represented in dimension three. This makes the user interested in 
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investigating which features contribute most to dimension three using the heatmap in the 
association subview. As shown in Figure 6-A, the heatmap displays the correlation 
between features and dimensions. There are six columns to represent six dimensions and 
44 rows to represent the features. The positive relationships between features and 
dimensions are encoded with colors ranging from light blue to dark blue, whereas 
negative ones range from light brown to dark brown. The cells are empty when the 
correlation between a specific row and column is not significant (e.g., between income 
and dimension two). In order to find the features that are related to dimension three, the 
user can click on “Dim3” column header once to sort the features in a descending order. 
This reveals that “income”, “volume depletion”, “delirium”, “mycoplasma”, and 
“dementia” are positively correlated to dimension three (Figure 6-B). Then the user can 
select these features in the projected-features subview to investigate these correlations 
more closely. 
After going through the above-mentioned process iteratively, the user finalizes the 
number of features, DR technique, and configuration parameters. At the final stage of the 
DR view, the user chooses the dimensions to be included in the CA engine by observing 
the line-column chart in the variance subview. This helps the user to understand the 
amount of variation retained by each dimension. Let us assume that the user selects 
checkboxes for dimension one, two, and three after analyzing them thoroughly, as shown 
in the bottom-left corner of Figure 2. Upon clicking the “submit” button, the system takes 
the user to the CA view. 
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(A) (B) 
Figure 5-34: Showing an overview of the association subview, which includes (A) a 
heatmap representing the association between six dimensions and 44 features and 
(B) a heatmap where all the features are sorted in a descending order based on 
dimension three. 
Once the CA view is loaded, the user chooses a CA technique and relevant configuration 
parameters to activate the CA engine. Let us assume that the user selects “kmeans” as 
their desired CA technique and sets the number of clusters and maximum number of 
iterations to “3” and “100”, respectively. Upon these selections, when the data items are 
generated based on the results of CA, VALENCIA updates the hierarchical, frequency, 
and projected-observations subviews. As shown in Figure 7-A, the projected-
observations subview displays the clustered observations in the low-dimensional space. 
The user can verify the output of the chosen CA technique by observing the distribution 
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of observations that are color-coded based on different clusters. For instance, the user can 
observe that the clusters are more distinguishable from each other in the scatter plots 
between dimensions one and two (Figure 7-A). In order to understand the distribution of 
the observations better and detect outliers, the user applies brushing on a region in a 
scatter plot (between dimensions one & two). This helps the user to investigate how the 
observations in the selected region are distributed in other scatter plots (Figure 7-B). As 
shown in Figure 7-C, when the user clicks on button “C-3”, the system removes all the 
observations belonging to cluster three.  
  
 
(A) (B) (C) 
Figure 5-35: Showing the overview of the projected-observation subview, which 
displays (A) all the observations color-coded based on clusters, (B) the brushing 
interaction, and (C) observations in cluster-1 and cluster-2 because cluster-3 is 
filtered out. 
This allows the user to compare the remaining clusters more easily. If the user becomes 
interested in getting additional information about the dimensions (e.g., which features are 
associated with these dimensions), they can use the association subview. Although this 
subview is also available in the DR view, it is included in the CA view to allow the user 
to retrieve such information without switching between views. As shown in the left 
corner of Figure 3, the association subview within the CA view contains information of 
the first three dimensions based on the user’s selection in the DR view. Next, if the user 
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is interested in exploring the hierarchical structure of the clustered data in high-
dimensional space (raw data), they can refer to the hierarchical subview.  
 
  
(A) (B) (C) 
  
(D) (E) 
Figure 5-36: Showing the overview of the hierarchical subview, which displays (A) 
all the clusters, (B) feature groups within cluster-1, (C) feature groups within 
cluster-2, (D) feature groups within cluster-3, and (E) features within the 
comorbidity group in cluster-3. 
The hierarchical subview allows the user to detect which clusters cover the maximum 
amount of variation of the data (Figure 8-A). The user clicks on a rectangle representing a 
cluster (i.e., cluster-1, cluster-2, and cluster-3) in this subview to observe how different 
feature groups contribute to the variance of a particular cluster. For instance, 
demographics, medications, and comorbidities have the highest contributions to cluster-1, 
cluster-2, and cluster-3, respectively (as shown in Figure 8-B, 8-C, and 8-D). Then, the 
user can click on the rectangle representing comorbidities within cluster-3, which reveals 
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that diabetes mellitus (DIAB) and hypertension (HYP) are the dominating features in this 
group (Figure 8-E).  
The user can consult the frequency subview to get the frequency distribution of clusters 
and features. As shown in Figure 9-A, 32%, 59%, and 9% of the patients are assigned to 
cluster one, two, and three, respectively. About 82% of these patients are aged between 
65 and 85, and most of them are assigned to the first two clusters. Upon interacting with 
the hierarchical subview, the frequency subview gets updated dynamically to allow the 
user to get additional information at every level. For instance, Figure 9-B displays the 
frequencies of the comorbidities when the user selects the “cluster-3”->“comorbidities” 
rectangles (Figure 8-E) in the hierarchical subview. The user can observe that 93% of the 
patients in cluster-3 have hypertension. In order to change the color of the ribbons based 
on the outcome of the heart failure feature (HF), they can reorder the horizontal bars by 
dragging hypertension (HYP) to the top.  
The user can also observe the distribution of all other comorbidity features within cluster-
3. Next, let us assume the user becomes interested in checking how the patients who have 
heart failure, diabetes mellitus, anemia, and delirium are subdivided into different 
clusters. The user can activate the collapsible tree structure by clicking on particular 
checkboxes corresponding to these features to filter the displayed information. Figure 9-C 
shows how patients in different clusters are subdivided into these features and vice versa. 
It is possible to explore the interrelationship between not only the clusters and features 
but also different features in this manner. For example, the user can observe that most of 
the patients belonging to cluster-1 have diabetes. In order to investigate this relationship 
more closely, the user can change (i.e., from clusters to feature) the ordering and color-
coding by moving diabetes mellitus (DIAB) to the top. The color scheme for clusters in 
the frequency, hierarchical, and projected-observations subviews are identical; this makes 
it easy for the user to visually perceive the connection between these subviews (Figure 
3).  
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(A) (B) (C) 
Figure 5-37: Showing the overview of the frequency subview, which shows the 
distribution of (A) different clusters and demographics, (B) all the comorbidities 
within a particular cluster, and (C) clusters and some user-selected features. 
At any stage of the analysis in the CA view, the user can click the “Back” button to 
navigate back to the DR view. They can switch between the DR and CA views as many 
times as is required. After going through this iterative process of applying different CA 
techniques, tuning configuration parameters, and analyzing results with different 
subviews, the user exports the resulting dataset by clicking on the “Export” button. The 
output dataset contains all the data elements along with cluster labels for each patient.  
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5.6 Conclusion 
In this study, we have shown how visual analytics systems can be designed to address the 
challenges of high-dimensional data stored in EHRs in a systematic way. To achieve this, 
we have reported the development of VALENCIA, a visual analytics system designed to 
assist healthcare stakeholders at the ICES-KDT program. VALENCIA incorporates two 
main components: an analytics engine, made up of two sub-engines: the DR engine and 
the CA engine; and an interactive visualization engine, made up of the DR view and the 
CA view. The main contribution of VALENCIA is to bring a wide range of state-of-the-
art and traditional analysis techniques, integrate them seamlessly, and make them 
accessible through interactive visualizations. VALENCIA offers a balanced distribution 
of processing load between users and the system through a proper integration of analytics 
techniques (i.e., the DR and CA engines) with visual representations (i.e., different 
interactive views in the interactive visualization engine) to facilitate the performance of 
high-level cognitive tasks. Through a real case study, we have demonstrated how 
VALENCIA can be used to analyze the healthcare administrative dataset of older patients 
who visited the hospital or emergency department in Ontario between 2014 to 2016. 
Through the formative evaluations conducted during the participatory design process, we 
have seen that VALENCIA assists healthcare experts in 1) exploring datasets using 
different DR and CA techniques, 2) generating hypotheses, 3) identifying relationships 
among data items, 4) evaluating results of the analysis, and 5) recognizing patterns and 
trends that would be otherwise difficult to identify without such a system. A number of 
training materials have been prepared to assist new users in getting familiar with the 
system. Users at the ICES-KDT program were able to identify suitable analysis 
techniques and configuration settings for their health administrative datasets. They got 
familiar with different analytics techniques quickly while exploring them through 
VALENCIA, although they never worked with those techniques before. They also have 
reported that the interactive visual interface makes it easy for them to explore the analysis 
results. 
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In terms of the scalability and extensibility of VALENCIA, we designed it in a modular 
way so that it can easily accept new data sources and analysis techniques (both DR and 
CA). VALENCIA can be used to analyze high-dimensional datasets in many other 
domains, such as insurance, biotechnology, finance, and image processing.  
The study should be evaluated with respect to four limitations. The first one is that, as the 
size of the dataset grows, its computational time for the DR and CA techniques increases; 
this limits the real-time functionality of the interactive visualizations. The second 
limitation is that, even though we have had a participatory design and healthcare experts 
have evaluated VALENCIA and have found it helpful and usable, we have not conducted 
any formal studies to assess its performance, nor the efficiency of its human-data 
discourse mechanisms. Third, since the system has been designed for a healthcare 
organization, we have not tested the performance of the system on any other domain 
except healthcare. Fourth, some subviews of the system may not function properly if the 
number of features in the dataset gets too large due to limitations of screen space and 
computational resources. 
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Chapter 6  
6 Predicting Acute Kidney Injury: A Machine Learning 
Approach using Electronic Health Records 
This chapter is accepted for publication as S.S. Abdullah, N. Rostamzadeh, K. Sedig, 
A.X. Garg, and E. McArthur, “Predicting Acute Kidney Injury: A Machine Learning 
Approach using Electronic Health Records” in the Information Journal, July 2020. We 
changed the format to match the general format of the dissertation. The Figure, Table, 
and Section numbers specified herein are relative to the chapter number. For example, 
“Table 1” corresponds to Table 6-1; “Figure 1” corresponds to Figure 6-1; and “Section 
1.1” corresponds to Section 6.1.1. Moreover, when the term “paper”, “research”, or 
"work" is used, it refers to this specific chapter. 
6.1 Introduction 
Acute kidney injury (AKI) is common among patients admitted to hospitals, affecting 
approximately 10% of hospitalized patients and more than 25% of patients in the 
intensive care unit (Porter et al., 2014; Selby et al., 2012). AKI is defined as an abrupt 
loss of kidney function over a short period of time [2].  AKI may lead to prolonged 
hospital stays, lower chance of survival, and a higher risk of developing chronic kidney 
disease. Over the last 10-15 years, the incidence rate of AKI has increased in the United 
States (Nadkarni et al., 2016; Wu et al., 2014), the United Kingdom (Kolhe et al., 2016), 
and Canada (Liu et al., 2010; Mehrabadi et al., 2014). The growing incidence rate of AKI 
is associated with the changing spectrum of diseases. There is an increasing body of 
evidence proving that patients with extrarenal complications and multiple comorbidities 
are at a greater risk of developing AKI (Mehta et al., 2004; Siddiqui et al., 2012). Aikar et 
al. (Waikar et al., 2006) have shown that the high comorbidity rate, measured by the 
Deyo-Charlson comorbidity index, is associated with AKI. As a patient's number of 
comorbid conditions grows, there is a rise in associated physician visits, healthcare 
utilization, medication intake, and hospitalizations (Zulman et al., 2014), ultimately 
leading to an increase in healthcare expenditure. Given the associated risk and expense, a 
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promising strategy is required to improve the care for AKI patients. However, a UK-
based report published in 2009 demonstrated significant under-recognition of AKI, 
leading to delayed recognition, inadequate treatment, and ineffective monitoring (Ali et 
al., 2007; Bagshaw et al., 2007). 
Thus, there is a rising demand for techniques that can be used for the detection of AKI. 
However, the complex pathophysiology and etiology of AKI make the diagnosis and 
management of this disease challenging. There are different guidelines such as RIFLE 
(Eriksen et al., 2003), AKIN (Palevsky et al., 2013), WRF (Gottlieb et al., 2002) and 
KDIGO (Clinical Practice Guideline, 2012) for AKI diagnosis. Most of these guidelines 
rely on a rise in serum creatinine (i.e., a laboratory test) alone as the gold standard. 
However, serum creatinine-based guidelines are often not ideal for the diagnosis of AKI 
among older patients because the age-related deteriorations in glomerular filtration rates 
affect the baseline measure (Kate et al., 2016). Another limitation of this measurement is 
due to the fact that serum creatinine may vary with muscle mass since it is a product of 
muscle catabolism (Delanaye et al., 2017). In addition, serum creatinine-based guidelines 
require a premorbid serum creatinine value to be used as a baseline creatinine, which may 
not be available for all patients (Mohamadlou et al., 2018). Although some guidelines 
also rely on urine output to diagnose AKI, it is only monitored for patients with reduced 
kidney function (Kate et al., 2016). Despite these challenges, even if AKI can be 
diagnosed properly, the clinicians often fail to intervene due to a lack of time and 
treatment options. The treatments of AKI are primarily focused on avoiding nephrotoxic 
medications and administering supportive care (Clinical Practice Guideline, 2012). 
Although more advanced treatments are identified in recent years, their effectiveness has 
not been proven in clinical trials yet (Pozzoli et al., 2018). Thus, interventions often have 
poor performance if a patient has developed AKI already (Lieske et al., 2014; Mehta, 
2011). So, it is more effective to predict AKI prior to its diagnosis. A number of recent 
studies have shown that AKI is predictable and avoidable if early risk factors can be 
identified using Electronic Health Records (EHRs).  For instance, Kate et al. (2016) have 
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revealed that it is possible to predict up to 30 percent of AKI cases in the hospital settings 
using the patient data stored in EHRs (Kate et al., 2016).  
EHR contains patient medical records, such as comorbid conditions, medications, 
laboratory test results, diagnosis codes, demographics, and discharge summaries, which 
can be used for the risk profiling of patients (Mohamadlou et al., 2018; Rostamzadeh et 
al., 2020). With the evolution of EHRs and the widespread use of information technology 
systems, these medical records are available nowadays for subsequent reuses (Abdullah 
et al., 2020a, 2020b; Abramson et al., 2011; Delamarre et al., 2015). EHRs offer an 
opportunity to employ machine learning techniques to recognize risk factors associated 
with AKI and identify patients at risk of developing AKI. Several clinical decision 
support systems have been developed in recent years for earlier detection of AKI using 
machine learning techniques (Abdullah et al., 2020c; Cheng et al., 2017; Davis et al., 
2017; Gameiro et al., 2020; Ibrahim et al., 2019; Rashidi et al., 2020; Tran et al., 2019). 
However, many of these systems suffer from various performance and design related 
issues such as lack of predictive power, substantial trade-offs between sensitivity and 
specificity, a limited number of machine learning techniques, small population size, lack 
of predictors, and limited patient populations (Gameiro et al., 2020; Mohamadlou et al., 
2018).  
This study is designed to predict AKI among hospitalized and emergency department 
patients using machine learning techniques. We incorporate ICES' healthcare 
administrative datasets containing one million older patients' medical records who visited 
the hospital or emergency department between 2014 and 2016. We developed 31 
prediction models based on different combinations of two sampling techniques, three 
ensemble methods, and eight classifiers. Our study differs from other studies in several 
ways: (1) we developed prediction models for patients who are at risk of developing AKI 
within 90 days timeframe after being discharged from hospital or emergency department; 
(2) we included a large number of predictors to train the models; and (3) we validated the 
important features of each model with healthcare experts through formative evaluations 
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to improve the performance and reliability of the models. The rest of this study is 
organized as follows. Section 2 describes the methodology employed for the design of the 
study. Section 3 presents the experimental results. Finally, Section 4 includes the 
discussion, and Section 5 describes the limitations of the study. 
6.2 Materials and Methods 
We discuss the data sources and methodology in this section that includes the design 
process, settings, design flow, data integration, cohort entry criteria, input features, 
outcomes, and proposed machine learning techniques. 
6.2.1 Design Process and Participants 
As a part of continuing clinical research, medical experts usually conduct clinical trials 
and case studies in their areas of expertise. In many situations, the result of these clinical 
studies is not reproducible due to limited and specific population size. Machine learning 
can help healthcare experts evaluate the relevance of such studies and explore more 
complicated relationships among data elements. Despite the advantages, one significant 
drawback of the machine learning approach is a general lack of interpretability. Thus, it is 
underexplored in clinical studies as most of the healthcare experts often find it difficult to 
understand these models and results (Spasic and Nenadic, 2020). On the other hand, 
although computer science experts are more experienced in working with machine 
learning techniques, they are not familiar with clinical terms. It becomes difficult for 
them to interpret and validate the analysis results without the help of domain experts. To 
address this issue, we adopted a participatory design approach to conceptualize and 
design our study. It is a co-operative approach that includes all stakeholders (e.g., users, 
designers, and evaluators) in the process to make sure the result of the analysis meets 
their needs (Muller, 2007). A clinician, a statistician, an epidemiologist, and several data 
scientists participated in the conceptualization, design and evaluation process of this 
study. During the primary stage of the design process, we came to know that healthcare 
experts perform studies to predict diseases in many different ways. There is no single 
correct analysis technique because different techniques have their strengths and 
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weaknesses, and the selection of an appropriate technique for a task is not 
straightforward. As such, we invited healthcare experts in our team to provide us with a 
list of analysis techniques, which they usually practice. We decided to employ both 
traditional and state-of-art analysis techniques to build trust with end-users and, at the 
same time, allow them to explore complex relationships in the dataset. 
6.2.2 Study Design and Setting 
We conducted a population-based retrospective cohort study in older patients who visited 
a hospital or emergency department between April 1st, 2014 and March 31st, 2016, using 
health administrative databases stored at ICES. These datasets were connected using 
unique encoded identifiers and analyzed at ICES.  
Ontario has a population of about 13 million residents with universal access to physician 
services and hospital care, which includes 1.9 million people aged 65 years or older. We 
suppressed the results of this study in cells with five or fewer patients to comply with 
ICES privacy regulations and minimize the possibility of reidentification of patients. 
6.2.3 Workflow 
Figure 1 shows the basic workflow of the study described in this paper. In the first step, 
we created an integrated dataset from five different health administrative databases. The 
data sources are discussed in Section 2.4. Next, we describe the inclusion and exclusion 
criteria in Section 2.5. The features in the comorbidity, prescription, demographic, and 
hospital admission codes data were encoded and transformed into suitable forms for the 
analysis in the preprocessing stage, which is discussed in Section 2.8. The analysis 
techniques and results are presented in Section 2.9 and 3, respectively. 
159 
 
 
 
 
Figure 6-38: Workflow diagram of the presented study where different colours are 
used to represent three main parts (data integration and preprocessing, analysis and 
validation). The figure shows how different combinations are formed using two 
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sampling techniques (i.e., under sampling and SMOTE), three ensemble methods 
(i.e., boosting, bagging, and XGBoost), and eight machine learning classifiers. 
6.2.4 Data Sources 
We ascertained patient characteristics, drug prescriptions, outcome and medical history 
data from 5 administrative databases (as shown in Appendix A). These datasets are linked 
using a unique identifier, which is derived from health card numbers. We collected vital 
statistics from the Ontario Registered Persons Database, which includes demographic 
data of all residents in Ontario who have a valid health card. We utilized the Ontario 
Drug Benefit Program database to get prescription medication use data. Ontario Drug 
Benefit Program holds all the outpatient prescription records dispensed to older patients, 
which has an error rate of less than 1% (Levy et al., 2003). We ascertained baseline 
comorbidity, emergency department visit, and hospital admission data from the National 
Ambulatory Care Reporting System (i.e., for the emergency department) and the 
Canadian Institute for Health Information Discharge Abstract Database (i.e., for hospital 
admissions). We applied the ICD-10 (i.e., International Classification of Diseases, post-
2002) codes to identify baseline comorbidities within the look-back window. In addition, 
Baseline comorbidity data were acquired from the Ontario Health Insurance Plan 
database, which holds claim records for physician services. ICES Physician Database was 
used to obtain the demographic, education, practice, and specialty information on all 
physicians. All the coding definitions for the comorbidity databases are provided in 
Appendix B. 
6.2.5 Cohort Entry Criteria 
We identified a cohort of individuals aged 65 years or older who visited the emergency 
department or were admitted to hospital between 2014 and 2016 (Figure 2). The hospital 
admission or emergency department discharge dates were taken as the cohort entry or 
index date. If a patient had multiple hospital admissions and emergency department 
visits, we chose the first incident. We excluded patients with invalid or missing age, sex, 
and health card number. In addition, we excluded patients who: (1) previously underwent 
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a kidney transplant or dialysis treatment as AKI is usually no longer relevant once 
patients develop end-stage kidney disease; (2) left the emergency department or hospital 
without being seen by a physician or against medical advice; and (3) developed AKI 
during emergency department visit or hospital admission as they are already under 
observation. The diagnosis codes for the exclusion criteria are presented in Appendix C. 
 
Figure 6-39: Provides an overview of data creation plan and how we prepared the 
final cohort. 
6.2.6 Input Features 
We used the Chi-Square test for feature selection and then filtered the selected features 
with a healthcare expert. The final cohort included about one million patients and a total 
of 86 unique features. The cohort contained eleven comorbidity features—namely, 
chronic kidney disease, diabetes mellitus, cerebrovascular disease, coronary artery 
disease, hypertension, chronic liver disease, major cancers, peripheral vascular disease, 
heart failure, and kidney stones. We applied a 5-year look-back window to detect these 
baseline comorbidities. There were four demographics features—namely, sex, age, 
region, and income quintile. We included 55 medications that were prescribed to the 
patients within 120 days before the first hospital admission or emergency department 
visit. These medications belonged to thirteen distinct drug classes—namely, ACE-
inhibitors (blood pressure and heart failure), beta-blockers (blood pressure), alpha-
adrenergic blocking agents (blood pressure), angiotensin-receptor blockers (blood 
pressure), calcium blockers (blood pressure), macrolides (antibiotics), fluoroquinolones 
(antibiotics), potassium-sparing diuretics (weak diuretic), other diuretics,  nonsteroidal 
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anti-inflammatory agents (pain relievers),  oral hypoglycemic (diabetes mellitus), and 
immunosuppressive agents (immune system activity). 
The cohort also included sixteen ICD-10 diagnosis codes that were identified during the 
index hospitalization or emergency department visit. The codes were related to delirium, 
mycoplasma pneumoniae, disorders of fluid, electrolyte and acid-base balance (e.g., 
hyperosmolality and hypernatraemia, hypo-osmolality and hyponatraemia, acidosis, 
alkalosis, mixed disorder of acid-base balance, hyperkalaemia, hypokalaemia, fluid 
overload, and other disorders of electrolyte and fluid balance), atrial fibrillation, anemia, 
femur fracture, valve disorders, atherosclerotic cardiovascular disease, diseases of the 
digestive system (e.g., paralytic ileus, intussusception, volvulus, gallstone ileus, other 
impaction of intestine, intestinal adhesions with obstruction, and other and unspecified 
intestinal obstruction ileus), Certain infectious and parasitic diseases (e.g., sepsis due to 
Staphylococcus aureus, other specified Staphylococcus, Haemophilus influenzae,  
Escherichia coli, Pseudomonas, Serratia marcescens, other gram-negative organisms, 
gram-negative Septicaemia, and Enterococcus), dehydration and other volume depletion, 
abnormal function (e.g., abnormal results of function tests of central nervous system, 
peripheral nervous system and special senses, pulmonary function tests, cardiovascular 
function tests, kidney function tests, liver function tests, thyroid function tests, other 
endocrine function tests, and electrocardiogram suggestive of ST-segment elevation 
myocardial infarction , abnormal cardiovascular function tests, and other abnormal results 
of cardiovascular function tests), chronic pulmonary (e.g., chronic obstructive pulmonary 
disease with acute lower respiratory infection and acute exacerbation and other specified 
chronic obstructive pulmonary disease), dementia, glomerular disorders (e.g., glomerular 
disorders in infectious and parasitic diseases, neoplastic diseases, blood diseases and 
disorders involving the immune mechanism, diabetes mellitus, other endocrine, 
nutritional and metabolic diseases, and systemic connective tissue disorders), and 
hyperplasia of prostate. 
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6.2.7 Outcome: Identification of AKI 
Machine learning models were built to predict AKI within 90 days after being discharged 
from the hospital or emergency department. Positive cases were those in which patients 
revisited hospital or emergency department with AKI within 90 days after being 
discharged, and negative cases were the ones when hospitalizations or emergency 
department visits with AKI never took place. There was a total of 899,449 negative and 
5,993 positive cases in the dataset. There were no recurrent AKI examples (i.e., excluded 
25,084 patients) in the data because we excluded the cases where AKI or dialysis was 
acquired during the index hospital stay or emergency department visit.  
The incidence of AKI was detected using the Canadian Institute for Health Information 
Discharge Abstract Database and National Ambulatory Care Reporting System based on 
the ICD-10 (International Classification of Diseases - Tenth Revision) diagnostic codes 
(i.e., ICD-10 code of AKI is "N17"). 
6.2.8 Data Preprocessing 
For each feature described in Section 2.5, the last recorded value before the first hospital 
admission or emergency department visit was captured. Medication, diagnosis code, and 
comorbidity features were set to either "Y" or "N." If a patient had a certain comorbid 
condition or was prescribed a medication, then its corresponding value was taken as "Y." 
Instead of reporting individual ages, we calculated age group features for the patients. If a 
patient's age laid within the specified range of an age group, we set the value to "1" for 
that corresponding feature. The sex feature took either "M" or "F" if the information is 
available in the dataset. Patients with invalid age or sex were removed from the cohort. 
The region feature took either "R" or "U" to represent rural and urban, respectively. The 
income feature took an integer value ranged between 1 to 5 to represent the income 
quintile of a particular patient.  
All these features from different data sources were integrated using the encoded 
identifiers derived by ICES using patient health card numbers. The features in the cohort 
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were transformed into a format and scale that was suitable for the machine learning 
techniques. For each patient, we aggregated multiple values (rows) of a single feature 
into one by considering the latest values of that feature. 
6.2.9 Analysis using Machine Learning Techniques 
We employed both traditional and state-of-art analysis techniques to build trust with end-
users and, at the same time, allow them to explore complex relationships in the dataset. 
We developed 31 AKI prediction models based on combinations of eight classifiers—
namely, classification and regression tree (CART) (Wilkinson, 2015), C5.0 (Quinlan, 
2014), naïve Bayes (NB) (Lewis, 1998), logistic regression (Bahnsen et al., 2014), and 
support vector machine (SVM) with four different kernels (linear, polynomial, sigmoid, 
and radial) (Cristianini and Shawe-Taylor, 2000), two sampling techniques—namely, 
under sampling and SMOTE, and three ensemble methods—namely, Boosting, Bagging, 
and XGBoost. These techniques are chosen for several reasons: 1) They each represent 
different types of machine learning methods. For example, the decision tree is a rule-
based, regression is a statistical, and naïve Bayes is a probability-based method. 2) Each 
of these methods has its own set of advantages and limitations. For instance, decision tree 
models are more human-interpretable but often fail to represent complex relationships 
among data elements. On the contrary, SVM is equipped to model complex non-linear 
relationships using different kernels but difficult to interpret. 3) Medical experts are more 
familiar with regression than other machine learning algorithms, which convinced us to 
include regression in this analysis. 
6.2.9.1 Ensemble-Based Methods 
Since the number of negative cases was significantly higher than the number of positive 
cases, we considered the dataset as highly imbalanced. Traditional machine learning 
techniques that are designed to optimize the overall accuracy tend to achieve poor 
performance in this class imbalanced learning scenario. An ensemble method offers a 
solution to this problem by combining several classification models to obtain better 
performance than the base classifiers (Dietterich, 2000). To deal with the class imbalance 
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issue in this study, we incorporated four different combinations of ensemble and 
sampling methods—namely, SMOTEBoost, SMOTE-Bagging, UnderBagging, and 
RUSBoost that are available in the "embc" package of R (Barandela et al., 2003; Freund 
and Schapire, 1997; Wang and Yao, 2009). The RUSBoost was implemented using the 
"rus" function in the "ebmc" package. The weak learners in RUSBoost are trained on 
random under-sampled datasets (Seiffert et al., 2010). Those learners are then combined 
to generate the final ensemble model. We used the "sbo" function to implement 
SMOTEBoost. SMOTE (Synthetic Minority Oversampling Technique) is a sampling 
technique that synthesizes new instances for the minority class using the k-nearest-
neighbours algorithm (Chawla et al., 2002). SMOTEBoost returns several weak learners 
that are trained on SMOTE-generated datasets along with their error estimations (Galar et 
al., 2012). The "sbag" function was used to implement SMOTEBagging, which combines 
SMOTE and random over-sampling to rebalance the dataset [44]. We used the "ub" 
function to implement the UnderBagging method. Unlike other ensemble methods 
discussed above, UnderBagging only incorporates random under-sampling to reduce the 
instances of the majority class in each bag to rebalance the class distribution. We 
configured this function in such a way that the amount of majority instances became 
equal compared to the minority instances (i.e., imbalance ratio = 1). We used NB, SVM, 
CART, and C50 as weak learners for the ensemble methods, which are discussed in the 
following subsections. 
6.2.9.1.1 Support Vector Machine 
The objective of the SVM is to find an optimal separating hyperplane in a multi-
dimensional space (i.e., depending on the number of features) that distinctly divides the 
instances of different classes. Although SVM models are often not human-interpretable, 
it has been proven to work well on prediction tasks involving a large number of features 
[18]. It has become popular in healthcare research recently because it is more effective in 
analyzing high dimensional EHRs. In addition, the regularisation parameters of SVM 
kernels help users avoid over-fitting. Since the performance of the models widely varies 
depending on the selection of the kernel (Tomar and Agarwal, 2013) and kernels are 
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quite sensitive to over-fitting (Cawley and Talbot, 2010), one of the main challenges is to 
select an appropriate kernel. Thus, we tested the performance of four well-known kernel 
functions in this study—namely, linear, polynomial, sigmoid, and radial. 
6.2.9.1.2 Decision Tree 
A decision tree is the representation of possible outcomes of a decision depending on 
certain conditions (Quinlan, 2014). It is similar to a flowchart where every non-leaf node 
represents a test for a specific feature, and the leaf node represents a particular outcome. 
Decision tree reduces the ambiguity of complicated clinical decisions and requires 
reduced effort for data preparation compared to other techniques. It can be an effective 
technique to analyze datasets with missing values because the tree-building process is not 
affected by the missing data (Niuniu and Yuxun, 2010). We choose the decision tree 
mainly because it is easy to interpret and understand. Despite the advantages, decision 
tree models are often volatile, meaning that a minor alteration in the training data may 
cause a massive change in the structure of the tree. To overcome this issue, we included 
other types of base classifiers along with decision tree and verified the structure of the 
generated tree with a healthcare expert. We incorporated two different algorithms to 
develop decision tree models in this study. The classification and regression tree (CART) 
were implemented using “rpart” package (Wilkinson, 2015), and the C5.0 classifier was 
implemented using the “C50” package in R (Quinlan, 2014). 
6.2.9.1.3 Naïve Bayes 
NB is a simple probabilistic classifier established on Bayes theorem (Lewis, 1998), which 
is exceptionally fast to train compared to other complex techniques (Tomar and Agarwal, 
2013). Classification of the new data using this technique only requires mathematical 
operations based on the feature probability. We choose NB mainly because it is less 
sensitive to missing data. However, since this technique is designed based on the 
assumption of feature independence, the performance may deteriorate when features in 
the training data are related. We used the "naive Bayes" package to implement the NB 
algorithm in this study (McCallum and Nigam, 1998). 
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6.2.9.2 Logistic Regression 
Logistic regression draws a separating line among the classes using the training dataset 
and then applies that line to classify the unknown data points. It is used to analyze the 
relationships between one dependent feature and one or more independent features. 
Logistic regression models are informative as they reveal the association among features 
in terms of odds ratios. Over the last decades, logistic regression techniques have become 
very popular in healthcare studies (Ismail and Anil, 2014). Although logistic regression 
models are not designed to support imbalanced classification directly, they can be 
modified to work with skewed distributions. In order to adjust the regression coefficients 
while training with the imbalance data, we implemented a cost-sensitive regression 
model. We adjusted the weight of the minority class based on the cost of its 
misclassification compared to the cost of misclassifying the majority class. We used 
internal 10-fold cross-validation during training to determine the appropriate weight for 
the minority class. 
6.2.9.3 XGBoost 
XGBoost (i.e., eXtreme Gradient Boosting) is an advanced implementation of gradient 
boosted decision trees that can be used for ranking, regression, and classification 
problems (Chen and Guestrin, 2016). One of the main advantages of XGBoost is that it 
supports parallel computation, which makes it faster than other implementations of 
gradient boosting. Because of its time complexity and performance superiority, it has 
been widely used in healthcare research, such as analysis of EHRs (C. Wang et al., 2018) 
and cancer diagnosis (C.-W. Wang et al., 2018). We used the "xgboost" package to 
implement XGBoost in R. Since this implementation of XGBoost only works with 
numeric data, we converted the categorical features in our dataset into numerical vectors. 
The "xgboost" package includes both a tree learning algorithm and linear model solver. 
We implemented both algorithms to compare their performance. This package has a 
built-in mechanism to control the balance of positive and negative weights as well. To 
train the models with unbalanced data, we adjusted the "scale_pos_weight" parameter 
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based on the ratio of the negative class to the positive class (Wang et al., 2019). We 
performed a grid search on the parameters of XGBoost and tuned the regularization 
parameters using the best parameters from the grid search. 
6.2.10 Tools and Technologies 
We primarily used two different data analysis software: SAS and R. SAS was used to cut 
and process the cohort because ICES health administrative databases were stored in a 
SAS server (“SAS Enterprise BI Server,” n.d.). We used SAS programming, SQL, and 
predefined macros to prepare data for analysis. Then we loaded the preprocessed dataset 
in R packages (“RStudio | Open source & professional software for data science teams,” 
n.d.) for additional analysis using machine learning techniques. We chose R mainly 
because it 1) is installed on the ICES workstations already, 2) has a rich array of machine 
learning libraries, 3) is open-source and platform-independent, and 4) is continuously 
providing updates with new libraries. 
6.3 Results 
This section presents the results of this study. We divided the results into two 
subsections. First, we provide an overview of the dataset in Subsection 3.1. The results of 
predictive models are presented in Subsection 3.2. 
6.3.1 Cohort Characteristics 
A total of 905,442 participants were included in the derivation cohort, of which 5,993 had 
AKI during their hospital admission or emergency department visit after being 
discharged from the index encounter. We excluded 25,084 patients who developed AKI 
during the index hospitalization or emergency department visit. Selected characteristics 
of the derivation cohort are presented in Table 1.  
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Table 6-10: Baseline characteristics of patients in the cohort who were admitted to 
the hospital or visited the emergency department between 2014 and 2016. 
Characteristics Patients admitted to hospital or visited ED 
 
Total Patients AKI No AKI 
Cohort size 905,442 5993 899,449 
Age, yr, mean (SD)  
65 to <70 181,088 (20%)  589 180,499 
70 to <80 371,231 (41%) 1911 369,320 
80 to <90 269,147 (30%) 2485 269,147 
>=90 81,489 (9%) 1008 80,481 
Sex  
Women 507,047 (56%) 2901 504,146 
Year of cohort entry (index date)  
2014-2015 588,537 (65%) 3987 584,550 
2015-2016 316,904 (34%) 2006 314,898 
Location  
Rural residence 144,870 (16%) 501 144,369 
LTC  
Long-term care 36,217 (4%) 745 35,472 
Income Quintile  
1 (lowest) 172,035 (19%) 1,306 170,729 
2 189,143 (21%) 1,318 187,825 
3 182,588 (20%) 1,173 181,415 
4 181,086 (20%) 1,154 179,932 
5 (highest) 180,590 (20%) 1,043 179,547 
Comorbid conditions (by codes)  
Hypertension 814,604 (88%) 5784 808,820 
Diabetes 358,472 (38%) 3306 355,166 
Heart failure 125,136 (14%) 1821 123,315 
Coronary artery disease 239,437 (26%) 2005 237,432 
Chronic liver disease 33,359 (4%) 297 33,062 
Cancer 145,286 (16%) 1016 144,270 
Chronic kidney disease 86,442 (9%) 1854 84,588 
Kidney stones 12,457 (1%) 93 12,364 
Peripheral vascular disease 13,197 (2%) 158 13,039 
Cerebrovascular disease 25,835 (3%) 282 25,553 
Hospital Diagnosis Codes  
Disorders of fluid, electrolyte and 
acid-base balance (E87) 
13563 (1%) 962 12601 
Delirium (F05) 4996 (1%) 342 4654 
Atrial fibrillation (I48.91) 34120 (4%) 1978 32142 
Mycoplasma pneumoniae (B96) 6197 (1%) 434 5763 
Anaemia (D64.9) 11814 (1%) 791 11023 
Valve disorders (I35) 1261 (1%) 186 1075 
Fracture of femur (S72) 7263 (1%) 231 7032 
Atherosclerotic cardiovascular 
disease (I25.10) 
21472 (2%) 1256 20216 
Volume depletion (E86.9) 3739 (1%) 240 3499 
Diseases of the digestive system 
(K00-K95) 
4552 (1%) 264 4288 
Abnormal functions of organs and 
systems (R94.8) 
11348 (2%) 725 10623 
Chronic pulmonary (J81.1) 24217 (3%) 971 23246 
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Hyperplasia of prostate (N40.1) 5047 (1%) 153 4894 
Certain infectious and parasitic 
diseases (A00-B99) 
1191 (1%) 105 1086 
Dementia (F03. 90) 8714 (1%) 390 8324 
Glomerular disorders (N08) 3988 (1%) 569 3419 
All the patients in the cohort were aged 65 years or older, where the mean age was 70 
years. Among the participants, about 56% were women. About six percent of patients 
were in long term care, and sixteen percent were from rural areas. The pre-existing 
comorbidities were diabetes (38%), hypertension (88%), major cancer (16%), coronary 
artery disease (25%), cerebrovascular disease (3%), heart failure (14%), chronic kidney 
disease (9%), kidney stones (1%), and peripheral vascular disease (2%). Some of the 
commonly prescribed medications were rosuvastatin calcium (22%), atorvastatin calcium 
(24%), amlodipine besylate (19%), metformin hcl (16%), and hydrochlorothiazide (20%). 
6.3.2 Classification Results 
We evaluated all of the machine learning models using 10-fold cross-validation 
(Japkowicz and Shah, 2011). The cohort was divided into ten equal groups, where nine 
groups were used for training, and the tenth group was used for testing. We repeated this 
process ten times, using different parts for training and testing, and assessed the 
performance of the models for each fold. We then combined the results of these folds to 
calculate the evaluation scores. We measured the validity of the tests in terms of 
sensitivity and specificity. Sensitivity is the capacity of a test to classify an individual as 
“at-risk” correctly. It represents the probability of a test being positive when “AKI” is 
present. On the contrary, specificity refers to the ability to classify an individual as “risk- 
free” correctly. Since predicting AKI was a binary classification problem (i.e., AKI or 
Non-AKI), all of the machine learning techniques were capable of providing a confidence 
score along with the output. The trade-off between sensitivity and 1-specificity was 
achieved by altering the threshold on the confidence scores, generating the receiver 
operating characteristic (ROC) curve. We used the ROC space to compare the 
performances of alternative tests in terms of 1-specificity and sensitivity. Thus, we 
computed and reported sensitivity, specificity, and area under the receiver operating 
171 
 
 
 
characteristic curve (AUROC). The AUROC ranged from 0.61 to 0.88 for predicting AKI 
among 31 machine learning models. The average AUROC values of ensemble methods 
were higher than the cost-sensitive logistic regression model. Among the sampling-based 
ensemble methods, the performances of the UnderBagging and RUSBoost methods were 
better than the SMOTE. We achieved the best result of AUROC 0.88 with 1) a 
combination of RUSBoost and SVM using a sigmoid kernel and 2) XGBoost using a tree 
learning algorithm. The AUROC of the linear boosting algorithm (XGBoost) was 0.84, 
which was higher than the cost-sensitive logistic regression but lower than the tree 
learning algorithm (XGBoost). Since it is a disease prediction problem, high sensitivity 
was more useful than specificity. The highest sensitivity was 0.90, which was achieved 
using SVM-sigmoid and SVM-radial kernels with RUSBoost and SMOTE-Bagging, 
respectively. The complete list of performance measures is presented in Table 2. 
Table 6-11: Performances of the machine learning techniques grouped by four 
ensemble-based methods and results of XGBoost and cost-sensitive regression 
analysis. 
Ensemble-Based Methods Machine Learning Techniques Sensitivity Specificity AUROC 
NA Logistic Regression 0.79 0.72 0.77 
SMOTEBoost 
CART 0.77 0.69 0.74 
C5.0 0.84 0.78 0.83 
NB 0.61 0.89 0.75 
SVM (linear) 0.84 0.74 0.79 
SVM (polynomial) 0.78 0.82 0.81 
SVM (sigmoid) 0.76 0.85 0.84 
SVM (radial) 0.70 0.83 0.82 
SMOTE-Bagging 
CART 0.60 0.71 0.68 
C5.0 0.62 0.84 0.79 
NB 0.69 0.73 0.72 
SVM (linear) 0.76 0.84 0.81 
SVM (polynomial) 0.82 0.73 0.80 
SVM (sigmoid) 0.84 0.71 0.81 
SVM (radial) 0.90 0.74 0.86 
UnderBagging 
CART 0.71 0.83 0.79 
C5.0 0.88 0.76 0.85 
NB 0.58 0.72 0.61 
SVM (linear) 0.77 0.84 0.83 
SVM (polynomial) 0.85 0.71 0.84 
SVM (sigmoid) 0.89 0.71 0.85 
SVM (radial) 0.79 0.90 0.86 
RUSBoost 
CART 0.78 0.74 0.76 
C5.0 0.84 0.77 0.82 
NB 0.68 0.72 0.71 
172 
 
 
 
SVM (linear) 0.84 0.78 0.83 
SVM (polynomial) 0.74 0.85 0.82 
SVM (sigmoid) 0.90 0.79 0.88 
SVM (radial) 0.71 0.87 0.85 
XGBoost 
Tree boosting 0.89 0.81 0.88 
Linear boosting 0.86 0.77 0.84 
6.4 Discussion  
In this study, we demonstrated how machine learning techniques could help with the 
prediction of AKI using administrative health databases stored at ICES. Several machine 
learning-based models have been developed in recent studies to predict AKI among 
patients in ICU and post-operative (Abdullah et al., 2020c; Cheng et al., 2017; Davis et 
al., 2017; Gameiro et al., 2020; Ibrahim et al., 2019; Rashidi et al., 2020; Tran et al., 
2019). However, most of these models only focus on a specific medical condition and 
consider the risk factors associated with that condition. For instance, Go et al. (2010) 
examined how AKI affects the risk of chronic kidney disease, cardiovascular events, and 
other patient-related outcomes in hospital settings (Go et al., 2010). The earlier AKI can 
be predicted, the better the chances are to prevent AKI and its associated cost. The 
features that have been used in most of the existing studies work better in predicting AKI 
if their values are recorded closer to the timing of AKI onset. However, it may not be 
beneficial to detect AKI close to its onset because clinicians will not have enough time to 
intervene. Thus, there is a trade-off between accuracy and usefulness, which can be 
optimized using information available in EHRs. Although some studies have developed 
risk stratification models for AKI using EHRs (Kane-Gill et al., 2015; Matheny et al., 
2010), they can only predict hospital-acquired AKI and do not consider patients who are 
at risk of developing AKI after being discharged. To our best knowledge, there are no 
previous studies in the literature that predict the risk of AKI after being discharged from 
the hospital using both the historical and healthcare utilization data. Thus, this study is 
not only novel but also clinically relevant because it provides clinicians with the ability to 
intervene and treat patients before AKI cause irreversible damage.  
We analyzed all AKI events that took place within 90 days after being discharged from 
the hospital or emergency department and developed prediction models to identify high-
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risk patients. We decided to choose 90 days timeframe for following up because 1) out of 
all AKI cases within six months after discharge, about 85 percent were acquired within 
this timeframe; and 2) it was a reasonable timeframe considering the trade-off between 
the models’ usefulness (from a clinical point of view) and predictive power (from a 
machine learning point of view). Table 3 shows how many AKI acquired cases were 
identified within different time intervals. The machine learning models presented in this 
study can be adapted to make predictions at any other timeframes if needed. 
We incorporated eight different machine learning classifiers and three ensemble methods, 
and two sampling techniques to develop 31 prediction models. Although each 
combination of machine learning techniques and ensemble-based methods performed 
reasonably well, the performance of SVM with sigmoid kernel and tree-based XGBoost 
produced better results than other techniques in general. The performance of all of the 
ensemble-based methods were consistent and produced similar results for different base 
classifiers. The results shown in Table 2 indicate that the models agreed with each other. 
Table 6-12: The number of AKI cases are grouped into six time periods. 
Intervals Readmission with AKI 
1-3 days 415 
4-7 days 534 
8-14 days 888 
15-30 days 1517 
31-60 days 3579 
61-90 days 1499 
To understand the models better, we explored the features that are important in each 
prediction model. We analyzed this information with a nephrologist to confirm the 
correctness of the models. We observed the odds ratio and p-value of the features in the 
regression model, feature importance in decision tree and XGBoost models, and 
coefficients in the SVM-linear models to understand the association between different 
features and AKI. The features included in this study can be divided into four 
categories—namely, demographics, comorbidities, medications, and diagnosis codes.  
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In general, features from comorbidities and hospital diagnosis codes were more 
associated with AKI. Although the importance of the features varied based on the 
machine learning techniques, most of the features that stood out were common among 
these models. For instance, diabetes mellitus, hypertension, coronary artery disease, heart 
failure, major cancers, chronic liver disease, peripheral vascular disease, and chronic 
kidney disease were the comorbidity features that were important in most of the 
prediction models. These comorbid conditions are already known to be associated with 
AKI in the literature (Dylewska et al., 2019; Girman et al., 2012; Hsu and Hsu, 2016; 
Olsson et al., 2013; Rydén et al., 2014). The medication features that contributed to the 
higher risk of AKI include furosemide, allopurinol, hydrochlorothiazide, atorvastatin, 
metolazone, sunitinib malate, spironolactone, dexamethasone, chlorthalidone, atenolol, 
dexamethasone and oseltamivir phosphate. These medications are known to be 
nephrotoxic (Chao et al., 2015; Ho and Power, 2010; Perez-Ruiz, 2017; Pierson-
Marchandise et al., 2017; Verdoodt et al., 2018; Wu et al., 2014). Delirium, anaemia, 
mycoplasma, fluid disorders, atrial fibrillation, atherosclerotic cardiovascular disease, 
mycoplasma pneumoniae, hyperplasia of prostate, glomerular disorders, and valve 
disorders were the features belonging to the diagnosis codes that were associated with 
increasing the risk of AKI in the prediction models. Several studies in the literature 
associate these medical conditions with AKI (Carrara et al., 2017; Godin et al., 2013; Ng 
et al., 2016; Siew et al., 2017; Zaleska-Kociecka et al., 2019). Among the demographic 
features, age, sex, location (i.e., urban or rural residence), and long-term care were found 
to be associated with AKI in most of the prediction models. Similar to comorbidity, 
medication, and diagnosis code, these demographic features are already known to be 
associated with AKI (Evans et al., 2017; Neugarten and Golestaneh, 2018; Yokota et al., 
2018) in the literature, which more conclusively proves the correctness of the prediction 
models. Through a comprehensive analysis of ICES' healthcare administrative datasets, 
this study shows that AKI is predictable using EHRs. Successful implementation of these 
prediction models in a healthcare setting can potentially reduce the risk of AKI among 
older patients.  
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6.5 Limitations and Future Work 
The study should be evaluated with respect to several limitations. First, our models were 
trained and tested on a cohort of older patients (65 years or older), which limits the 
generalizability of the models. Second, we excluded patients with missing or invalid 
demographics information. This may affect the performance of the models if the 
excluded data includes any interesting or rare cases. Third, the models are based on a 
cohort containing Ontario patients only, which limits this study to a specific geographic 
location. Fourth, the proposed prediction models are trained and tested on a specific 
patient cohort. It is essential to test the models' performance with real-time medical data 
before applying them in a clinical setting. Fifth, since we developed 31 prediction 
models, and many of them have different mechanisms to identify feature importance, the 
interrelationships produced by these models are very complex. This study only identifies 
the most significant predictors but does not incorporate any rankling system for 
predictors. Finally, we identified the episode of AKI using ICD-10 codes, which may not 
include undetected cases in hospital settings. Moreover, since AKI was identified using 
the diagnosis code, this study does not consider the severity of AKI. Our future work 
concerns a deeper analysis of severe AKI that requires dialysis. 
6.6 Conclusion 
AKI is characterized by a sharp decline in renal function and associated with increased 
health-related costs and mortality. AKI is avoidable and may be preventable through an 
earlier prediction using risk factors available in EHRs. This study is designed to identify 
older patients who are discharged from the hospital or emergency department and at risk 
of developing AKI within 90 days after discharge. We employ eight traditional and state-
of-art machine learning classifiers along with two sampling techniques, and three 
ensemble methods to build AKI prediction models. The performances of these models 
were consistent, and a maximum AUROC of 0.88 was achieved through 10-fold cross-
validation. We analyzed the models with a healthcare expert and identified features that 
are most relevant in predicting AKI. Most of these features are already known to be AKI-
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associated, which proves the correctness and feasibility of the prediction models. This 
study predicts the risk of AKI for a patient after being discharged from the hospital or 
emergency department, which provides healthcare providers enough time to intervene, 
monitor them more carefully, and avoid prescribing nephrotoxic medications for such 
patients. 
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Chapter 7  
7 Conclusion 
This dissertation has discussed several aspects relating to the design of VA for EHRs. 
First, a systematic literature survey has been conducted to analyze the design and 
implementation of existing EHR-based systems. We then presented a framework to 
evaluate EHR-data-driven tasks and activities in the existing systems. The gaps that we 
identified during the analysis with the framework motivated us to design new EHR-based 
VA systems. Therefore, we designed and developed two novel VA systems—namely, 
VISA_M3R3 (VISual Analytics, VISA for Multiple Regression analyses and fRequent 
itemset Mining of electronic Medical Records, M3R3) and VALENCIA (Visual 
Analytics for Cluster Analysis and Dimension Reduction of High Dimensional Electronic 
Health Records). We also conducted two independent population-based retrospective 
cohort study to test the hypothesis and ideas generated from the VA systems. These 
systems and studies are designed to assist the healthcare researchers at the ICES-KDT 
program. We demonstrated the effectiveness of the proposed systems by investigating the 
process of analyzing the health administrative data housed at ICES to solve different 
AKI-related problems.  
This chapter, which serves as a conclusion of the dissertation, is divided into three 
sections: 1) a review of the chapters and some of their contributions, 2) general 
contribution of this dissertation to the scientific literature, and 3) some future research 
areas. 
7.1 Dissertation Summary 
In Chapter 2, we have presented a framework to examine EHR-data-driven activities and 
tasks in the context of interactive visualizations. Using a literature survey of 19 EHR-based 
existing systems, we demonstrated how different combinations of sub-tasks, tasks, and sub-
activities work together to help users achieve their overall goals in the system. The 
proposed framework can help 1) designers to conceptualize activities, sub-activities, tasks, 
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and sub-tasks of new systems, 2) researchers to understand the design concepts in a 
systematic way, and 3) evaluators to assess existing EHR-based interactive visualization 
systems.  
In Chapter 3, we described how VA systems could be designed systematically to support 
EHR-driven tasks and investigate complex clinical problems. We developed VISA_M3R3 
that integrates multiple statistical and machine learning techniques with interactive 
visualization to identify potentially nephrotoxic medications. VISA_M3R3 has shown to 
assist healthcare researchers in 1) comparing multiple logistic regression models, 2) 
understanding the relationships among predictors and response variable, 3) identifying 
frequent itemsets from items of interest, and 4) interpreting regression results. 
VISA_M3R3 can also be used to develop an alert system to raise physicians’ awareness of 
AKI-associated medications. This, in turn, will prompt healthcare providers to carry out 
additional clinical investigations on these high-risk medications.  
VISA_M3R3 only visualizes regression models of medication combinations but do not 
investigate how individual medications within combinations are affecting AKI. In Chapter 
4, we presented a population-based retrospective cohort to overcome this limitation and 
understand the synergistic effect of AKI-inducing medication combinations more 
comprehensively. Through an investigation of prescription records of one million adult 
patients stored in the ICES datasets, we identified 55 AKI-inducing medications among a 
total of 595 medications and 78 AKI-inducing medication combinations among a total of 
7,748 frequent medication groups. We also identified 37 cases where a medication is 
associated with increased risk of developing AKI when combined with another medication. 
Finally, we performed an electronic literature search and consulted with a nephrologist to 
verify the findings of this study. Although many of the medications and medication 
combinations that we detected are already known to be nephrotoxic, some of them have 
not been investigated before. This study will assist healthcare researchers in identifying 
candidates for future drug-safety studies. 
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In Chapter 5, we explained how VA systems could be designed to address the challenges 
of high-dimensional EHRs. We introduced VALENCIA that integrates a wide range of 
traditional and state-of-the-art analysis techniques with several interactive visualizations to 
provide a deeper understanding of the structure of data, results, control parameters, and 
analytical processes. We have demonstrated the utility of VALENCIA using a case study. 
Through a number of formative evaluations, we have found that VALENCIA assists 
healthcare providers in 1) exploring EHRs using different dimension reduction and 
clustering techniques, 2) identifying relationships among different features, 3) generating 
hypotheses, and 4) comparing results of different analysis techniques.  
We identified multiple risk factors of AKI while performing a cluster analysis of the ICES 
dataset using VALENCIA, which motivated us to design another study for predicting AKI. 
In Chapter 6, we employed a number of machine learning techniques to develop prediction 
models to identify patients who were at risk of developing AKI within 90 days after they 
were discharged from the emergency department or hospital. We included demographics, 
comorbid conditions, medications, and hospital diagnosis codes as predictor variables. A 
total of sixteen prediction models based on combinations of four machine learning 
techniques and four ensemble-based methods, along with a cost-sensitive logistic 
regression model, were developed for this study. The performances of these models were 
consistent, and we achieved an AUROC of 0.88 through ten-fold cross-validation.  
7.2 General Contributions 
As described in Chapter 1, the broad concern of this research surrounds the design of 
visual analytics for EHRs. Currently, there is a scarcity of research in this field, and 
therefore, we intended to bridge the gap through this work. This dissertation presents the 
design process of human- and activity-centered computational systems for healthcare. It 
is often challenging to fulfill the computational and cognitive demands of healthcare 
providers when designing such systems. This dissertation also describes how different 
EHR-related challenges can be addressed by combining statistical methods, data mining 
algorithms, machine learning techniques, and information visualization. It demonstrates 
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how VA systems can be designed systematically and how healthcare providers' 
capabilities to interact with machine learning processes can be improved by VA. In 
addition, this dissertation offers the healthcare domain with evidence of the effectiveness 
of VA for managing EHRs. This research has suggestions for other domains that require 
their data to be made accessible and analyzable through VA. 
Through a systematic survey in Chapter 2, this dissertation provides a detailed analysis of 
the EHR-data-driven tasks and activities supported by the existing interactive 
visualization systems, which was lacking in the literature. Moreover, the proposed 
activity and task analysis framework is helpful for the designer and evaluators of any 
EHR-based visualization system. This framework will lead to the development of best 
practices for designing related frameworks in other domains.  
Another contribution of this dissertation is the VA systems, VISA_M3R3 and 
VALENCIA, that are discussed in Chapters 3 and 5. To help us learn how healthcare 
providers perform real-world tasks, and to help us design and develop these systems, we 
adopted a participatory design approach. We performed formative evaluations at every 
step of the design and development process with the stakeholders at the ICES-KDT 
program. Through these evaluations, the healthcare experts found the systems useful and 
sophisticated. The systems would benefit not only healthcare researchers across the globe 
but also designers of EHR-based VA systems. These systems are also scalable and can be 
reconfigured to work with other forms of data.  
Other contributions emerge from the population-based studies presented in Chapters 4 
and 6. Chapter 4 presented an automated approach to identify AKI-associated medication 
and medication combinations. The drug-safety studies in clinical settings are usually 
costly and time-consuming. The proposed approach can help healthcare researchers to 
prepare a short list of suitable candidates for clinical studies, which not only saves money 
and time but also supports the identification of potentially unknown nephrotoxic 
medication combinations. In addition, the study in Chapter 6 demonstrates how machine 
learning can be used to predict AKI using EHRs. Most of the existing AKI prediction 
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models are designed for a specific medical condition and predict AKI close to its onset. 
To the best of our knowledge, Chapter 6 presents the first study that predicts the risk of 
AKI for patients who are discharged from the hospital or emergency department, which 
provides enough time for clinicians to intervene. 
7.3 Limitations and Future Work  
The systems and studies presented in this dissertation lay a foundation for the usefulness 
of VA tools in healthcare. Through the activity and task analysis framework, we 
identified that there are a limited number of interactive visualization systems that support 
higher-level activity, “predicting” and “monitoring.” The proposed systems are primarily 
designed to support “interpreting” and “predicting.” More research is needed to explore 
how EHR-based VA systems can be extended to support the activity, “monitoring.”  
This dissertation reports the development of two VA systems—namely, VISA_M3R3 
and VALENCIA. We described the data sources, input, output, stakeholders, interface, 
design criteria, levels of abstraction and different subsystems of these systems in 
Chapters 3 and 5. Although we included workflow diagrams to describe the systems' 
design, the architectures of these systems are not described thoroughly. The description 
was mainly focused on the conceptual challenges but did not consider the practical 
difficulties of these complex systems. For instance, we did not investigate how many 
users can be supported by the systems simultaneously or the systems’ capability of 
interacting with other systems. Since both VISA_M3R3 and VALENCIA were 
developed to process sensitive patient records in an access-restricted offline setting, it 
was not required to create web services or implement any adapter (i.e., software that 
connects two systems and reconciles the distinctions between them). 
Another limitation of these systems lies in their ability to increase their functionalities 
and capacity based on users’ demand. The description of these systems does not describe 
the challenges regarding scalability and extensibility. Scalability refers to methods that 
guarantee that the functionality and quality of a system are maintained as the number of 
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users goes up or the complexity of the data increases. On the other hand, extensibility 
refers to a system's ability to adapt to new interfaces, functionalities, data, and input. We 
employed multiple programming languages, platforms, and servers for developing these 
systems. The current VISA_M3R3 and VALENCIA systems were implemented using 
HTML, JavaScript library D3, standard PHP programming language, SAS, and R 
packages. The datasets were stored in the SAS server. R server was incorporated to 
perform all the underlying processing. Web server (PHP) was used to host the HTML 
files to maintain communication with the R server. Since different technologies are 
combined to develop these systems, it is easy to incorporate new analysis algorithms 
(e.g., using a new library or package in R), additional features in the interface (e.g., 
modifying D3 functions), and supplementary data (e.g., incorporating new datasets). 
However, we were not able to determine the scalability of these systems. Since we 
developed them in an access-restricted virtual machine, we did not get a chance to access 
the systems' scalability. We will evaluate these systems more comprehensively in the 
future. 
Although healthcare experts have evaluated VISA_M3R3 and VALENCIA during the 
design process and found it useful, we have not conducted formal studies to assess their 
performances, nor the efficiency of their human-information discourse mechanisms. 
Thus, additional studies can help ascertain the effectiveness of these systems for both 
expert and non-expert users. 
Both systems presented in this dissertation are implemented and tested using ICES-KDT 
datasets. Studies that assess the effectiveness of these systems with different datasets and 
settings will provide a better understanding of the efficacy of the systems. 
 
183 
 
 
 
References 
Aamdal, S., 1992. Can ondansetron hydrochloride (Zofran) enhance the nephrotoxic 
potential of other drugs? Annals of oncology : official journal of the European 
Society for Medical Oncology 3, 774. 
https://doi.org/10.1093/oxfordjournals.annonc.a058342 
Abdi, H., Williams, L.J., 2010. Principal component analysis. Wiley interdisciplinary 
reviews: computational statistics 2, 433–459. 
Abdullah, S.S., Rostamzadeh, N., Sedig, K., Garg, A.X., McArthur, E., 2020a. Visual 
Analytics for Dimension Reduction and Cluster Analysis of High Dimensional 
Electronic Health Records. Informatics 7, 17. 
https://doi.org/10.3390/informatics7020017 
Abdullah, S.S., Rostamzadeh, N., Sedig, K., Garg, A.X., McArthur, E., 2020. Multiple 
Regression Analysis and Frequent Itemset Mining of Electronic Medical Records: 
A Visual Analytics Approach Using VISA_M3R3. Data 5, 33. 
https://doi.org/10.3390/data5020033 
Abdullah, S.S., Rostamzadeh, N., Sedig, K., Lizotte, D.J., Garg, A.X., McArthur, E., 
2020c. Machine Learning for Identifying Medication-Associated Acute Kidney 
Injury. Informatics 7, 18. https://doi.org/10.3390/informatics7020018 
Abramson, E.L., Barrón, Y., Quaresimo, J., Kaushal, R., 2011. Electronic prescribing 
within an electronic health record reduces ambulatory prescribing errors. Joint 
Commission Journal on Quality and Patient Safety 37, 470–478. 
https://doi.org/10.1016/S1553-7250(11)37060-2 
Adachi, S., 2017. Rigid geometry solves “curse of dimensionality” effects in clustering 
methods: An application to omics data. PLoS One 12. 
https://doi.org/10.1371/journal.pone.0179180 
Adhiyaman, V., Asghar, M., Oke, A., White, A.D., Shah, I.U., 2001. Nephrotoxicity in 
the elderly due to co-prescription of angiotensin converting enzyme inhibitors and 
nonsteroidal anti-inflammatory drugs. Journal of the Royal Society of Medicine 
94, 512–4. https://doi.org/10.1177/014107680109401005 
Agrawal, A., 2009. Medication errors: Prevention using information technology systems. 
British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-
2125.2009.03427.x 
184 
 
 
 
Agrawal, R., Swami, A., Imielinski, T., 1993. Database Mining: A Performance 
Perspective. IEEE Transactions on Knowledge and Data Engineering 5, 914–925. 
https://doi.org/10.1109/69.250074 
Aigner, W., Kaiser, K., Miksch, S., 2008. Visualization techniques to support authoring, 
execution, and maintenance of clinical guidelines. Computer-based Medical 
Guidelines and Protocols: A Primer and Current Trends 139, 140–159. 
Aimone, A.M., Perumal, N., Cole, D.C., 2013. A systematic review of the application 
and utility of geographical information systems for exploring disease-disease 
relationships in paediatric global health research: The case of anaemia and 
malaria. International Journal of Health Geographics 12. 
https://doi.org/10.1186/1476-072X-12-1 
Alexander, T., McArthur, E., Jandoc, R., Welk, B., Hayward, J.S., Jain, A.K., Braam, B., 
Flockerzi, V., Garg, A.X., Quinn, R.R., 2017. Antihypertensive medications and 
the risk of kidney stones in older adults: A retrospective cohort study. 
Hypertension Research 40, 837–842. https://doi.org/10.1038/hr.2017.42 
Ali, M., Jones, M.W., Xie, X., Williams, M., 2019. TimeCluster: dimension reduction 
applied to temporal data for visual analytics. Vis Comput 35, 1013–1026. 
https://doi.org/10.1007/s00371-019-01673-y 
Ali, T., Khan, I., Simpson, W., Prescott, G., Townend, J., Smith, W., Macleod, A., 2007. 
Incidence and outcomes in acute kidney injury: a comprehensive population-
based study. Journal of the American Society of Nephrology : JASN 18, 1292–8. 
https://doi.org/10.1681/ASN.2006070756 
Alirezaei, A., Argani, H., Asgharpour, M., Bahadorimonfared, A., Bakhtiyari, M., 2017. 
An update on allopurinol and kidney failure; new trend for an old drug. 
https://doi.org/10.15171/jrip.2017.57 
Allison, S.J., 2015. Effect of perioperative aspirin and clonidine on AKI. Nature Reviews 
Nephrology 11. 
Amarasingham, R., Patzer, R.E., Huesch, M., Nguyen, N.Q., Xie, B., 2014. 
Implementing electronic health care predictive analytics: considerations and 
challenges. Health Affairs 33, 1148–1154. 
https://doi.org/10.1377/hlthaff.2014.0352 
Anderson, F.A., Wyman, A., Varon, J., McCullough, P.A., Devlin, J.W., Weir, M.R., 
Katz, J.N., Szczech, L.A., Granger, C.B., Dasta, J.F., Amin, A., Frank, W., Frank 
Peacock, W., 2010. Circulation Treatment of Acute Hypertension Investigators 
Hypertension Acute Kidney Injury and Cardiovascular Outcomes in Acute Severe 
Hypertension Acute Kidney Injury and Cardiovascular Outcomes in Acute Severe 
185 
 
 
 
Hypertension 121, 2183–2191. 
https://doi.org/10.1161/CIRCULATIONAHA.109.896597 
Anderson, H.D., Pace, W.D., Brandt, E., Nielsen, R.D., Allen, R.R., Libby, A.M., West, 
D.R., Valuck, R.J., 2015. Monitoring suicidal patients in primary care using 
electronic health records. J Am Board Fam Med 28, 65–71. 
https://doi.org/10.3122/jabfm.2015.01.140181 
Arabie, P., 1994. Cluster analysis in marketing research. Advanced methods of marketing 
research 160–189. 
Arifin, S., Zulkardi, Z., Indra Putri, R., Hartono, Y., Susanti, E., 2017. Developing Ill-
defined problem-solving for the context of “South Sumatera.” Journal of Physics: 
Conference Series 943, 12038. https://doi.org/10.1088/1742-6596/943/1/012038 
Asimov, D., 1985. The grand tour: a tool for viewing multidimensional data. SIAM 
journal on scientific and statistical computing 6, 128–143. 
Assadi, F., Ghane Shahrbaf, F., 2015. Ghane Shahrbaf F, Assadi F. Drug-induced renal 
disorders. Journal of Renal Injury Prevention J Renal Inj Prev 4, 57–60. 
https://doi.org/10.12861/jrip.2015.12 
Audia, P., Feinfeld, D.A., Dubrow, A., Winchester, J.F., 2008. Metformin-induced lactic 
acidosis and acute pancreatitis precipitated by diuretic, celecoxib, and 
candesartan-associated acute kidney dysfunction. Clinical toxicology 
(Philadelphia, Pa.) 46, 164–6. https://doi.org/10.1080/15563650701355314 
Auffray, C., Balling, R., Barroso, I., Bencze, L., Benson, M., Bergeron, J., Bernal-
Delgado, E., Blomberg, N., Bock, C., Conesa, A., Del Signore, S., Delogne, C., 
Devilee, P., Di Meglio, A., Eijkemans, M., Flicek, P., Graf, N., Grimm, V., 
Guchelaar, H.-J., Guo, Y.-K., Gut, I.G., Hanbury, A., Hanif, S., Hilgers, R.-D., 
Honrado, Á., Hose, D.R., Houwing-Duistermaat, J., Hubbard, T., Janacek, S.H., 
Karanikas, H., Kievits, T., Kohler, M., Kremer, A., Lanfear, J., Lengauer, T., 
Maes, E., Meert, T., Müller, W., Nickel, D., Oledzki, P., Pedersen, B., Petkovic, 
M., Pliakos, K., Rattray, M., i Màs, J.R., Schneider, R., Sengstag, T., Serra-
Picamal, X., Spek, W., Vaas, L.A.I., van Batenburg, O., Vandelaer, M., Varnai, 
P., Villoslada, P., Vizcaíno, J.A., Wubbe, J.P.M., Zanetti, G., 2016. Making sense 
of big data in health research: Towards an EU action plan. Genome Medicine 8, 
71. https://doi.org/10.1186/s13073-016-0323-y 
Bade, R., Schlechtweg, S., Miksch, S., 2004. Connecting time-oriented data and 
information to a coherent interactive visualization, in: Proceedings of the SIGCHI 
Conference on Human Factors in Computing Systems. ACM, pp. 105–112. 
186 
 
 
 
Bagshaw, Sean M., Delaney, A., Jones, D., Ronco, C., Bellomo, R., 2007. Diuretics in 
the Management of Acute Kidney Injury: A Multinational Survey. Acute Kidney 
Injury 156, 236–249. https://doi.org/10.1159/000102089 
Bagshaw, Sean M, George, C., Bellomo, R., ANZICS Database Management Committee, 
2007. Changes in the incidence and outcome for early acute kidney injury in a 
cohort of Australian intensive care units. Critical care (London, England) 11, 
R68–R68. https://doi.org/10.1186/cc5949 
Bahnsen, A.C., Aouada, D., Ottersten, B., 2014. Example-Dependent Cost-Sensitive 
Logistic Regression for Credit Scoring, in: 2014 13th International Conference on 
Machine Learning and Applications. Presented at the 2014 13th International 
Conference on Machine Learning and Applications, pp. 263–269. 
https://doi.org/10.1109/ICMLA.2014.48 
Barandela, R., Valdovinos, R.M., Sánchez, J.S., 2003. New Applications of Ensembles of 
Classifiers. Patt. Analy. App. 6, 245–256. https://doi.org/10.1007/s10044-003-
0192-z 
Basile, A.O., Yahi, A., Tatonetti, N.P., 2019. Artificial Intelligence for Drug Toxicity and 
Safety. Trends in Pharmacological Sciences. 
https://doi.org/10.1016/j.tips.2019.07.005 
Basole, R.C., Braunstein, M.L., Kumar, V., Park, H., Kahng, M., Chau, D.H., Tamersoy, 
A., Hirsh, D.A., Serban, N., Bost, J., Lesnick, B., Schissel, B.L., Thompson, M., 
2015. Understanding variations in pediatric asthma care processes in the 
emergency department using visual analytics. Journal of the American Medical 
Informatics Association 22, 318–323. https://doi.org/10.1093/jamia/ocu016 
Baytas, I.M., Lin, K., Wang, F., Jain, A.K., Zhou, J., 2016. PhenoTree: Interactive Visual 
Analytics for Hierarchical Phenotyping From Large-Scale Electronic Health 
Records. IEEE Transactions on Multimedia 18, 2257–2270. 
https://doi.org/10.1109/TMM.2016.2614225 
Bennett, W.M., 2013. Cyclosporine and tacrolimus nephrotoxicity. Utd 1–18. 
Bernard, J., Sessler, D., Bannach, A., May, T., Kohlhammer, J., 2015. A visual active 
learning system for the assessment of patient well-being in prostate cancer 
research, in: ACM International Conference Proceeding Series. Association for 
Computing Machinery. https://doi.org/10.1145/2836034.2836035 
Bird, S.T., Etminan, M., Brophy, J.M., Hartzema, A.G., Delaney, J.A., 2013. Risk of 
acute kidney injury associated with the use of fluoroquinolones. Cmaj 185, E475–
E482. 
187 
 
 
 
Boccanfuso, J.A., Hutton, M., McAllister, B., 2000. The effects of megestrol acetate on 
nutritional parameters in a dialysis population. Journal of Renal Nutrition 10, 36–
43. https://doi.org/10.1016/S1051-2276(00)90021-9 
Boonstra, A., Versluis, A., Vos, J.F., 2014. Implementing electronic health records in 
hospitals: a systematic literature review. BMC health services research 14, 370. 
Bove, T., Belletti, A., Putzu, A., Pappacena, S., Denaro, G., Landoni, G., Bagshaw, S.M., 
Zangrillo, A., 2018. Intermittent furosemide administration in patients with or at 
risk for acute kidney injury: Meta-analysis of randomized trials. PLoS ONE 13, 
e0196088. https://doi.org/10.1371/journal.pone.0196088 
Brodbeck, D., Gasser, R., Degen, M., Reichlin, S., Luthiger, J., 2005. Enabling large-
scale telemedical disease management through interactive visualization. European 
Notes in Medical Informatics 1, 1172–1177. 
Caban, J.J., Gotz, D., 2015. Visual analytics in healthcare - opportunities and research 
challenges. Journal of the American Medical Informatics Association 22, 260–
262. https://doi.org/10.1093/jamia/ocv006 
Carrara, C., Abbate, M., Sabadini, E., Remuzzi, G., 2017. Acute Kidney Injury and 
Hemolytic Anemia Secondary to Mycoplasma pneumoniae Infection. Nephron 
137, 148–154. https://doi.org/10.1159/000478991 
Carroll, L.N., Au, A.P., Detwiler, L.T., Fu, T.-C., Painter, I.S., Abernethy, N.F., 2014. 
Visualization and analytics tools for infectious disease epidemiology: a systematic 
review. J Biomed Inform 51, 287–298. https://doi.org/10.1016/j.jbi.2014.04.006 
Cartin-Ceba, R., Kashiouris, M., Plataki, M., Kor, D.J., Gajic, O., Casey, E.T., 2012. Risk 
factors for development of acute kidney injury in critically ill patients: a 
systematic review and meta-analysis of observational studies. Critical care 
research and practice 2012, 691013. https://doi.org/10.1155/2012/691013 
Cavallo, M., Demiralp, Ç., 2018. A Visual Interaction Framework for Dimensionality 
Reduction Based Data Exploration, in: Proceedings of the 2018 CHI Conference 
on Human Factors in Computing Systems, CHI ’18. Association for Computing 
Machinery, Montreal QC, Canada, pp. 1–13. 
https://doi.org/10.1145/3173574.3174209 
Cawley, G.C., Talbot, N.L.C., 2010. On Over-fitting in Model Selection and Subsequent 
Selection Bias in Performance Evaluation 29. 
Chang, Y.-P., Huang, S.-K., Tao, P., Chien, C.-W., 2012. A population-based study on 
the association between acute renal failure (ARF) and the duration of 
polypharmacy. BMC nephrology 13, 96. https://doi.org/10.1186/1471-2369-13-96 
188 
 
 
 
Chao, C.-T., Tsai, H.-B., Wu, C.-Y., Lin, Y.-F., Hsu, N.-C., Chen, J.-S., Hung, K.-Y., 
2015. Cumulative Cardiovascular Polypharmacy Is Associated With the Risk of 
Acute Kidney Injury in Elderly Patients. Medicine 94, e1251. 
https://doi.org/10.1097/MD.0000000000001251 
Chawla, N.V., Bowyer, K.W., Hall, L.O., Kegelmeyer, W.P., 2002. SMOTE: Synthetic 
Minority Over-sampling Technique. Journal of Artificial Intelligence Research 
16, 321–357. https://doi.org/10.1613/jair.953 
Chen, T., Guestrin, C., 2016. XGBoost: A Scalable Tree Boosting System, in: 
Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge 
Discovery and Data Mining, KDD ’16. Association for Computing Machinery, 
San Francisco, California, USA, pp. 785–794. 
https://doi.org/10.1145/2939672.2939785 
Cheng, P., Waitman, L.R., Hu, Y., Liu, M., 2017. Predicting Inpatient Acute Kidney 
Injury over Different Time Horizons: How Early and Accurate? AMIA Annu 
Symp Proc 2017, 565–574. 
Chittaro, L., Combi, C., Trapasso, G., 2003. Data mining on temporal data: a visual 
approach and its clinical application to hemodialysis. Journal of Visual Languages 
& Computing 14, 591–620. 
Cho, H., Berger, B., Peng, J., 2016. Compact Integration of Multi-Network Topology for 
Functional Analysis of Genes. Cell Syst 3, 540-548.e5. 
https://doi.org/10.1016/j.cels.2016.10.017 
Choo, J., Lee, H., Liu, Z., Stasko, J., Park, H., 2013. An interactive visual testbed system 
for dimension reduction and clustering of large-scale high-dimensional data, in: 
Visualization and Data Analysis 2013. International Society for Optics and 
Photonics, p. 865402. 
Choudhury, D., Ahmed, Z., 2006. Drug-associated renal dysfunction and injury. Nature 
Clinical Practice Nephrology. https://doi.org/10.1038/ncpneph0076 
Christensen, T., Grimsmo, A., 2008. Instant availability of patient records, but 
diminished availability of patient information: a multi-method study of GP’s use 
of electronic patient records. BMC medical informatics and decision making 8, 
12. 
Clinical Practice Guideline, 2012. KDIGO Clinical Practice Guideline for Acute Kidney 
Injury 2. 
189 
 
 
 
Cohen, I.G., Amarasingham, R., Shah, A., Xie, B., Lo, B., 2014. The legal and ethical 
concerns that arise from using complex predictive analytics in health care. Health 
Affairs 33, 1139–1147. https://doi.org/10.1377/hlthaff.2014.0048 
Collins, N., 2018. AI predicts drug pair side effects | Stanford News [WWW Document]. 
URL https://news.stanford.edu/2018/07/10/ai-predicts-drug-pair-side-effects/ 
(accessed 1.5.20). 
Collister, D., Pannu, N., Ye, F., James, M., Hemmelgarn, B., Chui, B., Manns, B., 
Klarenbach, S., Alberta Kidney Disease Network, 2017. Health Care Costs 
Associated with AKI. Clinical journal of the American Society of Nephrology : 
CJASN 12, 1733–1743. https://doi.org/10.2215/CJN.00950117 
Combi, C., Keravnou-Papailiou, E., Shahar, Y., 2010. Temporal Information Systems in 
Medicine. Springer Science & Business Media. 
Cook, D., Swayne, D.F., Buja, A., 2007. Interactive and dynamic graphics for data 
analysis: with R and GGobi. Springer Science & Business Media. 
Cowie, M.R., Blomster, J.I., Curtis, L.H., Duclaux, S., Ford, I., Fritz, F., Goldman, S., 
Janmohamed, S., Kreuzer, J., Leenay, M., Michel, A., Ong, S., Pell, J.P., 
Southworth, M.R., Stough, W.G., Thoenes, M., Zannad, F., Zalewski, A., 2017. 
Electronic health records to facilitate clinical research. Clin Res Cardiol 106, 1–9. 
https://doi.org/10.1007/s00392-016-1025-6 
Cristianini, N., Shawe-Taylor, J., 2000. An Introduction to Support Vector Machines and 
Other Kernel-based Learning Methods [WWW Document]. Cambridge Core. 
https://doi.org/10.1017/CBO9780511801389 
Cui, W., 2019. Visual Analytics: A Comprehensive Overview. IEEE Access 7, 81555–
81573. https://doi.org/10.1109/ACCESS.2019.2923736 
Cunningham, P., 2008. Dimension Reduction, in: Cord, M., Cunningham, P. (Eds.), 
Machine Learning Techniques for Multimedia: Case Studies on Organization and 
Retrieval, Cognitive Technologies. Springer, Berlin, Heidelberg, pp. 91–112. 
https://doi.org/10.1007/978-3-540-75171-7_4 
Cybulski, J.L., Keller, S., Nguyen, L., Saundage, D., 2015. Creative problem solving in 
digital space using visual analytics. Computers in Human Behavior, Digital 
Creativity: New Frontier for Research and Practice 42, 20–35. 
https://doi.org/10.1016/j.chb.2013.10.061 
Da’as, N., Polliack, A., Cohen, Y., Amir, G., Darmon, D., Kleinman, Y., Goldfarb, A.W., 
Ben-Yehuda, D., 2001. Kidney involvement and renal manifestations in non-
Hodgkin’s lymphoma and lymphocytic leukemia: a retrospective study in 700 
190 
 
 
 
patients. European Journal of Haematology 67, 158–164. 
https://doi.org/10.1034/j.1600-0609.2001.5790493.x 
Davis, E., 2019. What is a health care contract? Health values 4, 82–86, 89. 
Davis, S.E., Lasko, T.A., Chen, G., Siew, E.D., Matheny, M.E., 2017. Calibration drift in 
regression and machine learning models for acute kidney injury. J Am Med 
Inform Assoc 24, 1052–1061. https://doi.org/10.1093/jamia/ocx030 
Dawlilng, S., Lynn, K., Rosser, R., Braithwaite, R., 1981. The pharmacokinetics of 
nortriptyline in patients with chronic renal failure. Br J Clin Pharmacol 12, 39–45. 
De Leeuw, J., 2005. Multivariate analysis with optimal scaling. 
De Soete, G., Carroll, J.D., 1994. K-means clustering in a low-dimensional Euclidean 
space, in: New Approaches in Classification and Data Analysis. Springer, pp. 
212–219. 
Delamarre, D., Bouzille, G., Dalleau, K., Courtel, D., Cuggia, M., 2015. Semantic 
integration of medication data into the EHOP Clinical Data Warehouse. Studies in 
health technology and informatics 210, 702–6. 
Demiralp, Ç., 2017. Clustrophile: A tool for visual clustering analysis. arXiv preprint 
arXiv:1710.02173. 
Dev, V., Dixon, S.N., Fleet, J.L., Gandhi, S., Gomes, T., Harel, Z., Jain, A.K., Shariff, 
S.Z., Tawadrous, D., Weir, M.A., Garg, A.X., 2014. Higher anti-depressant dose 
and major adverse outcomes in moderate chronic kidney disease: a retrospective 
population-based study. BMC Nephrol 15, 79. https://doi.org/10.1186/1471-2369-
15-79 
Dey, S., Luo, H., Fokoue, A., Hu, J., Zhang, P., 2018. Predicting adverse drug reactions 
through interpretable deep learning framework. BMC Bioinformatics 19, 476. 
https://doi.org/10.1186/s12859-018-2544-0 
Dietterich, T.G., 2000. Ensemble Methods in Machine Learning, in: Multiple Classifier 
Systems, Lecture Notes in Computer Science. Springer, Berlin, Heidelberg, pp. 1–
15. https://doi.org/10.1007/3-540-45014-9_1 
Dilts, D., Khamalah, J., Plotkin, A., 1995. Using cluster analysis for medical resource 
decision making. Medical Decision Making 15, 333–346. 
Ding, H., Wang, C., Huang, K., Machiraju, R., 2014. iGPSe: a visual analytic system for 
integrative genomic based cancer patient stratification. BMC Bioinformatics 15, 
203. https://doi.org/10.1186/1471-2105-15-203 
191 
 
 
 
Dixit, M., Doan, T., Kirschner, R., Dixit, N., 2010. Significant Acute Kidney Injury Due 
to Non-steroidal Anti-inflammatory Drugs: Inpatient Setting. Pharmaceuticals 
(Basel) 3, 1279–1285. https://doi.org/10.3390/ph3041279 
Doupi, P., 2012. Using EHR data for monitoring and promoting patient safety: reviewing 
the evidence on trigger tools. Stud Health Technol Inform 180, 786–790. 
Doust, D., Walsh, Z., 2011. Mediterranean Conference on Information Systems ( MCIS ) 
2011 DATA MINING CLUSTERING : A HEALTHCARE APPLICATION. 
Duke, J.D., Li, X., Grannis, S.J., 2010. Data visualization speeds review of potential 
adverse drug events in patients on multiple medications. Journal of Biomedical 
Informatics 43, 326–331. https://doi.org/10.1016/j.jbi.2009.12.001 
Dupont, A.G., 1992. Carvedilol and the kidney. The clinical investigator 70, S127–S131. 
Dylewska, M., Chomicka, I., Małyszko, J., 2019. Hypertension in patients with acute 
kidney injury. Wiad. Lek. 72, 2199–2201. 
EHRIntelligence, 2018. 40% of Physicians See More EHR Challenges than Benefits 
[WWW Document]. EHRIntelligence. URL https://ehrintelligence.com/news/40-
of-physicians-see-more-ehr-challenges-than-benefits (accessed 5.14.20). 
Erbayraktar, Z., Evlice, A., Yener, G., Ulusu, N.N., 2017. Effects of donepezil on liver 
and kidney functions for the treatment of Alzheimer’s disease. Journal of 
integrative neuroscience 16, 335–346. 
Eriksen, B.O., Hoff, K.R.S., Solberg, S., 2003. Prediction of acute renal failure after 
cardiac surgery: retrospective cross-validation of a clinical algorithm. Nephrol. 
Dial. Transplant. 18, 77–81. https://doi.org/10.1093/ndt/18.1.77 
Escofier, B., Pagès, J., 1994. Multiple factor analysis (AFMULT package). 
Computational Statistics & Data Analysis 18, 121–140. 
https://doi.org/10.1016/0167-9473(94)90135-X 
Ester, M., Kriegel, H.-P., Sander, J., Xu, X., 1996. A density-based algorithm for 
discovering clusters in large spatial databases with noise., in: Kdd. pp. 226–231. 
Estiri, H., Klann, J.G., Murphy, S.N., 2019. A clustering approach for detecting 
implausible observation values in electronic health records data. BMC Medical 
Informatics and Decision Making 19, 142. https://doi.org/10.1186/s12911-019-
0852-6 
Evans, R.D.R., Hemmilä, U., Craik, A., Mtekateka, M., Hamilton, F., Kawale, Z., 
Kirwan, C.J., Dobbie, H., Dreyer, G., 2017. Incidence, aetiology and outcome of 
192 
 
 
 
community-acquired acute kidney injury in medical admissions in Malawi. BMC 
Nephrology 18, 21. https://doi.org/10.1186/s12882-017-0446-4 
Fails, J.A., Karlson, A., Shahamat, L., Shneiderman, B., 2006. A visual interface for 
multivariate temporal data: Finding patterns of events across multiple histories, 
in: 2006 IEEE Symposium On Visual Analytics Science And Technology. IEEE, 
pp. 167–174. 
Faiola, A., Newlon, C., 2011. Advancing critical care in the ICU: a human-centered 
biomedical data visualization systems, in: International Conference on 
Ergonomics and Health Aspects of Work with Computers. Springer, pp. 119–128. 
Faisal, S., Blandford, A., Potts, H.W., 2013. Making sense of personal health 
information: Challenges for information visualization. Health Informatics Journal 
19, 198–217. https://doi.org/10.1177/1460458212465213 
Feldman, R., Sanger, J., 2007. The Text Mining Handbook: Advanced Approaches in 
Analyzing Unstructured Data. Cambridge University Press. 
Feng, C., Le, D., McCoy, A.B., 2019. Using Electronic Health Records to Identify 
Adverse Drug Events in Ambulatory Care: A Systematic Review. Appl Clin 
Inform 10, 123–128. https://doi.org/10.1055/s-0039-1677738 
Fleet, J.L., Weir, M.A., McArthur, E., Ozair, S., Devereaux, P.J., Roberts, M.A., Jain, 
A.K., Garg, A.X., 2014. Kidney function and population-based outcomes of 
initiating oral atenolol versus metoprolol tartrate in older adults. American journal 
of kidney diseases 64, 883–891. 
Foguet-Boreu, Q., Violán, C., Rodriguez-Blanco, T., Roso-Llorach, A., Pons-Vigués, M., 
Pujol-Ribera, E., Cossio Gil, Y., Valderas, J.M., 2015. Multimorbidity Patterns in 
Elderly Primary Health Care Patients in a South Mediterranean European Region: 
A Cluster Analysis. PLoS One 10. https://doi.org/10.1371/journal.pone.0141155 
Folorunso, O., Shawn Ogunseye, O., 2008. Challenges in the adoption of visualization 
system: a survey. Kybernetes 37, 1530–1541. 
https://doi.org/10.1108/03684920810907841 
Fournier, J.-P., Lapeyre-Mestre, M., Sommet, A., Dupouy, J., Poutrain, J.-C., Montastruc, 
J.-L., 2012. Laboratory monitoring of patients treated with antihypertensive drugs 
and newly exposed to non steroidal anti-inflammatory drugs: a cohort study. PloS 
one 7, e34187. https://doi.org/10.1371/journal.pone.0034187 
Fournier, J.-P., Sommet, A., Durrieu, G., Poutrain, J.-C., Lapeyre-Mestre, M., 
Montastruc, J.-L., French Network of Regional Pharmacovigilance Centres, 2014. 
Drug interactions between antihypertensive drugs and non-steroidal anti-
193 
 
 
 
inflammatory agents: a descriptive study using the French Pharmacovigilance 
database. Fundamental & clinical pharmacology 28, 230–5. 
https://doi.org/10.1111/fcp.12014 
Fraley, C., Raftery, A.E., 2002. Model-Based Clustering, Discriminant Analysis, and 
Density Estimation. Journal of the American Statistical Association 97, 611–631. 
https://doi.org/10.1198/016214502760047131 
Freund, Y., Schapire, R.E., 1997. A Decision-Theoretic Generalization of On-Line 
Learning and an Application to Boosting. Journal of Computer and System 
Sciences 55, 119–139. https://doi.org/10.1006/jcss.1997.1504 
F.R.S, K.P., 1901. LIII. On lines and planes of closest fit to systems of points in space. 
The London, Edinburgh, and Dublin Philosophical Magazine and Journal of 
Science 2, 559–572. https://doi.org/10.1080/14786440109462720 
Fujiwara, T., Chou, J.-K., Shilpika, Xu, P., Ren, L., Ma, K.-L., 2020. An Incremental 
Dimensionality Reduction Method for Visualizing Streaming Multidimensional 
Data. IEEE Trans. Visual. Comput. Graphics 26, 418–428. 
https://doi.org/10.1109/TVCG.2019.2934433 
Fusco, S., Garasto, S., Corsonello, A., Vena, S., Mari, V., Gareri, P., Ruotolo, G., 
Luciani, F., Roncone, A., Maggio, M., Lattanzio, F., 2016. Medication-Induced 
Nephrotoxicity in Older Patients. Current Drug Metabolism 17, 608–625. 
https://doi.org/10.2174/1389200217666160406115959 
Galar, M., Fernandez, A., Barrenechea, E., Bustince, H., Herrera, F., 2012. A Review on 
Ensembles for the Class Imbalance Problem: Bagging-, Boosting-, and Hybrid-
Based Approaches. IEEE Trans. Syst., Man, Cybern. C 42, 463–484. 
https://doi.org/10.1109/TSMCC.2011.2161285 
Gameiro, J., Branco, T., Lopes, J.A., 2020. Artificial Intelligence in Acute Kidney Injury 
Risk Prediction. J Clin Med 9. https://doi.org/10.3390/jcm9030678 
Gandhi, T.K., Burstin, H.R., Cook, E.F., Puopolo, A.L., Haas, J.S., Brennan, T.A., Bates, 
D.W., 2000. Drug complications in outpatients. Journal of General Internal 
Medicine 15, 149–154. https://doi.org/10.1046/j.1525-1497.2000.04199.x 
Georgaki-Angelaki, E., Stergiou, N., Naoum, E., Papassotiriou, I., Anagnostakou, M., 
2009. Olmesartan medoxomil-induced acute renal failure in a premature newborn 
following maternal exposure during pregnancy: a case report and review of the 
literature. NDT plus 2, 295–297. 
Gifi, A., 1990. Nonlinear multivariate analysis. Wiley. 
194 
 
 
 
Gildon, B., Condren, M., Hughes, C., 2019. Impact of Electronic Health Record Systems 
on Prescribing Errors in Pediatric Clinics. Healthcare 7, 57. 
https://doi.org/10.3390/healthcare7020057 
Gilhooly, K.J., 2004. Working Memory and Reasoning., in: The Nature of Reasoning. 
Cambridge University Press, Gilhooly, Kenneth J.: Psychology Group, Human 
Sciences Dept., Brunei University, West London, Uxbridge, United Kingdom, 
UBS 3PH, ken.gilhooly@brunel.ac.uk, pp. 49–77. 
Girman, C.J., Kou, T.D., Brodovicz, K., Alexander, C.M., O’Neill, E.A., Engel, S., 
Williams-Herman, D.E., Katz, L., 2012. Risk of acute renal failure in patients 
with Type 2 diabetes mellitus. Diabet. Med. 29, 614–621. 
https://doi.org/10.1111/j.1464-5491.2011.03498.x 
Glasziou, P., Irwig, L., Mant, D., 2005. Monitoring in chronic disease: a rational 
approach. BMJ 330, 644–648. https://doi.org/10.1136/bmj.330.7492.644 
Go, A.S., Parikh, C.R., Ikizler, T.A., Coca, S., Siew, E.D., Chinchilli, V.M., Hsu, C.-Y., 
Garg, A.X., Zappitelli, M., Liu, K.D., Reeves, W.B., Ghahramani, N., Devarajan, 
P., Faulkner, G.B., Tan, T.C., Kimmel, P.L., Eggers, P., Stokes, J.B., Assessment 
Serial Evaluation, and Subsequent Sequelae of Acute Kidney Injury Study 
Investigators, 2010. The assessment, serial evaluation, and subsequent sequelae of 
acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol 11, 
22. https://doi.org/10.1186/1471-2369-11-22 
Godin, Mélanie, Godin, M., Bouchard, J., Mehta, R.L., 2013. Fluid Balance in Patients 
with Acute Kidney Injury: Emerging Concepts. NEC 123, 238–245. 
https://doi.org/10.1159/000354713 
Gois, P.H.F., Canale, D., Volpini, R.A., Ferreira, D., Veras, M.M., Andrade-Oliveira, V., 
Câmara, N.O.S., Shimizu, M.H.M., Seguro, A.C., 2016. Allopurinol attenuates 
rhabdomyolysis-associated acute kidney injury: Renal and muscular protection. 
Free Radical Biology and Medicine 101, 176–189. 
https://doi.org/10.1016/j.freeradbiomed.2016.10.012 
Gottlieb, S.S., Abraham, W., Butler, J., Forman, D.E., Loh, E., Massie, B.M., O’connor, 
C.M., Rich, M.W., Stevenson, L.W., Young, J., Krumholz, H.M., 2002. The 
prognostic importance of different definitions of worsening renal function in 
congestive heart failure. Journal of cardiac failure 8, 136–41. 
Gotz, D.H., Sun, J., Cao, N., 2012. Multifaceted visual analytics for healthcare 
applications. IBM Journal of Research and Development 56, 6:1-6:12. 
https://doi.org/10.1147/jrd.2012.2199170 
195 
 
 
 
Graber, M.L., Byrne, C., Johnston, D., 2017. The impact of electronic health records on 
diagnosis. Diagnosis (Berl) 4, 211–223. https://doi.org/10.1515/dx-2017-0012 
Green, T.M., Maciejewski, R., 2013. A role for reasoning in visual analytics, in: 
Proceedings of the Annual Hawaii International Conference on System Sciences. 
pp. 1495–1504. https://doi.org/10.1109/HICSS.2013.58 
Greenacre, M., Blasius, J., 2006. Multiple correspondence analysis and related methods. 
CRC press. 
Gresh, D.L., Rabenhorst, D.A., Shabo, A., Slavin, S., 2002. Prima: A case study of using 
information visualization techniques for patient record analysis, in: IEEE 
Visualization, 2002. VIS 2002. IEEE, pp. 509–512. 
Groves, M., O’rourke, P., Alexander, H., 2003. Clinical reasoning: the relative 
contribution of identification, interpretation and hypothesis errors to misdiagnosis. 
Medical Teacher 25, 621–625. https://doi.org/10.1080/01421590310001605688 
Gruchalla, R.S., 2000. Clinical assessment of drug-induced disease. Lancet 356, 1505–
1511. https://doi.org/10.1016/S0140-6736(00)02885-3 
Guerra Gómez, J., Wongsuphasawat, K., Wang, T.D., Pack, M., Plaisant, C., 2011. 
Analyzing incident management event sequences with interactive visualization, 
in: Transportation Research Board 90th Annual Meeting Compendium of Papers. 
Gupta, A., Puri, V., Sharma, R., Puri, S., 2012. Folic acid induces acute renal failure 
(ARF) by enhancing renal prooxidant state. Experimental and toxicologic 
pathology 64, 225–232. 
Halford, G.S., Baker, R., McCredden, J.E., Bain, J.D., 2005. How many variables can 
humans process? Psychological Science 16, 70–76. 
https://doi.org/10.1111/j.0956-7976.2005.00782.x 
Halpern, Y., Horng, S., Nathanson, L.A., Shapiro, N.I., Sontag, D., 2012. A comparison 
of dimensionality reduction techniques for unstructured clinical text, in: Icml 
2012 Workshop on Clinical Data Analysis. 
Han, J., Kamber, M., 2011. Data Mining: Concepts and Techniques. 
Han, J., Kamber, M., Pei, J., 2011. Data Mining. Concepts and Techniques, 3rd Edition 
(The Morgan Kaufmann Series in Data Management Systems). 
Hannan, T.J., 1999. Detecting adverse drug reactions to improve patient outcomes, in: 
International Journal of Medical Informatics. Elsevier Science Ireland Ltd, pp. 
61–64. https://doi.org/10.1016/S1386-5056(99)00020-9 
196 
 
 
 
Haraty, R.A., Dimishkieh, M., Masud, M., 2015. An Enhanced k-Means Clustering 
Algorithm for Pattern Discovery in Healthcare Data. International Journal of 
Distributed Sensor Networks 11, 615740. https://doi.org/10.1155/2015/615740 
Hartigan, J.A., Wong, M.A., 1979. Algorithm AS 136: A K-Means Clustering Algorithm. 
Journal of the Royal Statistical Society. Series C (Applied Statistics) 28, 100–108. 
https://doi.org/10.2307/2346830 
Hauskrecht, M., Batal, I., Valko, M., Visweswaran, S., Cooper, G.F., Clermont, G., 2013. 
Outlier detection for patient monitoring and alerting. Journal of Biomedical 
Informatics 46, 47–55. https://doi.org/10.1016/j.jbi.2012.08.004 
Heer, J., Kandel, S., 2012. Interactive analysis of big data. XRDS: Crossroads, The ACM 
Magazine for Students 19, 50. https://doi.org/10.1145/2331042.2331058 
Heer, J., Perer, A., 2014. Orion: a system for modeling, transformation and visualization 
of multidimensional heterogeneous networks. Information Visualization 13, 111–
133. https://doi.org/10.1177/1473871612462152 
Hege, H.C., Hotz, I., Muntzner, T., 2009. iPCA: An Interactive System for PCA-based 
Visual Analytics. 
Heisey-Grove, D., Danehy, L.N., Consolazio, M., Lynch, K., Mostashari, F., 2014. A 
national study of challenges to electronic health record adoption and meaningful 
use. Medical Care 52, 144–148. https://doi.org/10.1097/MLR.0000000000000038 
Heuer, R.J., 1999. Psychology of intelligence analysis. Center for the Study of 
Intelligence, Central Intelligence Agency. 
Himmelstein, D.U., Wright, A., Woolhandler, S., 2010. Hospital computing and the costs 
and quality of care: A national study. The American Journal of Medicine 123, 40–
46. https://doi.org/10.1016/j.amjmed.2009.09.004 
Hinum, K., Miksch, S., Aigner, W., Ohmann, S., Popow, C., Pohl, M., Rester, M., 2005. 
Gravi++: Interactive Information Visualization to Explore Highly Structured 
Temporal Data. J. UCS 11, 1792–1805. https://doi.org/10.3217/jucs-011-11-1792 
Hirschfeld, H.O., 1935. A Connection between Correlation and Contingency. 
Mathematical Proceedings of the Cambridge Philosophical Society 31, 520–524. 
https://doi.org/10.1017/S0305004100013517 
Ho, Kwok M., Power, B.M., 2010. Benefits and risks of furosemide in acute kidney 
injury. Anaesthesia. https://doi.org/10.1111/j.1365-2044.2009.06228.x 
Ho, K. M., Power, B.M., 2010. Benefits and risks of furosemide in acute kidney injury. 
Anaesthesia 65, 283–293. https://doi.org/10.1111/j.1365-2044.2009.06228.x 
197 
 
 
 
Honigman, B., Light, P., Pulling, R.M., Bates, D.W., 2001. A computerized method for 
identifying incidents associated with adverse drug events in outpatients. 
International Journal of Medical Informatics 61, 21–32. 
https://doi.org/10.1016/S1386-5056(00)00131-3 
Horn, W., Popow, C., Unterasinger, L., 2001. Support for fast comprehension of ICU 
data: Visualization using metaphor graphics. Methods of information in medicine 
40, 421–424. 
Hotelling, H., 1933. Analysis of a complex of statistical variables into principal 
components. Journal of Educational Psychology 24, 417–441. 
https://doi.org/10.1037/h0071325 
Hsu, R.K., Hsu, C., 2016. THE ROLE OF ACUTE KIDNEY INJURY IN CHRONIC 
KIDNEY DISEASE. Semin Nephrol 36, 283–292. 
https://doi.org/10.1016/j.semnephrol.2016.05.005 
Huang, C.W., Syed-Abdul, S., Jian, W.S., Iqbal, U., Nguyen, P.A., Lee, P., Lin, S.H., 
Hsu, W.D., Wu, M.S., Wang, C.F., Ma, K.L., Li, Y.C., 2015. A novel tool for 
visualizing chronic kidney disease associated polymorbidity: A 13-year cohort 
study in Taiwan. Journal of the American Medical Informatics Association 22, 
290–298. https://doi.org/10.1093/jamia/ocu044 
Hwang, Y.J., Dixon, S.N., Reiss, J.P., Wald, R., Parikh, C.R., Gandhi, S., Shariff, S.Z., 
Pannu, N., Nash, D.M., Rehman, F., 2014. Atypical antipsychotic drugs and the 
risk for acute kidney injury and other adverse outcomes in older adults: a 
population-based cohort study. Annals of internal medicine 161, 242–248. 
Ibrahim, N.E., McCarthy, C.P., Shrestha, S., Gaggin, H.K., Mukai, R., Magaret, C.A., 
Rhyne, R.F., Januzzi, J.L., 2019. A clinical, proteomics, and artificial 
intelligence-driven model to predict acute kidney injury in patients undergoing 
coronary angiography. Clin Cardiol 42, 292–298. 
https://doi.org/10.1002/clc.23143 
Ismail, B., Anil, M., 2014. Regression methods for analyzing the risk factors for a life 
style disease among the young population of India. Indian Heart J 66, 587–592. 
https://doi.org/10.1016/j.ihj.2014.05.027 
Jacob, K.A., Leaf, D.E., Dieleman, J.M., Dijk, D. van, Nierich, A.P., Rosseel, P.M., 
Maaten, J.M. van der, Hofland, J., Diephuis, J.C., Lange, F. de, Boer, C., Kluin, 
J., Waikar, S.S., 2015. Intraoperative High-Dose Dexamethasone and Severe AKI 
after Cardiac Surgery. JASN 26, 2947–2951. 
https://doi.org/10.1681/ASN.2014080840 
198 
 
 
 
Jain, A.K., 2010. Data clustering: 50 years beyond K-means. Pattern Recognition Letters, 
Award winning papers from the 19th International Conference on Pattern 
Recognition (ICPR) 31, 651–666. https://doi.org/10.1016/j.patrec.2009.09.011 
Japkowicz, N., Shah, M., 2011. Evaluating Learning Algorithms: A Classification 
Perspective. Cambridge University Press. 
Jeong, D.H., Ji, S.Y., Suma, E.A., Yu, B., Chang, R., 2015. Designing a collaborative 
visual analytics system to support users’ continuous analytical processes. Human-
centric Computing and Information Sciences 5. https://doi.org/10.1186/s13673-
015-0023-4 
Jha, P.K., Vankalakunti, M., Siddini, V., Bonu, R., Prakash, G.K., Babu, K., Ballal, H.S., 
2013. Sunitinib induced nephrotic syndrome and thrombotic microangiopathy. 
Indian journal of nephrology 23, 67. 
Jiang, Y., McCombs, J.S., Park, S.H., 2017. A Retrospective Cohort Study of Acute 
Kidney Injury Risk Associated with Antipsychotics. CNS Drugs 31, 319–326. 
https://doi.org/10.1007/s40263-017-0421-4 
Juncos, L.A., Juncos, L.I., 2016. Mineralocorticoid receptor antagonism in AKI: a new 
hope? Am Soc Nephrol. 
Kamal, N., 2014. Big Data and Visual Analytics in Health and Medicine: From Pipe 
Dream to Reality. Journal of Health & Medical Informatics 05. 
https://doi.org/10.4172/2157-7420.1000e125 
Kameshwaran, K., Malarvizhi, K., 2014. Survey on Clustering Techniques in Data 
Mining 5, 5. 
Kandasamy, K., Chuah, J.K.C., Su, R., Huang, P., Eng, K.G., Xiong, S., Li, Y., Chia, 
C.S., Loo, L.-H., Zink, D., 2015. Prediction of drug-induced nephrotoxicity and 
injury mechanisms with human induced pluripotent stem cell-derived cells and 
machine learning methods. Sci Rep 5. https://doi.org/10.1038/srep12337 
Kandler, K., Jensen, M.E., Nilsson, J.C., Møller, C.H., Steinbrüchel, D.A., 2014. Acute 
kidney injury is independently associated with higher mortality after cardiac 
surgery. Journal of Cardiothoracic and Vascular Anesthesia 28, 1448–1452. 
https://doi.org/10.1053/j.jvca.2014.04.019 
Kane-Gill, S.L., Sileanu, F.E., Murugan, R., Trietley, G.S., Handler, S.M., Kellum, J.A., 
2015. Risk factors for acute kidney injury in older adults with critical illness: a 
retrospective cohort study. Am. J. Kidney Dis. 65, 860–869. 
https://doi.org/10.1053/j.ajkd.2014.10.018 
199 
 
 
 
Kankanhalli, A., Hahn, J., Tan, S., Gao, G., 2016. Big data and analytics in healthcare: 
Introduction to the special section. Inf Syst Front 18, 233–235. 
https://doi.org/10.1007/s10796-016-9641-2 
Karajala, V., Mansour, W., Kellum, J.A., 2009. Diuretics in acute kidney injury. Minerva 
Anestesiol 75, 251–257. 
Kate, R.J., Perez, R.M., Mazumdar, D., Pasupathy, K.S., Nilakantan, V., 2016. Prediction 
and detection models for acute kidney injury in hospitalized older adults. BMC 
Med Inform Decis Mak 16. https://doi.org/10.1186/s12911-016-0277-4 
Kaufman, J., Dhakal, M., Patel, B., Hamburger, R., 1991. Community-Acquired Acute 
Renal Failure. American Journal of Kidney Diseases 17, 191–198. 
https://doi.org/10.1016/S0272-6386(12)81128-0 
Kehrer, J., Hauser, H., 2013. Visualization and visual analysis of multifaceted scientific 
data: A survey. IEEE Transactions on Visualization and Computer Graphics. 
https://doi.org/10.1109/TVCG.2012.110 
Keim, D., Kohlhammer, J., Ellis, G., Mansmann, F., 2010a. Mastering the Information 
Age Solving Problems with Visual Analytics. Eurographics Association. 
http://diglib.eg.org/handle/10.2312/14803 
Keim, D., Mansmann, F., Schneidewind, J., Thomas, J., Ziegler, H., 2008. Visual 
analytics: Scope and challenges, in: Lecture Notes in Computer Science 
(Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in 
Bioinformatics). pp. 76–90. https://doi.org/10.1007/978-3-540-71080-6_6 
Keim, D., Mansmann, F., Thomas, J., 2010b. Visual Analytics : How Much Visualization 
and How Much Analytics ? ACM SIGKDD Explorations Newsletter 11, 5–8. 
https://doi.org/10.1145/1809400.1809403 
Khalid, S., Judge, A., Pinedo-Villanueva, R., 2018. An Unsupervised Learning Model for 
Pattern Recognition in Routinely Collected Healthcare Data:, in: Proceedings of 
the 11th International Joint Conference on Biomedical Engineering Systems and 
Technologies. Presented at the 11th International Conference on Health 
Informatics, SCITEPRESS - Science and Technology Publications, Funchal, 
Madeira, Portugal, pp. 266–273. https://doi.org/10.5220/0006535602660273 
Khan, S., Loi, V., Rosner, M.H., 2017. Drug-Induced Kidney Injury in the Elderly. Drugs 
and Aging. https://doi.org/10.1007/s40266-017-0484-4 
Kho, A., Rotz, D., Alrahi, K., Cárdenas, W., Ramsey, K., Liebovitz, D., Noskin, G., 
Watts, C., 2007. Utility of commonly captured data from an EHR to identify 
200 
 
 
 
hospitalized patients at risk for clinical deterioration. AMIA Annu Symp Proc 
2007, 404–408. 
Klimov, D., Shahar, Y., Taieb-Maimon, M., 2010. Intelligent visualization and 
exploration of time-oriented data of multiple patients. Artificial Intelligence in 
Medicine 49, 11–31. https://doi.org/10.1016/j.artmed.2010.02.001 
Klimov, D., Shknevsky, A., Shahar, Y., 2015. Exploration of patterns predicting renal 
damage in patients with diabetes type II using a visual temporal analysis 
laboratory. Journal of the American Medical Informatics Association 22, 275–
289. https://doi.org/10.1136/amiajnl-2014-002927 
Koh, H.C., Tan, G., 2005. Data mining applications in healthcare. Journal of healthcare 
information management : JHIM 19, 64–72. 
https://doi.org/10.4314/ijonas.v5i1.49926 
Kohli, H.S., Bhaskaran, M.C., Muthukumar, T., Thennarasu, K., Sud, K., Jha, V., Gupta, 
K.L., Sakhuja, V., 2000. Treatment-related acute renal failure in the elderly: a 
hospital-based prospective study. Nephrology, dialysis, transplantation : official 
publication of the European Dialysis and Transplant Association - European 
Renal Association 15, 212–7. https://doi.org/10.1093/ndt/15.2.212 
Kolhe, N. V, Muirhead, A.W., Wilkes, S.R., Fluck, R.J., Taal, M.W., 2016. The 
epidemiology of hospitalised acute kidney injury not requiring dialysis in England 
from 1998 to 2013: retrospective analysis of hospital episode statistics. 
International journal of clinical practice 70, 330–9. 
https://doi.org/10.1111/ijcp.12774 
Komaroff, A.L., 1979. The variability and inaccuracy of medical data. Proceedings of the 
IEEE 67, 1196–1207. https://doi.org/10.1109/PROC.1979.11435 
Kosara, R., 2010. Turning a table into a tree: Growing parallel sets into a purposeful 
project. Beautiful Visualization: Looking at Data through the Eyes of Experts, 
Steele J., Iliinsky N.,(Eds.). O’Reilly 193–204. 
Kosara, R., Miksch, S., 2002. Visualization methods for data analysis and planning in 
medical applications, in: International Journal of Medical Informatics. pp. 141–
153. https://doi.org/10.1016/S1386-5056(02)00072-2 
Kruskal, J.B., 1964. Nonmetric multidimensional scaling: A numerical method. 
Psychometrika 29, 115–129. https://doi.org/10.1007/BF02289694 
Kumar, M., Stoll, N., Kaber, D., Thurow, K., Stoll, R., 2007. Fuzzy filtering for an 
intelligent interpretation of medical data, in: 2007 IEEE International Conference 
on Automation Science and Engineering. Presented at the 2007 IEEE 
201 
 
 
 
International Conference on Automation Science and Engineering, pp. 225–230. 
https://doi.org/10.1109/COASE.2007.4341714 
Kumar, S., Allen, D.A., Kieswich, J.E., Patel, N.S.A., Harwood, S., Mazzon, E., 
Cuzzocrea, S., Raftery, M.J., Thiemermann, C., Yaqoob, M.M., 2009. 
Dexamethasone Ameliorates Renal Ischemia-Reperfusion Injury. JASN 20, 
2412–2425. https://doi.org/10.1681/ASN.2008080868 
Kusiak, A., 2001. Feature transformation methods in data mining. IEEE Transactions on 
Electronics Packaging Manufacturing 24, 214–221. 
https://doi.org/10.1109/6104.956807 
Låg, T., Bauger, L., Lindberg, M., Friborg, O., 2014. The role of numeracy and 
intelligence in health-risk estimation and medical data interpretation. Journal of 
Behavioral Decision Making 27, 95–108. https://doi.org/10.1002/bdm.1788 
Lau, F., Price, M., Boyd, J., Partridge, C., Bell, H., Raworth, R., 2012. Impact of 
electronic medical record on physician practice in office settings: a systematic 
review. BMC Medical Informatics and Decision Making 12, 10–10. 
https://doi.org/10.1186/1472-6947-12-10 
Lavado, R., Hayrapetyan, S., Kharazyan, S., 2018. Expansion of the Benifits Package: 
The Experience of Armenia, The World Bank Group. 
https://doi.org/10.1145/958491.958516 
Leaf, D.E., Swinkels, D.W., 2016. Catalytic iron and acute kidney injury. American 
Journal of Physiology-Renal Physiology 311, F871–F876. 
Lee, C.H., Yoon, H.J., 2017. Medical big data: Promise and challenges. Kidney Research 
and Clinical Practice 36, 3–11. https://doi.org/10.23876/j.krcp.2017.36.1.3 
Leighton, J.P., 2004. Defining and Describing Reason., in: The Nature of Reasoning. 
Cambridge University Press, Leighton, Jacqueline P.: Centre for Research in 
Applied Measurement and Evaluation (CRAME), Department of Educational 
Psychology, University of Alberta, 6-110 Education North, Edmonton, AB, 
Canada, T6G 2G5, Jacqueline.Leighton@ualberta.ca, pp. 3–11. 
Lesselroth, B.J., Pieczkiewicz, D.S., 2011. Data visualization strategies for the electronic 
health record. Nova Science Publishers, Inc. 
Levy, A.R., O’Brien, B.J., Sellors, C., Grootendorst, P., Willison, D., 2003. Coding 
accuracy of administrative drug claims in the Ontario Drug Benefit database. 
Canadian Journal of Clinical Pharmacology 10, 67–71. 
Lewis, D.D., 1998. Naive (Bayes) at forty: The independence assumption in information 
retrieval, in: Nédellec, C., Rouveirol, C. (Eds.), Machine Learning: ECML-98, 
202 
 
 
 
Lecture Notes in Computer Science. Springer, Berlin, Heidelberg, pp. 4–15. 
https://doi.org/10.1007/BFb0026666 
Lex, A., Streit, M., Partl, C., Kashofer, K., Schmalstieg, D., 2010. Comparative Analysis 
of Multidimensional, Quantitative Data. IEEE Trans Vis Comput Graph 16, 
1027–1035. https://doi.org/10.1109/TVCG.2010.138 
Li, X., Wang, Y., 2016. Adaptive online monitoring for ICU patients by combining just-
in-time learning and principal component analysis. J Clin Monit Comput 30, 807–
820. https://doi.org/10.1007/s10877-015-9778-4 
Liao, M., Li, Y., Kianifard, F., Obi, E., Arcona, S., 2016. Cluster analysis and its 
application to healthcare claims data: a study of end-stage renal disease patients 
who initiated hemodialysis. BMC Nephrol 17. https://doi.org/10.1186/s12882-
016-0238-2 
Lieske, J.C., Chawla, L., Kashani, K., Kellum, J.A., Koyner, J.L., Mehta, R.L., 2014. 
Biomarkers for acute kidney injury: where are we today? Where should we go? 
Clin. Chem. 60, 294–300. https://doi.org/10.1373/clinchem.2012.201988 
Lipson, E.J., Huff, C.A., Holanda, D.G., McDevitt, M.A., Fine, D.M., 2010. 
Lenalidomide-induced acute interstitial nephritis. The oncologist 15, 961. 
Liu, J., Sun, G., He, Y., Song, F., Chen, S., Guo, Z., Liu, B., Lei, L., He, L., Chen, J., 
2019. Early β-blockers administration might be associated with a reduced risk of 
contrast-induced acute kidney injury in patients with acute myocardial infarction. 
Journal of thoracic disease 11, 1589. 
Liu, K.D., Yang, J., Tan, T.C., Glidden, D. V, Zheng, S., Pravoverov, L., Hsu, C.-Y., Go, 
A.S., 2019. Risk Factors for Recurrent Acute Kidney Injury in a Large 
Population-Based Cohort. American journal of kidney diseases : the official 
journal of the National Kidney Foundation 73, 163–173. 
https://doi.org/10.1053/j.ajkd.2018.08.008 
Liu, S., Joseph, K.S., Bartholomew, S., Fahey, J., Lee, L., Allen, A.C., Kramer, M.S., 
Sauve, R., Young, D.C., Liston, R.M., Kirby, R., León, J.A., 2010. Temporal 
Trends and Regional Variations in Severe Maternal Morbidity in Canada, 2003 to 
2007. Journal of Obstetrics and Gynaecology Canada 32, 847–855. 
https://doi.org/10.1016/S1701-2163(16)34656-4 
Loboz, K.K., Shenfield, G.M., 2005. Drug combinations and impaired renal function - 
The “triple whammy.” British Journal of Clinical Pharmacology 59, 239–243. 
https://doi.org/10.1111/j.0306-5251.2004.2188.x 
203 
 
 
 
Lopau, K., Hefner, L., Bender, G., Heidbreder, E., Wanner, C., 2001. Haemodynamic 
effects of valsartan in acute renal ischaemia/reperfusion injury. Nephrology 
Dialysis Transplantation 16, 1592–1597. 
L’Yi, S., Ko, B., Shin, D., Cho, Y.-J., Lee, J., Kim, B., Seo, J., 2015. XCluSim: a visual 
analytics tool for interactively comparing multiple clustering results of 
bioinformatics data. BMC bioinformatics 16, S5. 
Lysenko, A., Sharma, A., Boroevich, K.A., Tsunoda, T., 2018. An integrative machine 
learning approach for prediction of toxicity-related drug safety. Life Science 
Alliance 1. https://doi.org/10.26508/lsa.201800098 
Maaten, L. van der, Hinton, G., 2008. Visualizing Data using t-SNE. Journal of Machine 
Learning Research 9, 2579–2605. 
Mackowski, A., Chen, H.-K., Levitt, M., 2015. Successful management of chronic high-
output ileostomy with high dose loperamide. BMJ Case Rep 2015. 
https://doi.org/10.1136/bcr-2015-209411 
Malbrain, M.L.N.G., Lambrecht, G.L.Y., Daelemans, R., Lins, R.L., Hermans, P., 
Zachee, P., 1994. Acute renal failure due to bilateral lymphomatous infiltrates - 
Primary extranodal non-Hodgkin’s lymphoma (p-EN-NHL) of the kidneys: Does 
it really exist? Clinical Nephrology 42, 163–169. 
Malik, S., Du, F., Monroe, M., Onukwugha, E., Plaisant, C., Shneiderman, B., 2015. 
Cohort comparison of event sequences with balanced integration of visual 
analytics and statistics, in: Proceedings of the 20th International Conference on 
Intelligent User Interfaces, IUI ’15. ACM, New York, NY, USA, pp. 38–49. 
https://doi.org/10.1145/2678025.2701407 
Malik, S., Du, F., Monroe, M., Onukwugha, E., Plaisant, C., Shneiderman, B., 2014. An 
evaluation of visual analytics approaches to comparing cohorts of event 
sequences, in: EHRVis Workshop on Visualizing Electronic Health Record Data 
at VIS. 
Mane, K.K., Bizon, C., Schmitt, C., Owen, P., Burchett, B., Pietrobon, R., Gersing, K., 
2012. VisualDecisionLinc: A visual analytics approach for comparative 
effectiveness-based clinical decision support in psychiatry. Journal of Biomedical 
Informatics 45, 101–106. https://doi.org/10.1016/j.jbi.2011.09.003 
Marlin, B.M., Kale, D.C., Khemani, R.G., Wetzel, R.C., 2012. Unsupervised pattern 
discovery in electronic health care data using probabilistic clustering models, in: 
Proceedings of the 2nd ACM SIGHIT Symposium on International Health 
Informatics - IHI ’12. Presented at the the 2nd ACM SIGHIT symposium, ACM 
Press, Miami, Florida, USA, p. 389. https://doi.org/10.1145/2110363.2110408 
204 
 
 
 
Martines, A.M.F., Masereeuw, R., Tjalsma, H., Hoenderop, J.G., Wetzels, J.F.M., 
Swinkels, D.W., 2013. Iron metabolism in the pathogenesis of iron-induced 
kidney injury. Nature Reviews Nephrology. 
https://doi.org/10.1038/nrneph.2013.98 
Matheny, M.E., Miller, R.A., Ikizler, T.A., Waitman, L.R., Denny, J.C., Schildcrout, J.S., 
Dittus, R.S., Peterson, J.F., 2010. Development of inpatient risk stratification 
models of acute kidney injury for use in electronic health records. Med Decis 
Making 30, 639–650. https://doi.org/10.1177/0272989X10364246 
McCallum, A., Nigam, K., 1998. A Comparison of Event Models for Naive Bayes Text 
Classification 8. 
McCoy, A.B., Waitman, L.R., Gadd, C.S., Danciu, I., Smith, J.P., Lewis, J.B., 
Schildcrout, J.S., Peterson, J.F., 2010. A computerized provider order entry 
intervention for medication safety during acute kidney injury: a quality 
improvement report. American journal of kidney diseases 56, 832–841. 
McLachlan, G.J., 1992. Cluster analysis and related techniques in medical research. 
Statistical Methods in Medical Research 1, 27–48. 
Mehrabadi, A., Liu, S., Bartholomew, S., Hutcheon, J.A., Magee, L.A., Kramer, M.S., 
Liston, R.M., Joseph, K.S., Canadian Perinatal Surveillance System Public Health 
Agency of Canada, 2014. Hypertensive disorders of pregnancy and the recent 
increase in obstetric acute renal failure in Canada: population based retrospective 
cohort study. BMJ (Clinical research ed.) 349, g4731. 
https://doi.org/10.1136/bmj.g4731 
Mehta, R.L., 2011. Management of Acute Kidney Injury: It’s the Squeaky Wheel That 
Gets the Oil! CJASN 6, 2102–2104. https://doi.org/10.2215/CJN.07720811 
Mehta, R.L., Pascual, M.T., Soroko, S., Savage, B.R., Himmelfarb, J., Ikizler, T.A., 
Paganini, E.P., Chertow, G.M., 2004. Spectrum of acute renal failure in the 
intensive care unit: The PICARD experience. Kidney International 66, 1613–
1621. https://doi.org/10.1111/j.1523-1755.2004.00927.x 
Miller, A., Price, G., 2009. Gabapentin toxicity in renal failure: the importance of dose 
adjustment. Pain medicine 10, 190–192. 
Mishima, E., Maruyama, K., Nakazawa, T., Abe, T., Ito, S., 2017. Acute kidney injury 
from excessive potentiation of calcium-channel blocker via synergistic CYP3A4 
inhibition by clarithromycin plus voriconazole. Internal Medicine 56, 1687–1690. 
205 
 
 
 
Mitsuhiro, M., Yadohisa, H., 2015. Reduced k-means clustering with MCA in a low-
dimensional space. Computational Statistics 30, 463–475. 
https://doi.org/10.1007/s00180-014-0544-8 
Mittelstädt, S., Hao, M.C., Dayal, U., Hsu, M.C., Terdiman, J., Keim, D.A., 2014. 
Advanced visual analytics interfaces for adverse drug event detection, in: 
Proceedings of the Workshop on Advanced Visual Interfaces AVI. Association 
for Computing Machinery, pp. 237–244. 
https://doi.org/10.1145/2598153.2598156 
Miyahara, T., 1978. Drug-induced renal disorders. Nippon rinsho. Japanese journal of 
clinical medicine Suppl, 2320–2321. https://doi.org/10.12861/jrip.2015.12 
Moffett, B.S., Goldstei, S.L., 2011. Acute kidney injury and increasing nephrotoxic-
medication exposure in noncritically-Ill children. Clinical Journal of the American 
Society of Nephrology 6, 856–863. https://doi.org/10.2215/CJN.08110910 
Mohamadlou, H., Lynn-Palevsky, A., Barton, C., Chettipally, U., Shieh, L., Calvert, J., 
Saber, N.R., Das, R., 2018. Prediction of Acute Kidney Injury With a Machine 
Learning Algorithm Using Electronic Health Record Data. Can J Kidney Health 
Dis 5. https://doi.org/10.1177/2054358118776326 
Monroe, M., Lan, R., Lee, H., Plaisant, C., Shneiderman, B., 2013. Temporal event 
sequence simplification. IEEE transactions on visualization and computer 
graphics 19, 2227–2236. 
Morgan, S.G., Hunt, J., Rioux, J., Proulx, J., Weymann, D., Tannenbaum, C., 2016. 
Frequency and cost of potentially inappropriate prescribing for older adults: a 
cross-sectional study. CMAJ Open 4, E346–E351. 
https://doi.org/10.9778/cmajo.20150131 
Mori, Y., Matsubara, H., Nose, A., Shibasaki, Y., Masaki, H., Kosaki, A., Okigaki, M., 
Fujiyama, S., Tanaka-Uchiyama, Y., Hasegawa, T., Iba, O., Tateishi, E., Amano, 
K., Iwasaka, T., 2001. Safety and availability of doxazosin in treating 
hypertensive patients with chronic renal failure. Hypertens. Res. 24, 359–363. 
https://doi.org/10.1291/hypres.24.359 
Muller, M., 2007. Participatory Design. pp. 1061–1081. 
https://doi.org/10.1201/9781410615862.ch54 
Munsaka, M.S., 2017. Leveraging Machine Learning in the Analysis of Safety Data in 
Drug Research and Healthcare Informatics. 
206 
 
 
 
Murdoch, T.B., Detsky, A.S., 2013. The inevitable application of big data to health care. 
JAMA - Journal of the American Medical Association. 
https://doi.org/10.1001/jama.2013.393 
Nadkarni, G.N., Patel, A.A., Ahuja, Y., Annapureddy, N., Agarwal, S.K., Simoes, P.K., 
Konstantinidis, I., Kamat, S., Archdeacon, M., Thakar, C. V, 2016. Incidence, 
Risk Factors, and Outcome Trends of Acute Kidney Injury in Elective Total Hip 
and Knee Arthroplasty. American journal of orthopedics (Belle Mead, N.J.) 45, 
E12–E19. 
Nam, E.J., Han, Y., Mueller, K., Zelenyuk, A., Imre, D., 2007. ClusterSculptor: A Visual 
Analytics Tool for High-Dimensional Data, in: 2007 IEEE Symposium on Visual 
Analytics Science and Technology. Presented at the 2007 IEEE Symposium on 
Visual Analytics Science and Technology, pp. 75–82. 
https://doi.org/10.1109/VAST.2007.4388999 
Nandikanti, D.K., Gosmanova, E.O., Gosmanov, A.R., 2016. Acute kidney injury 
associated with linagliptin. Case reports in endocrinology 2016. 
Nash, K., Hafeez, A., Hou, S., 2002. Hospital-acquired renal insufficiency. American 
Journal of Kidney Diseases 39, 930–936. https://doi.org/10.1053/ajkd.2002.32766 
Neugarten, J., Golestaneh, L., 2018. Female sex reduces the risk of hospital-associated 
acute kidney injury: a meta-analysis. BMC Nephrology 19, 314. 
https://doi.org/10.1186/s12882-018-1122-z 
Neyra, J.A., Rocha, N.A., Bhargava, R., Vaidya, O.U., Hendricks, A.R., Rodan, A.R., 
2015. Rhabdomyolysis-induced acute kidney injury in a cancer patient exposed to 
denosumab and abiraterone: a case report. BMC nephrology 16, 118. 
Ng, R.R.G., Tan, G.H.J., Liu, W., Ti, L.K., Chew, S.T.H., 2016. The Association of 
Acute Kidney Injury and Atrial Fibrillation after Cardiac Surgery in an Asian 
Prospective Cohort Study. Medicine (Baltimore) 95, e3005. 
https://doi.org/10.1097/MD.0000000000003005 
Nielsen, F., 2016. Hierarchical Clustering, in: Nielsen, F. (Ed.), Introduction to HPC with 
MPI for Data Science, Undergraduate Topics in Computer Science. Springer 
International Publishing, Cham, pp. 195–211. https://doi.org/10.1007/978-3-319-
21903-5_8 
Ninkov, A., Sedig, K., 2019. VINCENT: A visual analytics system for investigating the 
online vaccine debate. Online Journal of Public Health Informatics 11. 
https://doi.org/10.5210/ojphi.v11i2.10114 
207 
 
 
 
Niuniu, X., Yuxun, L., 2010. Review of decision trees. pp. 105–109. 
https://doi.org/10.1109/ICCSIT.2010.5564437 
Obaid, H.S., Dheyab, S.A., Sabry, S.S., 2019. The Impact of Data Pre-Processing 
Techniques and Dimensionality Reduction on the Accuracy of Machine Learning, 
in: 2019 9th Annual Information Technology, Electromechanical Engineering and 
Microelectronics Conference (IEMECON). IEEE, pp. 279–283. 
Ola, O., Sedig, K., 2018. Discourse with visual health data: design of human-data 
interaction. Multimodal Technologies and Interaction 2, 10. 
https://doi.org/10.3390/mti2010010 
Ola, O., Sedig, K., 2014. The Challenge of Big Data in Public Helth: An Opportunity for 
Visual Analytics. Online Journal of Public Health Informatics 5. 
https://doi.org/10.5210/ojphi.v5i3.4933 
Olsson, D., Sartipy, U., Braunschweig, F., Holzmann, M.J., 2013. Acute kidney injury 
following coronary artery bypass surgery and long-term risk of heart failure. Circ 
Heart Fail 6, 83–90. https://doi.org/10.1161/CIRCHEARTFAILURE.112.971705 
Ordonez, P., Oates, T., Lombardi, M.E., Hernandez, G., Holmes, K.W., Fackler, J., 
Lehmann, C.U., 2012. Visualization of multivariate time-series data in a neonatal 
ICU. IBM Journal of Research and Development 56, 7–1. 
Ozturk, S., Kayaalp, M., McDonald, C.J., 2014. Visualization of patient prescription 
history data in emergency care. AMIA ... Annual Symposium proceedings / 
AMIA Symposium. AMIA Symposium 2014, 963–968. 
Palevsky, P.M., Liu, K.D., Brophy, P.D., Chawla, L.S., Parikh, C.R., Thakar, C.V., 
Tolwani, A.J., Waikar, S.S., Weisbord, S.D., 2013. KDOQI US commentary on 
the 2012 KDIGO clinical practice guideline for acute kidney injury. Am. J. 
Kidney Dis. 61, 649–672. https://doi.org/10.1053/j.ajkd.2013.02.349 
Pannu, N., Nadim, M.K., 2008. An overview of drug-induced acute kidney injury. 
Critical care medicine 36, S216-23. 
https://doi.org/10.1097/CCM.0b013e318168e375 
Parsons, P., Sedig, K., 2014. Distribution of information processing while performing 
complex cognitive activities with visualization tools, in: Handbook of Human 
Centric Visualization. Springer New York, pp. 693–715. 
https://doi.org/10.1007/978-1-4614-7485-2_28 
Parsons, P., Sedig, K., Mercer, R.E., Khordad, M., Knoll, J., Rogan, P., 2015. Visual 
Analytics for supporting evidence-based interpretation of molecular cytogenomic 
findings, in: ACM International Conference Proceeding Series. Association for 
208 
 
 
 
Computing Machinery, New York, New York, USA, pp. 1–8. 
https://doi.org/10.1145/2836034.2836036 
Perazella, M.A., 2015. The Urine Sediment as a Biomarker of Kidney Disease. American 
Journal of Kidney Diseases 66, 748–755. 
https://doi.org/10.1053/j.ajkd.2015.02.342 
Perer, A., Sun, J., 2012. MatrixFlow: temporal network visual analytics to track symptom 
evolution during disease progression. AMIA Annu Symp Proc 2012, 716–725. 
Perer, A., Wang, F., Hu, J., 2015. Mining and exploring care pathways from electronic 
medical records with visual analytics. Journal of Biomedical Informatics 56, 369–
378. https://doi.org/10.1016/j.jbi.2015.06.020 
Peres, L.A.B., da Cunha, A.D., 2013. Acute nephrotoxicity of cisplatin: molecular 
mechanisms. Jornal brasileiro de nefrologia : ʹorgão oficial de Sociedades 
Brasileira e Latino-Americana de Nefrologia. https://doi.org/10.5935/0101-
2800.20130052 
Perez-Ruiz, F., 2017. Treatment with Allopurinol is Associated with Lower Risk of 
Acute Kidney Injury in Patients with Gout: A Retrospective Analysis of a Nested 
Cohort. Rheumatology and Therapy 4, 419–425. https://doi.org/10.1007/s40744-
017-0082-2 
Peskoe, S.T., McMillan, J.H., Lorch, A., Sussman, H., Ozawa, T., 1978. Reversible acute 
renal failure associated with chlorthalidone therapy: possible drug-induced 
interstitial nephritis. J Med Assoc Ga 67, 17–18. 
Pieczkiewicz, D.S., Finkelstein, S.M., Hertz, M.I., 2007. Design and evaluation of a web-
based interactive visualization system for lung transplant home monitoring data, 
in: AMIA Annual Symposium Proceedings. American Medical Informatics 
Association, p. 598. 
Pierson-Marchandise, M., Gras, V., Moragny, J., Micallef, J., Gaboriau, L., Picard, S., 
Choukroun, G., Masmoudi, K., Liabeuf, S., 2017. The drugs that mostly 
frequently induce acute kidney injury: a case − noncase study of a 
pharmacovigilance database. British Journal of Clinical Pharmacology 83, 1341–
1349. https://doi.org/10.1111/bcp.13216 
Pike, W.A., Stasko, J., Chang, R., O’Connell, T.A., 2009. The science of interaction. 
Information Visualization 8, 263–274. https://doi.org/10.1057/ivs.2009.22 
Plaisant, C., Mushlin, R., Snyder, A., Li, J., Heller, D., Shneiderman, B., 1998. LifeLines: 
using visualization to enhance navigation and analysis, in: Of Patient Records”, 
209 
 
 
 
Proceedings of the American Medical Informatic Association Annual Fall 
Symposium. 
Pohl, M., Wiltner, S., Rind, A., Aigner, W., Miksch, S., Turic, T., Drexler, F., 2011. 
Patient development at a glance: An evaluation of a medical data visualization, in: 
Campos, P., Graham, N., Jorge, J., Nunes, N., Palanque, P., Winckler, M. (Eds.), 
Human-Computer Interaction – INTERACT 2011. Springer Berlin Heidelberg, 
Berlin, Heidelberg, pp. 292–299. https://doi.org/10.1007/978-3-642-23768-3_24 
Porter, C.J., Juurlink, I., Bisset, L.H., Bavakunji, R., Mehta, R.L., Devonald, M.A.J., 
2014. A real-time electronic alert to improve detection of acute kidney injury in a 
large teaching hospital. Nephrology, dialysis, transplantation : official publication 
of the European Dialysis and Transplant Association - European Renal 
Association 29, 1888–1893. https://doi.org/10.1093/ndt/gfu082 
Pozzoli, S., Simonini, M., Manunta, P., 2018. Predicting acute kidney injury: current 
status and future challenges. J Nephrol 31, 209–223. 
https://doi.org/10.1007/s40620-017-0416-8 
Proctor, R., Vu, K., 2012. Human-Computer Interaction Fundamentals Human Factors 
and Ergonomics Handbook of Human Factors in Web Design Handbook of 
Standards and Guidelines in Ergonomics and Human Factors. 
Puri, N., Mohey, V., Singh, M., Kaur, T., Pathak, D., Buttar, H.S., Singh, A.P., 2016. 
Dipyridamole attenuates ischemia reperfusion induced acute kidney injury 
through adenosinergic A1 and A2A receptor agonism in rats. Naunyn-
Schmiedeberg’s archives of pharmacology 389, 361–368. 
Quinlan, J.R., 2014. C4.5: Programs for Machine Learning. Elsevier. 
Raghupathi, W., Raghupathi, V., 2014. Big data analytics in healthcare: promise and 
potential. Health Inf Sci Syst 2, 3. https://doi.org/10.1186/2047-2501-2-3 
Rammohan, M., Kalantar-Zadeh, K., Liang, A., Ghossein, C., 2005. Megestrol Acetate in 
a Moderate Dose for the Treatment of Malnutrition-Inflammation Complex in 
Maintenance Dialysis Patients. Journal of Renal Nutrition 15, 345–355. 
https://doi.org/10.1016/j.jrn.2004.10.006 
Rashidi, H.H., Sen, S., Palmieri, T.L., Blackmon, T., Wajda, J., Tran, N.K., 2020. Early 
Recognition of Burn- and Trauma-Related Acute Kidney Injury: A Pilot 
Comparison of Machine Learning Techniques. Sci Rep 10, 205. 
https://doi.org/10.1038/s41598-019-57083-6 
Rostamzadeh, N., Abdullah, S.S., Sedig, K., 2020. Data-Driven Activities Involving 
Electronic Health Records: An Activity and Task Analysis Framework for 
210 
 
 
 
Interactive Visualization Tools. Multimodal Technologies and Interaction 4, 7. 
https://doi.org/10.3390/mti4010007 
Rind, A., 2013. Interactive Information Visualization to Explore and Query Electronic 
Health Records. Foundations and Trends® in Human–Computer Interaction 5, 
207–298. https://doi.org/10.1561/1100000039 
Rind, Alexander, Aigner, W., Miksch, S., Wiltner, S., Pohl, M., Drexler, F., Neubauer, 
B., Suchy, N., 2011a. Visually exploring multivariate trends in patient cohorts 
using animated scatter plots, in: Robertson, M.M. (Ed.), Ergonomics and Health 
Aspects of Work with Computers, Lecture Notes in Computer Science. Springer 
Berlin Heidelberg, pp. 139–148. 
Rind, Alexander, Aigner, W., Miksch, S., Wiltner, S., Pohl, M., Turic, T., Drexler, F., 
2011b. Visual exploration of time-oriented patient data for chronic diseases: 
design study and evaluation. Information Quality in e- … 301–320. 
https://doi.org/10.1007/978-3-642-25364-5_22 
Rind, A., Wagner, M., Aigner, W., 2019. Towards a Structural Framework for Explicit 
Domain Knowledge in Visual Analytics. 2019 IEEE Workshop on Visual 
Analytics in Healthcare (VAHC) 33–40. 
https://doi.org/10.1109/VAHC47919.2019.8945032 
Rind, A., Wang, T.D., Aigner, W., Miksch, S., Wongsuphasawat, K., Plaisant, C., 
Shneiderman, B., 2013. Interactive Information Visualization to Explore and 
Query Electronic Health Records. Found. Trends Hum.-Comput. Interact. 5, 207–
298. https://doi.org/10.1561/1100000039 
Rind, A, Wang, T.D., Aigner, W, Miksch, S, Wongsuphasawat, K, Plaisant, C, 
Shneiderman, B, B., David Wang, T., Aigner, Wolfgang, Miksch, Silvia, 
Wongsuphasawat, Krist, Plaisant, Catherine, Shneiderman, Ben, 2011. Interactive 
Information Visualization to Explore and Query Electronic Health Records. 
Foundations and Trends R in Human-Computer Interaction 5, 207–298. 
https://doi.org/10.1561/1100000039 
Rinner, C., Grossmann, W., Sauter, S.K., Wolzt, M., Gall, W., 2015. Effects of Shared 
Electronic Health Record Systems on Drug-Drug Interaction and Duplication 
Warning Detection. BioMed Research International 2015. 
https://doi.org/10.1155/2015/380497 
Rivosecchi, Ryan M., Kellum, J.A., Dasta, J.F., Armahizer, M.J., Bolesta, S., Buckley, 
M.S., Dzierba, A.L., Frazee, E.N., Johnson, H.J., Kim, C., Murugan, R., 
Smithburger, P.L., Wong, A., Kane Gill, S.L., 2016. Drug Class Combination–
Associated Acute Kidney Injury. Annals of Pharmacotherapy. 
https://doi.org/10.1177/1060028016657839 
211 
 
 
 
Rivosecchi, Ryan M, Kellum, J.A., Dasta, J.F., Armahizer, M.J., Bolesta, S., Buckley, 
M.S., Dzierba, A.L., Frazee, E.N., Johnson, H.J., Kim, C., Murugan, R., 
Smithburger, P.L., Wong, A., Kane Gill, S.L., 2016. Drug Class Combination-
Associated Acute Kidney Injury. The Annals of pharmacotherapy 50, 953–972. 
https://doi.org/10.1177/1060028016657839 
Rocci, R., Gattone, S.A., Vichi, M., 2011. A new dimension reduction method: Factor 
discriminant k-means. Journal of classification 28, 210–226. 
Rokach, L., Maimon, O., 2005. Clustering Methods, in: Maimon, O., Rokach, L. (Eds.), 
Data Mining and Knowledge Discovery Handbook. Springer US, Boston, MA, 
pp. 321–352. https://doi.org/10.1007/0-387-25465-X_15 
Ronan, T., Qi, Z., Naegle, K.M., 2016. Avoiding common pitfalls when clustering 
biological data. Sci Signal 9, re6. https://doi.org/10.1126/scisignal.aad1932 
Rp, B., 2019. Metolazone and Furosemide Combination in Cardiorenal Syndrome: Short-
Term Safety and Efficacy Among Admitted Patients in a Tertiary Hospital. 
https://doi.org/10.19080/jojun.2018.06.555686 
RStudio | Open source & professional software for data science teams [WWW 
Document], n.d. URL https://rstudio.com/ (accessed 2.19.20). 
Ruan, T., Lei, L., Zhou, Y., Zhai, J., Zhang, L., He, P., Gao, J., 2019. Representation 
learning for clinical time series prediction tasks in electronic health records. BMC 
Medical Informatics and Decision Making 19, 259. 
https://doi.org/10.1186/s12911-019-0985-7 
Rydén, L., Sartipy, U., Evans, M., Holzmann, M.J., 2014. Acute kidney injury after 
coronary artery bypass grafting and long-term risk of end-stage renal disease. 
Circulation 130, 2005–2011. 
https://doi.org/10.1161/CIRCULATIONAHA.114.010622 
Saeed, M., Lieu, C., Raber, G., Mark, R.G., 2002. MIMIC II: a massive temporal ICU 
patient database to support research in intelligent patient monitoring, in: 
Computers in Cardiology. Presented at the Computers in Cardiology, pp. 641–
644. https://doi.org/10.1109/CIC.2002.1166854 
Saffer, J.D., Burnett, V.L., Chen, G., van der Spek, P., 2004. Visual analytics in the 
pharmaceutical industry. IEEE Computer Graphics and Applications 24, 10–15. 
https://doi.org/10.1109/MCG.2004.40 
Sahu, H., Shrma, S., Gondhalakar, S., 2008. A Brief Overview on Data Mining Survey. 
Ijctee 1, 114–121. 
212 
 
 
 
Sari, A., 2019. Nephrotoxic Effects of Drugs. Poisoning in the Modern World - New 
Tricks for an Old Dog? https://doi.org/10.5772/intechopen.83644 
Saruta, T., Kanno, Y., Hayashi, K., Suzuki, H., 1995. Renal effects of amlodipine. 
Journal of human hypertension 9, S11–6. 
SAS Enterprise BI Server [WWW Document], n.d. URL 
https://www.sas.com/en_ca/software/enterprise-bi-server.html (accessed 2.19.20). 
Schetz, M., Dasta, J., Goldstein, S., Golper, T., 2005. Drug-induced acute kidney injury. 
Current Opinion in Critical Care. 
https://doi.org/10.1097/01.ccx.0000184300.68383.95 
Schmider, J., Kumar, K., LaForest, C., Swankoski, B., Naim, K., Caubel, P.M., 2019. 
Innovation in Pharmacovigilance: Use of Artificial Intelligence in Adverse Event 
Case Processing. Clinical Pharmacology & Therapeutics 105, 954–961. 
https://doi.org/10.1002/cpt.1255 
Sears, A., Jacko, J.A., 2007. The human-computer interaction handbook: Fundamentals, 
evolving technologies and emerging applications, Second Edition. CRC Press. 
Sedig, K., Parsons, P., 2016. Design of Visualizations for Human-Information 
Interaction: A Pattern-Based Framework. Synthesis Lectures on Visualization 4, 
1–185. https://doi.org/10.2200/s00685ed1v01y201512vis005 
Sedig, K., Parsons, P., 2013. Interaction Design for Complex Cognitive Activities with 
Visual Representations: A Pattern-Based Approach. AIS Transactions on Human-
Computer Interaction 5, 84–133. https://doi.org/10.17705/1thci.00055 
Sedig, K., Parsons, P., Babanski, A., 2012. Towards a Characterization of Interactivity in 
Visual Analytics. JMPT 3, 12–28. 
Seiffert, C., Khoshgoftaar, T.M., Van Hulse, J., Napolitano, A., 2010. RUSBoost: A 
Hybrid Approach to Alleviating Class Imbalance. IEEE Trans. Syst., Man, 
Cybern. A 40, 185–197. https://doi.org/10.1109/TSMCA.2009.2029559 
Selby, Nicholas M., Crowley, L., Fluck, R.J., McIntyre, C.W., Monaghan, J., Lawson, N., 
Kolhe, N. V., 2012. Use of electronic results reporting to diagnose and monitor 
AKI in hospitalized patients. Clinical Journal of the American Society of 
Nephrology 7, 533–540. https://doi.org/10.2215/CJN.08970911 
Selby, N. M., Crowley, L., Fluck, R.J., McIntyre, C.W., Monaghan, J., Lawson, N., 
Kolhe, N. V., 2012. Use of Electronic Results Reporting to Diagnose and Monitor 
AKI in Hospitalized Patients. Clinical Journal of the American Society of 
Nephrology 7, 533–540. https://doi.org/10.2215/CJN.08970911 
213 
 
 
 
Sembiring, R.W., Zain, J.M., Embong, A., 2011. Dimension Reduction of Health Data 
Clustering. arXiv:1110.3569 [cs]. 
Seo, J., Shneiderman, B., 2003. Interactively Exploring Hierarchical Clustering Results, 
in: The Craft of Information Visualization. Elsevier, pp. 334–340. 
https://doi.org/10.1016/B978-155860915-0/50042-1 
Shepard, R.N., 1962. The analysis of proximities: Multidimensional scaling with an 
unknown distance function. II. Psychometrika 27, 219–246. 
https://doi.org/10.1007/BF02289621 
Shickel, B., Tighe, P.J., Bihorac, A., Rashidi, P., 2018. Deep EHR: A Survey of Recent 
Advances in Deep Learning Techniques for Electronic Health Record (EHR) 
Analysis. IEEE J Biomed Health Inform 22, 1589–1604. 
https://doi.org/10.1109/JBHI.2017.2767063 
Shulenberger, C.E., Jiang, A., Devabhakthuni, S., Ivaturi, V., Liu, T., Reed, B.N., 2016. 
Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in 
Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance. 
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36, 
852–860. https://doi.org/10.1002/phar.1798 
Siddiqui, N.F., Coca, S.G., Devereaux, P.J., Jain, A.K., Li, L., Luo, J., Parikh, C.R., 
Paterson, M., Thiessen Philbrook, H., Wald, R., Walsh, M., Whitlock, R., Garg, 
A.X., 2012. Secular trends in acute dialysis after elective major surgery - 1995 to 
2009. CMAJ 184, 1237–1245. https://doi.org/10.1503/cmaj.110895 
Siegel, E., 2013. Predictive analytics: The power to predict who will click, buy, lie, or 
die. John Wiley & Sons. 
Siew, E.D., Fissell, W.H., Tripp, C.M., Blume, J.D., Wilson, M.D., Clark, A.J., Vincz, 
A.J., Ely, E.W., Pandharipande, P.P., Girard, T.D., 2017. Acute Kidney Injury as 
a Risk Factor for Delirium and Coma during Critical Illness. Am J Respir Crit 
Care Med 195, 1597–1607. https://doi.org/10.1164/rccm.201603-0476OC 
Siew, E.D., Parr, S.K., Abdel-Kader, K., Eden, S.K., Peterson, J.F., Bansal, N., Hung, 
A.M., Fly, J., Speroff, T., Ikizler, T.A., Matheny, M.E., 2016. Predictors of 
Recurrent AKI. Journal of the American Society of Nephrology : JASN 27, 1190–
200. https://doi.org/10.1681/ASN.2014121218 
Simpao, A.F., Ahumada, L.M., Desai, B.R., Bonafide, C.P., Gálvez, J.A., Rehman, M.A., 
Jawad, A.F., Palma, K.L., Shelov, E.D., 2015. Optimization of drug-drug 
interaction alert rules in a pediatric hospital’s electronic health record system 
using a visual analytics dashboard. J Am Med Inform Assoc 22, 361–369. 
https://doi.org/10.1136/amiajnl-2013-002538 
214 
 
 
 
Simpao, A. F., Ahumada, L.M., Desai, B.R., Bonafide, C.P., Galvez, J.A., Rehman, 
M.A., Jawad, A.F., Palma, K.L., Shelov, E.D., 2014. Optimization of drug-drug 
interaction alert rules in a pediatric hospital’s electronic health record system 
using a visual analytics dashboard. Journal of the American Medical Informatics 
Association. https://doi.org/10.1136/amiajnl-2013-002538 
Simpao, Allan F., Ahumada, L.M., Gálvez, J.A., Rehman, M.A., 2014. A review of 
analytics and clinical informatics in health care. J Med Syst 38, 45. 
https://doi.org/10.1007/s10916-014-0045-x 
Singer, A., Duarte Fernandez, R., 2015. The effect of electronic medical record system 
use on communication between pharmacists and prescribers. BMC Family 
Practice 16. https://doi.org/10.1186/s12875-015-0378-7 
Siwek, K., Osowski, S., Markiewicz, T., Korytkowski, J., 2013. Analysis of medical data 
using dimensionality reduction techniques. Przegląd Elektrotechniczny 89, 279–
281. 
Sorzano, C.O.S., Vargas, J., Montano, A.P., 2014. A survey of dimensionality reduction 
techniques. arXiv:1403.2877 [cs, q-bio, stat]. 
Soyiri, I.N., Reidpath, D.D., 2013. An overview of health forecasting. Environ Health 
Prev Med 18, 1–9. https://doi.org/10.1007/s12199-012-0294-6 
Spasic, I., Nenadic, G., 2020. Clinical Text Data in Machine Learning: Systematic 
Review. JMIR Medical Informatics 8, e17984. https://doi.org/10.2196/17984 
Spence, R., 2002. Sensitivity encoding to support information space navigation: A design 
guideline. Information Visualization 1, 120–129. 
https://doi.org/10.1057/palgrave.ivs.9500019 
Stasko, J., Görg, C., Liu, Z., 2008. Jigsaw: Supporting Investigative Analysis through 
Interactive Visualization. Information Visualization 7, 118–132. 
https://doi.org/10.1057/palgrave.ivs.9500180 
Steinhäuslin, F., Munafo, A., Buclin, T., Macciocchi, A., Biollaz, J., 1993. Renal effects 
of nimesulide in furosemide-treated subjects. Drugs 46 Suppl 1, 257–62. 
https://doi.org/10.2165/00003495-199300461-00066 
Tandon, V.R., Khajuria, V., Mahajan, V., Sharma, A., Gillani, Z., Mahajan, A., 2015. 
Drug-induced diseases (DIDs): An experience of a tertiary care teaching hospital 
from India. Indian Journal of Medical Research 142, 33–39. 
https://doi.org/10.4103/0971-5916.162093 
Tang, P.C., McDonald, C.J., 2006. Electronic health record systems, in: Shortliffe, E.H., 
Cimino, J.J. (Eds.), Biomedical Informatics: Computer Applications in Health 
215 
 
 
 
Care and Biomedicine, Health Informatics. Springer New York, New York, NY, 
pp. 447–475. https://doi.org/10.1007/0-387-36278-9_12 
Thomas, J.J., Cook, K.A., 2006. A visual analytics agenda. IEEE Computer Graphics and 
Applications 26, 10–13. https://doi.org/10.1109/MCG.2006.5 
Thomas, J.J., Cook, K.A., 2005. Illuminating the Path: The Research and Development 
Agenda for Visual Analytics. 
Tia Gao, Greenspan, D., Welsh, M., Juang, R.R., Alm, A., 2005. Vital signs monitoring 
and patient tracking over a wireless network, in: 2005 IEEE Engineering in 
Medicine and Biology 27th Annual Conference. Presented at the 2005 IEEE 
Engineering in Medicine and Biology 27th Annual Conference, pp. 102–105. 
https://doi.org/10.1109/IEMBS.2005.1616352 
Timmerman, M.E., Ceulemans, E., Kiers, H.A., Vichi, M., 2010. Factorial and reduced 
K-means reconsidered. Computational Statistics & Data Analysis 54, 1858–1871. 
Tomar, D., Agarwal, S., 2013. A survey on data mining approaches for healthcare. 
International Journal of Bio-Science and Bio-Technology 5, 241–266. 
https://doi.org/10.14257/ijbsbt.2013.5.5.25 
Tominski, C., 2015. Interaction for Visualization. Synthesis Lectures on Visualization 3, 
1–107. https://doi.org/10.2200/S00651ED1V01Y201506VIS003 
Torgerson, W.S., 1958. Theory and methods of scaling, Theory and methods of scaling. 
Wiley, Oxford, England. 
Tran, N.K., Sen, S., Palmieri, T.L., Lima, K., Falwell, S., Wajda, J., Rashidi, H.H., 2019. 
Artificial intelligence and machine learning for predicting acute kidney injury in 
severely burned patients: A proof of concept. Burns 45, 1350–1358. 
https://doi.org/10.1016/j.burns.2019.03.021 
Turner, A.M., Stavri, Z., Revere, D., Altamore, R., 2008. From the ground up: 
information needs of nurses in a rural public health department in Oregon. J Med 
Libr Assoc 96, 335–342. https://doi.org/10.3163/1536-5050.96.4.008 
Uchino, S., Kellum, J.A., Bellomo, R., Doig, G.S., Morimatsu, H., Morgera, S., Schetz, 
M., Tan, I., Bouman, C., Macedo, E., Gibney, N., Tolwani, A., Ronco, C., 
Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) 
Investigators, 2005. Acute renal failure in critically ill patients: a multinational, 
multicenter study. JAMA 294, 813–8. https://doi.org/10.1001/jama.294.7.813 
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., 
Madabhushi, A., Shah, P., Spitzer, M., Zhao, S., 2019. Applications of machine 
216 
 
 
 
learning in drug discovery and development. Nature Reviews Drug Discovery. 
https://doi.org/10.1038/s41573-019-0024-5 
Van der Corput, P., Arends, J., Van Wijk, J.J., 2014. Visualization of Medicine 
Prescription Behavior. Computer Graphics Forum 33, 161–170. 
https://doi.org/10.1111/cgf.12372 
Vanderperren, B., Rizzo, M., Angenot, L., Haufroid, V., Jadoul, M., Hantson, P., 2005. 
Acute Liver Failure with Renal Impairment Related to the Abuse of Senna 
Anthraquinone Glycosides. Ann Pharmacother 39, 1353–1357. 
https://doi.org/10.1345/aph.1E670 
Varga, M., Varga, C., 2016. Visual Analytics: Data, Analytical and Reasoning 
Provenance. pp. 141–150. https://doi.org/10.1007/978-3-319-40226-0_9 
Verdoodt, A., Honore, P.M., Jacobs, R., Waele, E. De, Gorp, V. Van, Regt, J. De, 
Spapen, H.D., 2018. Do statins induce or protect from acute kidney injury and 
chronic kidney disease: An update review in 2018. Journal of Translational 
Internal Medicine 6, 21–25. https://doi.org/10.2478/jtim-2018-0005 
Vichi, M., Kiers, H.A., 2001. Factorial k-means analysis for two-way data. 
Computational Statistics & Data Analysis 37, 49–64. 
Waikar, S.S., Curhan, G.C., Wald, R., McCarthy, E.P., Chertow, G.M., 2006. Declining 
mortality in patients with acute renal failure, 1988 to 2002. Journal of the 
American Society of Nephrology : JASN 17, 1143–50. 
https://doi.org/10.1681/ASN.2005091017 
Wang, C., Deng, C., Wang, S., 2019. Imbalance-XGBoost: Leveraging Weighted and 
Focal Losses for Binary Label-Imbalanced Classification with XGBoost. 
arXiv:1908.01672 [cs, stat]. 
Wang, C., Wang, S., Shi, F., Wang, Z., 2018. Robust Propensity Score Computation 
Method based on Machine Learning with Label-corrupted Data. 
arXiv:1801.03132 [cs, stat]. 
Wang, C.-W., Lee, Y.-C., Calista, E., Zhou, F., Zhu, H., Suzuki, R., Komura, D., 
Ishikawa, S., Cheng, S.-P., 2018. A benchmark for comparing precision medicine 
methods in thyroid cancer diagnosis using tissue microarrays. Bioinformatics 34, 
1767–1773. https://doi.org/10.1093/bioinformatics/btx838 
Wang, S., Yao, X., 2009. Diversity analysis on imbalanced data sets by using ensemble 
models, in: 2009 IEEE Symposium on Computational Intelligence and Data 
Mining. Presented at the 2009 IEEE Symposium on Computational Intelligence 
and Data Mining, pp. 324–331. https://doi.org/10.1109/CIDM.2009.4938667 
217 
 
 
 
Wang, T.D., Plaisant, C., Quinn, A.J., Stanchak, R., Murphy, S., Shneiderman, B., 2008. 
Aligning temporal data by sentinel events: Discovering patterns in electronic 
health records, in: Proceedings of the SIGCHI Conference on Human Factors in 
Computing Systems, CHI ’08. ACM, New York, NY, USA, pp. 457–466. 
https://doi.org/10.1145/1357054.1357129 
Wang, T.D., Plaisant, C., Shneiderman, B., Spring, N., Roseman, D., Marchand, G., 
Mukherjee, V., Smith, M., 2009. Temporal summaries: supporting temporal 
categorical searching, aggregation and comparison. IEEE Transactions on 
Visualization and Computer Graphics 15, 1049–1056. 
https://doi.org/10.1109/TVCG.2009.187 
Wang, Y., Kung, L., Byrd, T.A., 2018. Big data analytics: Understanding its capabilities 
and potential benefits for healthcare organizations. Technological Forecasting and 
Social Change 126, 3–13. https://doi.org/10.1016/j.techfore.2015.12.019 
Watanabe, R., Takahashi, K., Tada, K., Ishimura, A., 2014. A case of acute kidney injury 
associated with the use of oseltamivir and clarithromycin that was treated by 
hemodialysis. Nihon Toseki Igakkai Zasshi 47, 755–759. 
https://doi.org/10.4009/jsdt.47.755 
Wenskovitch, J., Crandell, I., Ramakrishnan, N., House, L., Leman, S., North, C., 2018. 
Towards a Systematic Combination of Dimension Reduction and Clustering in 
Visual Analytics. IEEE Trans. Visual. Comput. Graphics 24, 131–141. 
https://doi.org/10.1109/TVCG.2017.2745258 
Wetzel, R.C., 2001. The virtual pediatric intensive care unit: Practice in the new 
millennium. Pediatric Clinics 48, 795–814. 
Wilke, C.O., 2019. Fundamentals of Data Visualization: A Primer on Making 
Informative and Compelling Figures, 1 edition. ed. O’Reilly Media, Sebastopol, 
CA. 
Wilkinson, L., 2015. Classification and Regression Trees 23. 
Williams, D.A., McCullagh, P., Nelder, J.A., 1984. Generalized Linear Models. 
Biometrics 40, 566. https://doi.org/10.2307/2531415 
Wilson, J.R., 2014. Fundamentals of systems ergonomics/human factors. Applied 
Ergonomics 45, 5–13. https://doi.org/10.1016/j.apergo.2013.03.021 
Wise, J.A., 1999. The ecological approach to text visualization. Journal of the American 
Society for Information Science 50, 1224–1233. 
218 
 
 
 
Wongsuphasawat, K., 2009. Finding comparable patient histories: A temporal categorical 
similarity measure with an interactive visualization, in: IEEE Symposium on 
Visual Analytics Science and Technology (VAST). 
Wongsuphasawat, K., Gotz, D., 2012. Exploring flow, factors, and outcomes of temporal 
event sequences with the Outflow visualization. IEEE Transactions on 
Visualization and Computer Graphics 18, 2659–2668. 
https://doi.org/10.1109/TVCG.2012.225 
Wongsuphasawat, K., Gotz, D., 2011. Outflow: Visualizing patient flow by symptoms 
and outcome, in: IEEE VisWeek Workshop on Visual Analytics in Healthcare, 
Providence, Rhode Island, USA. American Medical Informatics Association, pp. 
25–28. 
Wongsuphasawat, K., Guerra Gómez, J.A., Plaisant, C., Wang, T.D., Taieb-Maimon, M., 
Shneiderman, B., 2011. LifeFlow: visualizing an overview of event sequences, in: 
Proceedings of the SIGCHI Conference on Human Factors in Computing 
Systems, CHI ’11. ACM, New York, NY, USA, pp. 1747–1756. 
https://doi.org/10.1145/1978942.1979196 
Wu, X., Zhang, W., Ren, H., Chen, X., Xie, J., Chen, N., 2014. Diuretics associated acute 
kidney injury: clinical and pathological analysis. Renal failure 36, 1051–5. 
https://doi.org/10.3109/0886022X.2014.917560 
Xin Geng, De-Chuan Zhan, Zhi-Hua Zhou, 2005. Supervised nonlinear dimensionality 
reduction for visualization and classification. IEEE Transactions on Systems, 
Man, and Cybernetics, Part B (Cybernetics) 35, 1098–1107. 
https://doi.org/10.1109/TSMCB.2005.850151 
Xue, J.L., Daniels, F., Star, R.A., Kimmel, P.L., Eggers, P.W., Molitoris, B.A., 
Himmelfarb, J., Collins, A.J., 2006. Incidence and mortality of acute renal failure 
in Medicare beneficiaries, 1992 to 2001. Journal of the American Society of 
Nephrology : JASN 17, 1135–42. https://doi.org/10.1681/ASN.2005060668 
Yamada, H., Katsumori, Y., Kawano, M., Mori, S., Takeshige, R., Mukai, J., Imada, H., 
Shimoura, H., Takahashi, H., Horai, T., 2018. Quetiapine-related Acute Kidney 
Injury Requiring Transient Continuous Hemodiafiltration. Internal Medicine 57, 
1763–1767. 
Yan, J., Zhang, B., Liu, N., Yan, S., Cheng, Q., Fan, W., Yang, Q., Xi, W., Chen, Z., 
2006. Effective and efficient dimensionality reduction for large-scale and 
streaming data preprocessing. IEEE transactions on Knowledge and Data 
Engineering 18, 320–333. 
219 
 
 
 
Yokota, L.G., Sampaio, B.M., Rocha, E.P., Balbi, A.L., Sousa Prado, I.R., Ponce, D., 
2018. Acute kidney injury in elderly patients: narrative review on incidence, risk 
factors, and mortality. Int J Nephrol Renovasc Dis 11, 217–224. 
https://doi.org/10.2147/IJNRD.S170203 
Yoo, I., Alafaireet, P., Marinov, M., Pena-Hernandez, K., Gopidi, R., Chang, J.F., Hua, 
L., 2012. Data mining in healthcare and biomedicine: A survey of the literature. 
Journal of Medical Systems 36, 2431–2448. https://doi.org/10.1007/s10916-011-
9710-5 
Zaleska-Kociecka, M., Dabrowski, M., Stepinska, J., 2019. Acute kidney injury after 
transcatheter aortic valve replacement in the elderly: outcomes and risk 
management. Clin Interv Aging 14, 195–201. 
https://doi.org/10.2147/CIA.S149916 
Zhang, L., Stoffel, A., Behrisch, M., Mittelstadt, S., Schreck, T., Pompl, R., Weber, S., 
Last, H., Keim, D., 2012. Visual analytics for the big data era — A comparative 
review of state-of-the-art commercial systems, in: 2012 IEEE Conference on 
Visual Analytics Science and Technology (VAST). Presented at the 2012 IEEE 
Conference on Visual Analytics Science and Technology (VAST), pp. 173–182. 
https://doi.org/10.1109/VAST.2012.6400554 
Zhang, X., Donnan, P.T., Bell, S., Guthrie, B., 2017. Non-steroidal anti-inflammatory 
drug induced acute kidney injury in the community dwelling general population 
and people with chronic kidney disease: systematic review and meta-analysis. 
BMC Nephrology 18, 256. https://doi.org/10.1186/s12882-017-0673-8 
Zhou, J., Konecni, S., Grinstein, G., 2009. Visually comparing multiple partitions of data 
with applications to clustering, in: Visualization and Data Analysis 2009. 
International Society for Optics and Photonics, p. 72430J. 
Zitnik, M., Agrawal, M., Leskovec, J., 2018. Modeling polypharmacy side effects with 
graph convolutional networks, in: Bioinformatics. Oxford University Press, pp. 
i457–i466. https://doi.org/10.1093/bioinformatics/bty294 
Zulman, D.M., Asch, S.M., Martins, S.B., Kerr, E.A., Hoffman, B.B., Goldstein, M.K., 
2014. Quality of care for patients with multiple chronic conditions: The role of 
comorbidity interrelatedness. Journal of General Internal Medicine 29, 529–537. 
https://doi.org/10.1007/s11606-013-2616-9 
 
220 
 
 
 
Appendices 
Appendix A: List of databases held at ICES. 
Data Source Description Study Purpose 
Canadian Institute for Health 
Information Discharge 
Abstract Database and 
National Ambulatory Care 
Reporting System 
 
The Canadian Institute for Health Information Discharge Abstract 
Database and National Ambulatory Care Reporting System collect 
diagnostic and procedural variables for inpatient stays and ED visits, 
respectively. Diagnostic and inpatient procedural coding use the 10th 
version of the Canadian Modified International Classification of Disease 
system 10th Revision (after 2002). 
Cohort creation, 
description, exposure, 
and outcome 
estimation 
Ontario Drug Benefits 
The Ontario Drug Benefits database includes a wide range of outpatient 
prescription medications available to all Ontario citizens over the age of 
65. The error rate in the Ontario Drug Benefits database is less than 1%. 
Medication 
prescriptions, 
description, and 
exposure 
Registered Persons Database 
 
The Registered Persons Database captures demographic (sex, date of 
birth, postal code) and vital status information on all Ontario residents. 
Relative to the Canadian Institute for Health Information Discharge 
Abstract Database in-hospital death flag, the Registered Persons 
Database has a sensitivity of 94% and a positive predictive value of 
100%. 
Cohort creation, 
description, and 
exposure 
Ontario Health Insurance 
Plan 
The Ontario Health Insurance Plan database contains information on 
Ontario physician billing claims for medical services using fee and 
diagnosis codes outlined in the Ontario Health Insurance Plan Schedule 
of Benefits. These codes capture information on outpatient, inpatient, 
and laboratory services rendered to a patient. 
Cohort creation, 
stratification, 
description, exposure, 
and outcome 
Appendix B: Coding definitions for co-morbid conditions. 
Variable Database Code Set Code 
Major cancer 
Canadian Institute for 
Health Information 
Discharge Abstract 
Database 
International Classification of 
Diseases 9th Revision 
150, 154, 155, 157, 162, 174, 175, 185, 203, 
204, 205, 206, 207, 208, 2303, 2304, 2307, 
2330, 2312, 2334 
International Classification of 
Diseases 10th Revision 
971, 980, 982, 984, 985, 986, 987, 988, 989, 
990, 991, 993, C15, C18, C19, C20, C22, C25, 
C34, C50, C56, C61, C82, C83, C85, C91, C92, 
C93, C94, C95, D00, D010, D011, D012, D022, 
D075, D05 
Ontario Health Insurance 
Plan 
Diagnosis 
203, 204, 205, 206, 207, 208, 150, 154, 155, 
157, 162, 174, 175, 183, 185 
Chronic liver 
disease 
Canadian Institute for 
Health Information 
Discharge Abstract 
Database 
International Classification of 
Diseases 9th Revision 
4561, 4562, 070, 5722, 5723, 5724, 5728, 573, 
7824, V026, 571, 
2750, 2751, 7891, 7895 
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International Classification of 
Diseases 10th Revision 
B16, B17, B18, B19, I85, R17, R18, R160, 
R162, B942, Z225, E831, E830, K70, K713, 
K714, K715, K717, K721, K729, K73, K74, 
K753, K754, K758, K759, K76, K77 
Ontario Health Insurance 
Plan 
Diagnosis 571, 573, 070 
Fee code Z551, Z554 
Coronary artery 
disease 
(excluding 
angina) 
Canadian Institute for 
Health Information 
Discharge Abstract 
Database 
Canadian Classification of 
Diagnostic, Therapeutic and 
Surgical Procedures 
4801, 4802, 4803, 4804, 4805, 481, 482, 483 
Canadian Classification of 
Health Interventions 
1IJ50, 1IJ76 
International Classification of 
Diseases 9th Revision 
412, 410, 411 
International Classification of 
Diseases 10th Revision 
I21, I22, Z955, T822 
Ontario Health Insurance 
Plan 
 
Diagnosis 410, 412 
Fee code 
R741, R742, R743, G298, E646, E651, E652, 
E654, E655, Z434, 
Z448 
Diabetes 
 
Canadian Institute for 
Health Information 
Discharge Abstract 
Database 
International Classification of 
Diseases 9th Revision 
250 
International Classification of 
Diseases 10th Revision 
E10, E11, E13, E14 
Ontario Health Insurance 
Plan 
Diagnosis 250 
Fee code Q040, K029, K030, K045, K046 
Heart failure 
Canadian Institute for 
Health Information 
Discharge Abstract 
Database 
 
Canadian Classification of 
Diagnostic, Therapeutic and 
Surgical Procedures 
4961, 4962, 4963, 4964 
 
Canadian Classification of 
Health Interventions 
1HP53, 1HP55, 1HZ53GRFR, 1HZ53LAFR, 
1HZ53SYFR 
International Classification of 
Diseases 9th Revision 
I500, I501, I509, I255, J81 
International Classification of 
Diseases 10th Revision 
I21, I22, Z955, T822 
Ontario Health Insurance 
Plan 
Diagnosis 428 
Fee code R701, R702, Z429 
Hypertension 
Canadian Institute for 
Health Information 
International Classification of 
Diseases 9th Revision 
401, 402, 403, 404, 405 
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Discharge Abstract 
Database International Classification of 
Diseases 10th Revision 
I10, I11, I12, I13, I15 
Ontario Health Insurance 
Plan 
Diagnosis 401, 402, 403 
Kidney stones 
Canadian Institute for 
Health Information 
Discharge Abstract 
Database 
 
International Classification of 
Diseases 9th Revision 
5920, 5921, 5929, 5940, 5941, 5942, 5948, 
5949, 27411 
International Classification of 
Diseases 10th Revision 
N200 , N201 , N202 ,  N209 ,  N210 ,  N211 ,  
N218 ,  N219 , N220 , N228 
Peripheral 
vascular disease 
 
Canadian Institute for 
Health Information 
Discharge Abstract 
Database 
 
Canadian Classification of 
Diagnostic, Therapeutic and 
Surgical Procedures 
5125, 5129, 5014, 5016, 5018, 5028, 5038, 
5126, 5159 
Canadian Classification of 
Health Interventions 
1KA76, 1KA50, 1KE76, 1KG50, 1KG57, 
1KG76MI, 1KG87, 1IA87LA, 1IB87LA, 
1IC87LA, 1ID87LA, 1KA87LA, 1KE57 
International Classification of 
Diseases 9th Revision 
4402, 4408, 4409, 5571, 4439, 444 
International Classification of 
Diseases 10th Revision 
I700, I702, I708, I709, I731, I738, I739, K551 
Ontario Health Insurance 
Plan 
 
Fee code 
R787, R780, R797, R804, R809, R875, R815, 
R936, R783, R784, R785, E626, R814, R786, 
R937, R860, R861, R855, R856, R933, R934, 
R791, E672, R794, R813, R867, E649 
Cerebrovascular 
disease (stroke 
or transient 
ischemic attack) 
 
Canadian Institute for 
Health Information 
Discharge Abstract 
Database 
 
International Classification of 
Diseases 9th Revision 
430, 431, 432, 4340, 4341, 4349, 435, 436, 3623 
International Classification of 
Diseases 10th Revision 
I62, I630, I631, I632, I633, I634, I635, I638, 
I639, I64, H341, I600, I601, I602, I603, I604, 
I605, I606, I607, I609, I61, G450, G451, G452, 
G453, G458, G459, H340 
Chronic kidney 
disease 
Canadian Institute for 
Health Information 
Discharge Abstract 
Database 
 
International Classification of 
Diseases 9th Revision 
4030, 4031, 4039, 4040, 4041, 4049, 585, 586, 
5888, 5889, 2504 
International Classification of 
Diseases 10th Revision 
E102, E112, E132, E142, I12, I13, N08, N18, 
N19 
Ontario Health Insurance 
Plan 
Diagnosis 403, 585 
Appendix C: Diagnostic codes for exclusion criteria. 
Variable Database Code Set Code 
Dialysis 
Canadian Institute 
for Health 
Information 
Canadian 
Classification of 
Diagnostic, 
5127, 5142, 5143, 5195, 6698 
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Discharge Abstract 
Database 
Therapeutic and 
Surgical Procedures 
Canadian 
Classification of 
Health Interventions 
1PZ21, 1OT53DATS, 1OT53HATS, 1OT53LATS, 1SY55LAFT, 
7SC59QD, 1KY76, 1KG76MZXXA, 1KG76MZXXN, 1JM76NC, 
1JM76NCXXN 
International 
Classification of 
Diseases 9th Revision 
V451, V560, V568, 99673 
International 
Classification of 
Diseases 10th 
Revision 
T824, Y602, Y612, Y622, Y841, Z49, Z992 
Ontario Health 
Insurance Plan 
Fee code 
R850, G324, G336, G327, G862, G865, G099, R825, R826, R827, 
R833, R840, R841, R843, R848, R851, R946, R943, R944, R945, 
R941, R942, Z450, Z451, Z452, G864, R852, R853, R854, R885, 
G333, H540, H740, R849, G323, G325, G326, G860, G863, G866, 
G330, G331, G332, G861, G082, G083, G085, G090, G091, G092, 
G093, G094, G095, G096, G294, G295 
Kidney 
transplant 
Canadian Institute 
for Health 
Information 
Discharge Abstract 
Database 
Canadian 
Classification of 
Health Interventions 
1PC85 
Ontario Health 
Insurance Plan 
Fee code S435, S434 
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